Minimal Genome Design and Engineering:Algorithms and whole-cell Models by Rees-Garbutt, Joshua P
                          
This electronic thesis or dissertation has been





Minimal Genome Design and Engineering
Algorithms and whole-cell Models
General rights
Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License.   A
copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode  This license sets out your rights and the
restrictions that apply to your access to the thesis so it is important you read this before proceeding.
Take down policy
Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research.
However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of
a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity,
defamation, libel, then please contact collections-metadata@bristol.ac.uk and include the following information in your message:
•	Your contact details
•	Bibliographic details for the item, including a URL
•	An outline nature of the complaint
Your claim will be investigated and, where appropriate, the item in question will be removed from public view as soon as possible.
  
  
Minimal  Genome  Design  and   
Engineering:   
Algorithms  and  whole-cell  Models   
  
  











A  dissertation  submitted  to  the  University  of  Bristol  in  accordance  with  the   




School  of  Biological  Sciences,     
September  2020   
  








Abstract     
Tailoring  entire  genomes  to  produce  custom-made  cells  is  now  on  the  horizon.  This   
level  of  control  and  understanding  has  been  a  goal  for  biologists  since  the  publication   
of  the  first  genome  sequence  in  1977.  The  field  of  genetics  has  expanded  and  grown   
since,  advancing  with  the  progress  of  genetic  sequencing,  synthesis,  and  editing,  and   
with  the  discipline  of  synthetic  biology  emerging  following  the  millennium.  The  editing   
and  sequencing  barriers  to  designing  cells  reduced  dramatically  in  the  early  2010s,  with   
the  publication  of  CRISPR-cas9  and  the  development  of  the  MinION  sequencer.     
  
However,  entire  genome  design  still  alludes  us.  Genome  engineering  progresses  by   
systematic  comparison  of  experimental  results.  The  complexity  and  lack  of  knowledge   
of  gene  interactions  still  causes  unexpected  results.  Libraries  of  genetic  knockouts  can   
only  scale  to  encompass  all  possible  double  gene  knockouts,  before  becoming   
economically  infeasible,  restricting  data  collection.   
  
The  publication  of  the  first  whole-cell  model  in  2012  (for  Mycoplasma  genitalium ),   
combined  with  the  availability  and  advancement  of  supercomputers  from  the   
mid-2000s,  offers  a  way  to  tackle  the  complexity  of  gene  interactions.  It  also  allows   
genome  engineers  the  possibility  to  emulate  the  work  of  metabolic  engineers,  who  have   
an  established  cycle  of  in-silico  design  and  in-vivo  editing  for  their  more  constrained,   
sub-cellular  systems.     
  
In  this  thesis,  I  design  entire  genomes  in-silico  by  producing  a  genome  design  algorithm   
to  guide  thousands  of  whole-cell  model  simulations  running  on  supercomputers.  I  also   
simulate  theoretical  minimal  genomes  that  have  never  been  tested;  and  produce   
preliminary  data  from  the  second  whole-cell  model  (for  Escherichia  coli ).   
  
This  thesis  aims  to  show  that  it  is  now  possible  to  design  entire  genomes  in-silico .  The   
combination  of  in-silico  (genome  design  algorithms,  whole-cell  models,   
supercomputers)  and  in-vivo  (CRISPR-cas9  genetic  editing,  MinION  genetic   
sequencing)  components  means  the  stage  is  now  set  for  the  in-vivo  production  of   
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Chapter  1  -  Introduction   
1.1 Statement  of  Collaboration     
Sections  of  the  Introduction  have  previously  been  published  with  the  author  of  this   
thesis  as  the  lead  or  co-first  author.  The  publications  and  contributions  are  listed  below.   
The  sections  reproduced  here  are  solely  this  author's  work.     
● Landon,  S.,  Rees-Garbutt,  J.,  Marucci,  L.  &  Grierson,  C.  Genome-driven  cell   
engineering  review:  in  vivo  and  in  silico  metabolic  and  genome  engineering.   
Essays  Biochem.  63 ,  267–284  (2019).   
○ Co-first  author.   
● Rees-Garbutt,  J.  et  al .  Designing  minimal  genomes  using  whole-cell  models.   
Nat.  Commun .  11 ,  836  (2020).   
○ Lead  author   
● Rees-Garbutt,  J.,  Grierson,  C.  &  Marucci,  L.  Testing  theoretical  minimal   
genomes  using  whole-cell  models.  bioRxiv.  doi:10.1101/2020.03.26.010363   
(2020).   
○ Lead  author     
● Rees-Garbutt,  J.  Minesweeper  Genome  Design  Algorithm.  Github .   
https://github.com/squishybinary/Minesweeper  (2020).   
○ Lead  author   
  
1.2 Genome  Design:  Prior  State  of  the  Field     
Genome  engineering  is  the  extensive  and  intentional  genetic  modification  of  a   
replicating  system  for  a  specific  purpose  1 .  Genome  design  is  the  selection  of  the   
genetic  modifications  to  produce  the  specified  purpose.  Currently,  genome  engineering   
progresses  by  systematic  comparison  of  experimental  results,  with  genome  design   
primarily  occurring  in  the  initial  stage  of  experiments.  In  comparison,  metabolic   
engineering  has  an  established  process  of  cycling  between  in-silico  design  (100s  of   
models,  10s  of  algorithms)  2,3   and  in-vivo  editing  (100s  of  strains  of  several  bacterial   
species)  4 .  The  designs  can  be  tested  in-silico  before  they  are  implemented  in  the  lab   
(which  is  cheaper  and  faster  if  the  computational  infrastructure  is  available),  reducing   
the  quantity  of  lab  experimentation  and  decreasing  the  risk  of  errors  5 .  To  do  this,  you   
19   
  
need  a  model  of  the  cell,  an  algorithm  (analogous  to  a  recipe,  a  series  of  steps  that   
solves  a  problem),  and  adequate  genetic  tools  to  recreate  the  resulting  design  in  living   
cells.   
  
The  development  of  whole-cell  mathematical  models  6   and  CRISPR-cas9  gene  editing   
techniques  7–9 ,  could  result  in  a  similar  combination  of  experimental  biological  research   
and  computational  mathematical  modelling  ( in-silico  design  and  in-vivo  editing)  for   
genome  engineering.  At  the  start  of  this  project,  models  and  genome  engineering  tools   
were  available,  but  algorithms  for  genome  design  had  not  been  developed.   
  
To  create  an  algorithm  we  need  to  have  a  genome  engineering  problem  to  solve.   
Minimal  genomes,  cells  containing  only  the  DNA  essential  to  survive  until  successful   
division,  are  the  best  proof-of-concept  for  genome  engineering  as  they  have  a  simple   
functionality  assessment,  the  cell  either  replicates  or  not  10 .  Mycoplasma  genitalium   
( M.genitalium )  is  used  in  minimal  genome  research  as  it  has  the  smallest  genome  of  any   
naturally  occurring,  self  replicating  organism.  This  has  made  it  the  basis  for  minimal   
gene  sets  and  the  first  whole-cell  model  6 ,  but  little  other  progress  has  been  made  with   
the  species  as  it  is  difficult  to  use  experimentally  11–13 .     
  
1.3 Genome-driven  Cell  Engineering   
Synthetic  biology  is  the  rational  design  and  engineering  of  cells  and  cellular  systems   
using  genetic  manipulations  14,15 .  It  is  divided  into  three  fields  16   :  DNA-based  device   
construction  (production  of  functioning  biological  components  to  be  inserted  into  cells),   
synthetic  protocell  development  (construction  of  rudimentary  representations  of  living   
cells),  and  genome-driven  cell  engineering.  For  more  about  DNA-based  device   
construction  principles  see  Brophy  and  Voight  17   and  for  an  introduction  to  protocell   
development  see  Dzieciol  and  Mann  18 .  To  introduce  this  thesis,  I  will  focus  on   
genome-driven  cell  engineering.  Table  1  provides  a  summary  of  the  key  terms  in  the   
field.     
  
Genome-driven  cell  engineering  encompasses  both  metabolic  engineering  (control  of  
cellular  production  processes)  and  genome  engineering  (production  of  minimal   
20   
  
genomes,  recoded  genomes,  and  cellular  chassis/factories).  It  encompasses  diverse   
types  and  scales  of  genetic  modifications  and  underscores  the  genome  as  the  major   
driver  of  cellular  events  16 .  Metabolic  engineering  attempts  to  improve  titre,   
accumulation  rate,  and  yield  of  a  specific  metabolite,  often  from  microorganisms  in  an   
industrial  setting  19 .  Genome  engineering  attempts  to  generate  understanding,  reduce   
risks,  and  improve  metabolite  production.  Minimal  genome  research  generates   
understanding  by  comprehending  biology  through  the  engineering  of  cellular  systems   
20 .  Recoding  genomes  produces  reduced  risk  by  restricting  bacteria  to  specific  media   
and  preventing  viral  transformation  21 .  “Optimal”  chassis  cell  development  produces   
improved  metabolite  production  through  a  variety  of  means  22 .   
  
Genome  engineering    Extensive  and  intentional  genetic  modification  of  a  replicating  system  for  a  specific   purpose  1 .   
Metabolic  engineering      Enhances  the  production  of  native  or  introduced  metabolites,  often  in  a  microbial   strain  19 .   
Minimal  genomes   
Reduced  genomes  containing  only  the  genetic  material  essential  for  survival,  with   
an  appropriately  rich  medium  and  no  external  stresses.  No  single  gene  can  be   
removed  without  loss  of  viability  13 .   
Minimal  gene  sets    Genes  selected  to  produce  a  minimal  genome,  but  have  yet  to  be  tested.     
Recoded  genomes   
Genomes  with  codon/s  that  have  been  freed,  substituting  codons  for  synonymous   
codons  that  encode  the  same  amino  acid,  so  that  they  can  be  assigned  to  new   
functions  23,24 .   
Platform  Cell  /  Cell  Factory  /   
Chassis  (interchangeable)   
A  bacterial  species  that  can  efficiently  convert  raw  materials  into  a  product  of   
interest,  through  genome  engineering  or  hosting  genetic  components  19,25–28 .   
Multiplex  gene  editing    Simultaneous  introduction  of  multiple  distinct  modifications  to  a  genome  29 .   
Algorithm    Series  of  steps  or  rules  to  attempt  to  solve  a  problem,  often  implemented  in  a   computer.   
Model    Mathematical  description  of  a  system.   
Metabolic  Flux    Metabolic  reaction  rate  (i.e.  turnover  of  molecules  through  a  metabolic  reaction).   
Genome-scale  biological   
models   
Category  of  models  containing:  metabolic  models,  transcription  regulatory   
networks,  protein–protein  interaction  networks,  integrated  cellular  models,  and   
whole-cell  models  3 .   
Genome-scale  metabolic   
models   
Models  representing  all  active  reactions  in  a  cell/organism  as  a  matrix  of   
compound  values,  and  linking  reactions  with  gene  products  that  catalyse  them.   
Abbreviated  to  GSMMs  or  GEMs  30,31 .   
Whole-cell  models    Describe  the  life  cycle  of  a  single  cell,  modelling  individual  molecules  and   interactions,  and  includes  the  function  of  every  known  gene  product  6 .   
Table  1.  Key  Terms   
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1.3.1 Metabolic  Engineering  in-vivo     
Metabolic  engineering  uses  genetic  editing  to  introduce  or  modify  the  desired  pathway,   
while  taking  control  of  core  metabolism,  cellular  regulation  and  stress  responses  4,19 .   
Applications  are  wide  ranging,  including  fuels,  feed  additives,  and  pharmaceuticals  4,32 ,   
with  the  application  determining  the  most  appropriate  bacteria  for  production  (Table  2).     
  
Industry  ready  strains  only  exist  for  a  small  number  of  bacteria  such  as:  Escherichia  coli   
(E.coli) ,  Bacillus  subtilis  (B.subtilis) ,  Streptomyces  sp. ,  Pseudomonas  putida   4 ,  and   
Corynebacterium  glutamicum  19 .  Requirements  for  industrial  bacteria  are  simple   
nutritional  needs,  fast  and  efficient  growth,  high  resistance  to  extreme  physical  and   
chemical  conditions,  and  efficient  secretion  systems  19 .  Also  required  are  sufficient   
genetic  and  metabolic  knowledge  about  the  species,  a  range  of  genetic  tools  (such  as   
promoters  and  terminators  with  varying  expression  levels),  and  well-characterised   
plasmids  for  precise  manipulations.  Metabolic  engineering  has  recently  been  reviewed   
for  E.coli  33   and  B.subtilis  34 .  Due  to  the  development  of  CRISPR-cas9  gene  editing   
tools  35,36 ,  a  number  of  novel  bacterial  species  are  becoming  available,  including  Vibrio   
natriegens  (with  the  shortest  known  doubling  time,  at  15  minutes),  Cyanobacteria  
(which  are  photosynthetic)  and  Roseobacter  and  Halomonas  (which  are  marine  species   
with  high  salt  tolerances)  19 .  Some  examples  of  organisms  used  for  metabolic   
production  are  summarised  in  Table  2.     
  
The  metabolic  production  pathway  is  constructed,  reconstructed  or  tweaked  in  the   
strain,  and  can  then  be  iterated  upon  to  produce  improvements  in  titre,  rate,  and  yield.   
There  are  six  well  established  strategies  34   for  improving  these:  i)  modular  pathway   
engineering,  which  divides  up  the  production  pathway  to  produce  and  combine   
modules  with  different  expression  levels  37 ;  ii)  cofactor  engineering,  in  which  metabolic   
flux  to  the  desired  products  is  enhanced  through  gene  edits  that  alter  non-protein   
cofactor  levels  38 ;  iii)  scaffold-guided  protein  engineering,  where  the  spatial  locations  of   
proteins  in  the  cell  are  modified  to  increase  local  concentrations  of  intermediates  39 ;  iv)   
transporter  engineering,  which  improves  the  import  of  substrates  40   and  export  of   
products  41 ;  v)  dynamic  pathway  analysis  which  identifies  unknown  network  interactions   
and  promotes  or  suppresses  them  to  increase  levels  of  product  42 ;  and  vi)  evolutionary   
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engineering,  which  mimics  natural  evolutionary  approaches  to  produce  greater   
amounts  of  product  43–45 .      
  
The  development  of  an  “industry  ready”  strain  takes  several  years  and  is  costly.  Strains   
for  Artemisinin  and  1,3-propanediol  production  took  10  years  and  $50,000,000,  and  15   
years  and  $130,000,000  to  develop,  respectively  4 ,  though  sales  of  metabolic  products   
are  expected  to  reach  $6.2  billion  dollars  by  2020  46 .  The  time  and  cost  is  due  to   
complex  interactions  and  regulations  in  metabolism.  Metabolite  intermediates  and   
products  can  cause  toxicity  and  act  as  inhibitors  of  other  reactions,  or  be  misrouted  or   
modified  by  unrelated  enzyme  reactions,  leading  to  decreasing  titre,  rate,  and  yield  19 .     
  
Recently,  the  availability  of  accurate  genome-scale  metabolic  models,  refined  with  data   
captured  using  omics  technologies,  has  begun  to  overcome  these  limitations  and   
support  rounds  of  in-silico  design  and  in-vivo  editing  19,34 .   
  
Bacteria    Primary  Feature    Applications    Product  Examples    Strain  Examples   
Escherichia  coli    Variety  of  tools  /   
knowledge   
Exploratory  production,   
established  industrial   
strain   
1-3-Propanediol,  1-4-Butanediol,   
butanol,  insulin,  limonene,  L-threonine,   
L-serine,  PHAs,  propane,  succinate.   
Based  on  K-12  and  B  ancestor   
strains.  Derivatives  of  MG1655,   
W3110,  BW25113.     
Specific  strains:     
BL21  Rosetta,  DH1,  ATCC  31884,   
DH10B.   
Bacillus  subtilis   
Efficient  secretion   
systems    Protein  production     
amylases,  bacitracin,  biotin,  cellulosome,   
chiral  stereoisomers,  cobalamin,   
glucanases,  guanosine,  laccases   
monophosphate,  riboflavin,  subtilisin,   
vitamin  B6.   
Proteases-defective  mutants:   
WB600,  WB800.     
Specific  strains:  168,  RH33,   
BSUL08,  1A1,  E8,  KU303   
Pseudomonas   
putida    Chemical  resistance  
Harsh  conditions  and   
toxic  product  production  
3-methyl-catechol,  anthranilate,  cinnamic   
acid,  PHAs,  phenol,  o-cresol,  styrene,   
terpenoids,  vanillate.   
Specific  strains:   
  KT2440,  EM42,  Gpo1,  S12   
Cyanobacteria    Photosynthetic    Light-driven  production   
  1-butanol,  1,3-propanediol,  bisabolene,   
ethanol,  farnesene,  isoprene,  isopropanol,   
PHAs.   
Specific  strains:     
PCC-6803,  PCC-7942.  PCC-7002   
Table  2.  A  selection  of  bacteria  used  for  metabolite  production.  Information  collated   
from  Nielsen  and  Keasling  4 ,  Calero  and  Nikel  19 ,  Gu  et  al.  34 ,  and  Pontrelli  et  al.  33 .   
  
  
1.3.2 Genome  Engineering  in-vivo   
Genome  engineering  is  the  production  of  modified  genomes  using  either  a  prescriptive,   
existing  genome  design  or  a  clear  laboratory  based  algorithm  to  iteratively  produce   




1.3.2.a Essentiality   
A  simple  definition  of  a  cell  as  “living”  is  if  it  can  reproduce,  an  “ essential ”  gene  being   
indispensable  for  cell  division.  A  “ non-essential ”  gene  can  be  removed  without   
preventing  division  10,47 .  But  a  cell’s  need  for  specific  genes  and  their  products  is   
dependent  on  the  external  cellular  environment  (i.e.  how  cells  are  grown  48 )  and  on  the   
genomic  context  10 ,  which  is  the  presence  or  absence  of  other  genes  in  the  genome   
and  resulting  gene  products,  that  can  change  each  time  a  gene  is  removed.     
Some  essential  genes  can  become  dispensable  with  the  removal  of  a  particular  gene   
(i.e.  a  toxic  byproduct  is  no  longer  produced,  so  its  removal  is  unnecessary),  referred  to   
as  “protective  essential”  genes  10,49,50 .  Likewise,  some  non-essential  genes  become   
essential  when  a  functionally  equivalent  gene  is  removed,  leaving  a  single  pathway  to  a   
metabolite  (a  “redundant  essential”  gene  pair).  Gene  products  can  perform  together  as   
a  complex,  with  individually  non-essential  genes  involved  in  producing  an  essential   
function  51 .  When  enough  deletions  accumulate  to  disrupt  the  group,  the  remaining   
genes  become  essential.  The  cellular  death  that  occurs  when  redundant  essential   
genes  are  removed  together,  or  complexes  are  disrupted,  is  referred  to  as  synthetic   
lethality  12,13,52 .  Other  important  classifications  for  genome  engineering  include   
quasi-essential,  where  removal  reduces  growth  rate  substantially  12 ;  and  synthetic   
rescue,  where  multiple  genes  that  are  essential  individually,  can  be  removed  together   
53,54 .     
  
A  recent  review  10   updates  gene  essentiality  from  a  binary  categorisation  to  a  gradient   
with  four  categories:  no  essentiality  (if  dispensable  in  all  contexts),  low  essentiality  (if   
dispensable  in  some  contexts,  i.e.  redundant  essential  and  complexes),  high   
essentiality  (if  indispensable  in  most  contexts,  i.e.  protective  essential),  and  complete  
essentiality  (if  indispensable  in  all  contexts).  These  broad  labels  describe  an  individual   
gene’s  essentiality  in  different  genomic  contexts,  and  are  compatible  with  other  labels   
that  explain  underlying  mechanisms  and  interactions  in  greater  levels  of  detail.  Single   
gene  knockout  studies  (implemented  by  systematic  removal,  inactivation,  transposon   
mutagenesis,  and  antisense  RNA  55 )  are  still  used  to  provide  an  initial  assessment  of   
gene  essentiality,  but  further  work  is  required  to  assess  essentiality  dependent  on   
environmental  context  and  genomic  context  10 .   
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This  redefinition  of  essentiality  has  underlined  the  existence  of  multiple  minimal   
genomes  for  individual  bacterial  species,  depending  on  environmental  conditions  10,28 ,   
and  the  selection  of  redundant  genetic  pathways  in  the  cell  56 .     
  
1.3.2.b Species  of  Interest     
There  are  several  species  of  interest  for  genome  engineering  research:  M.genitalium   
due  to  its  size,  E.coli  due  to  its  existing  knowledge  base,  and  JCVI-syn3.0  due  to  its   
synthetic  nature  and  size.  There  are  a  number  of  sequenced  insect  endosymbionts  
( Wigglesworthia  glossinidia ,  Blochmannia  floridanus ,  Buchnera  species  etc  57 )  that  are   
noted  in  the  literature  for  their  small  genome  sizes.  However,  due  to  their  parasitic   
lifestyle  they  are  not  suitable  for  genome  studies  and,  in  addition,  most  are  labelled  as   
Candidatus  due  their  inability  to  be  cultured  in  the  lab.  S.cerevisiae ,  apart  from  an  entry   
in  Table  3,  is  not  considered  in  this  thesis.  Although  there  is  considerable  interest  and   
progress  being  made  on  synthetic  chromosomes  in  yeast  (with  a  complete  design  for   
each  chromosome  and  a  third  of  the  chromosomes  having  been  synthesised  and   
assembled  124 ),  in  this  thesis  I  am  focused  on  prokaryotes.   
  
1.3.2.b.1 Mycoplasma  genitalium   
The  smallest  genome  of  an  independent  organism  in  nature  belongs  to  M.genitalium ,  at   
0.58  mb  and  525  genes  58 .  As  a  human  parasite  that  has  shed  functional  redundancies   
over  evolutionary  time  it  has  proved  a  useful  starting  point  for  comparative  genomics.   
The  estimated  number  of  essential  genes  ranges  from:  256  by  comparative  genomics   
59 ;  388  by  global  transposon  mutagenesis  and  comparative  genomics  60 ;  and  381  by   
single  gene  knockout  61 .  Extrapolating  a  comparison  of  single  gene  deletions  of   
Mycoplasma  genomes  and  the  genome  of  JCVI-syn3.0 ,  resulted  in  a  prediction  of  413   
genes  for  a  minimal  Mycoplasma  genome  13 .  The  number  of  genes  that  do  not  have  an   
annotated  function  has  been  reported  as  111  60   and  134  61 .  The  M.genitalium  genome   
has  been  reproduced  elsewhere,  constructed  from  25  synthetic  parts  within  yeast  62 .  It   




1.3.2.b.2 JCVI-syn3.0   
JCVI-syn3.0  is  a  near  minimal  version  of  the  first  synthetic  microorganism  JCVI-syn1.0 ,   
reduced  by  over  50%  through  hundreds  of  iterative  cycles  12   (originally  derived  from   
Mycoplasma  mycoides ).  A  large  amount  of  interest  has  been  generated  post   
publication,  due  to  its  unique  synthetic  nature,  though  at  publication  it  contained  149   
genes  of  unknown  function  (66  genes  have  subsequently  been  assigned  a  function  63 )   
and  has  only  recently  had  a  metabolic  model  developed  64 .  Recent  estimates  suggest   
that  of  the  genes  of  unknown  function  an  additional  60  genes  could  be  removed  to   
make  the  genome  truly  minimal  13 .   
  
1.3.2.b.3 Escherichia  coli   
E.coli  is  the  workhorse  of  microbiology  research.  Although  much  larger  in  size,  4.6  Mbp   
for  K-12  derivative  MG1655  (4288  genes,  38%  unannotated  65 ),  it  has  easy  to  use  and   
well  established  methods  and  techniques,  and  a  Species  Knowledge  Index  31  times   
larger  than  M.genitalium ’s  28 .  Previous  research  has  investigated  single  gene  essentiality   
in  E.coli  66 ,  produced  single  gene  deletion  libraries  for  E.coli  via  Tn5  mutagenesis  67   and   
in-frame  knockouts  of  3985  genes  68 ,  along  with  double  mutant  libraries  to  investigate   
synthetic  lethality  69 .  The  number  of  essential  genes  has  been  estimated  as  303  by   
single  gene  deletion  68   and  630  by  transposon  based  analysis  70 ,  though  estimates  for   
reductions  that  maintain  wild  type  growth  are  between  2600  and  3000  genes  22,71 .   
Excitingly,  an  E.coli  cell  with  a  synthetic,  recoded  genome  has  recently  been  produced   
72   (Section  1.3.2.e).    
  
1.3.2.c Minimal  Gene  Sets   
Genome  engineering  builds  on  historical  gene  essentiality  research  (Figure  1).  The   
sequencing  of  small  bacterial  genomes  58,73   led  to  comparative  genomics,  initially   
between  pairs  of  bacteria  59 ,  then  greater  numbers  of  bacteria  as  genome  sequencing   
increased,  which  led  to  the  development  of  minimal  gene  sets  6,55,57,59–61,74–77 .     
Minimal  gene  sets  are  lists  of  genes  selected  to  produce  a  minimal  genome,  but  have   
yet  to  be  tested.  A  minimal  genome  is  a  reduced  genome  containing  only  the  genetic   
material  essential  for  survival,  with  an  appropriately  rich  medium  and  no  external   
stresses.  No  single  gene  can  be  removed  without  loss  of  viability  13 .     
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Minimal  gene  sets  and  minimal  genomes  focus  on  protein-coding  genes  ignoring:   
essential  promoter  regions,  tRNAs,  small  noncoding  RNAs  28 ,  regulatory  noncoding   
sequences  55 ,  and  the  physical  layout  of  the  genome  55,78 .  Predictions  for  the  size  of  a   
viable,  generic,  bacterial  minimal  genome  range  from  151  genes  75 ,  to  between  300   
and  500  genes,  though  up  to  1000  genes  if  the  cell  is  required  to  survive  on  minimal   
media  78 .  As  the  ratio  of  genes  to  base  pairs  is  approximately  one  gene  per  kilobase  79 ,   
the  size  expectation  of  a  minimal  genome  is  between  0.15  mb  and  0.5  mb.     
  
M.genitalium  is  the  focal  point  of  minimal  gene  set  creation  due  it  is  naturally  small   
genome  size  and  available  sequenced  genome  58 .  Minimal  gene  sets  are  constructed   
using  three  different  approaches:  protocell  development;  universal  minimal  genome   






Figure  1.  An  incomplete  history  of  genome  engineering  in  microorganisms.     
  
Minimal  gene  sets  designed  as  protocells  are  not  expected  to  function  as  full  cells,   
instead  functioning  as  a  self-replicating,  membrane-encapsulated  collection  of   
biomolecules  75 ,  with  the  sets  containing  very  small  numbers  of  genes.     
  
The  universal  minimal  genome  concept  is  a  theory  that  comparing  bacterial  genome   
sequences  for  common  genes  will  give  a  gene  list  that  represents  essential  functions  of   
the  cell,  and  may  resemble  LUCA  (the  Last  Universal  Common  Ancestor  for  life  on   
Earth)  80 .  This  has  been  used  to  construct  minimal  gene  sets,  however,  as  the  number   
of  genomes  sequenced  have  increased,  the  hope  around  discovering  a  universal   
minimal  genome  strictly  from  genetic  sequences  has  decreased.  Lagesen  81   found  that   
only  four  genes  are  recognisably  conserved  among  1000  bacterial  genomes,  and  even   
among  the  evolutionarily  reduced  Mycoplasmas  only  196  orthologs  (genes  that  have   
evolved  differently  from  an  ancestral  gene  but  are  still  recognisably  related  and  retain   
the  same  function)  were  found  across  the  20  species  sequenced  13 .  This  apparent  low   
conservation  of  cellular  functions  is  due  to  non-orthologous  gene  displacements,   
independently  evolved  or  diverged  proteins  that  perform  the  same  function  but  are  not   
recognisably  related  13,59 .  This  means  that  minimal  gene  sets  designed  by  the  universal   
minimal  genome  concept  or  comparative  genomics  (subsequently  referred  to  as   
comparative  genomics)  could  remove  a  large  numbers  of  genes  essential  to   
M.genitalium  depending  on  the  number  of  bacterial  genomes  compared,  as  those   
genes  are  not  required  by  the  other  bacterial  species.  Fewer  genes  may  be  removed  if   
a  smaller  number  of  genomes  are  compared.  This  comparative  work  continues  to  be   
built  on  computationally,  analysing  the  growing  number  of  genomic  data  sets  for  key   
features  that  could  be  used  to  match  non-orthologous  gene  displacements  82 .   
  
Minimal  gene  sets  designed  using  single  gene  essentiality  experiments  should,  in   
theory,  not  remove  any  essential  genes,  but  do  fall  prey  to  issues  with  transposon   
mutagenesis,  with  differing  transposon  variants,  antibiotic  resistance  genes,  and  growth   
periods  producing  different  essentiality  classification  for  genes  83,84 .     
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There  are  eight  minimal  gene  sets  in  the  literature  with  detailed  gene  lists  (Table  21).   
Two  are  designed  as  protocells:  Tomita  et  al.  74   and  Church  et  al.  75 .  Three  are  designed   
from  comparative  genomics:  Mushegian  and  Koonin  59 ,  Huang  et  al.  76 ,  and  Gil  55,57 .   
Three  are  designed  from  single  gene  essentiality  experiments:  Hutchison  et  al.  60 ,  Glass   
et  al.  61 ,  and  Karr  et  al.  6 .  Due  to  the  difficulty  of  using  M.genitalium  in  the  lab  85 ,   
combined  with  its  long  replication  time  of  12  -  15  hours  11–13 ,  none  of  these  minimal   
gene  sets  have  been  tested  as  minimal  genomes,  even  with  modern  techniques  11 .   
  
1.3.2.d Minimal  Genomes   
Previously  large-scale  gene  reductions  were  either  prescriptively  designed,  with   
requirements  based  on  existing  biological  knowledge,  or  knowledge  generated  by   
extensive  laboratory  testing  of  the  essentiality  of  individual  genes.  Most  commonly,  the   
reductions  were  placed  into  several  groups  by  genome  location,  with  each  modified   
genome  segment  tested  individually  in  different  cells,  before  being  combined  into  a   
single  cell.  This  process  is,  however,  time  consuming  and  expensive  due  to  the   
limitations  of  current  techniques  and  unexpected  cell  death  caused  by  unknown   
genetic  interactions.  This  hinders  progress  as  laboratories  can  only  follow  a  small   
number  of  high-risk  research  avenues  with  limited  ability  to  backtrack  10 .  The  largest   
scale  genome  reductions  to  date  (Table  3)  include:  JCVI-syn3.0  12 ,  and  B.subtilis  PG10   
and  PS38  86   which  were  produced  to  understand  and  identify  minimal  genomes;  and   
E.coli  Δ  33a  87   and  DGF-298  22   which  were  produced  as  chassis  cells  for  industrial   
production.     
  
Research  for  understanding  minimal  genomes  and  developing  chassis  (Table  4)  both   
involve  large  numbers  of  gene/base  pair  deletions  and  use  similar  genetic  tools.   
However,  they  differ  in  intent:  no  single  gene  can  be  removed  without  loss  of  viability  in   
minimal  genomes  13 ,  whereas  the  cellular  growth  rate  is  maintained  or  promoted  in   
chassis  development.  Additionally,  minimal  genomes  ignore  any  cellular  component   
that  is  not  protein-coding  genes,  at  least  some  of  which  will  be  of  interest  to  chassis   
development.  Finally,  bacterial  species  that  do  not  have  a  use  industrially  are  of  use  in   
minimal  genome  research.  M.genitalium  only  synthesizes  DNA,  RNA,  and  proteins  from   
imported  precursors,  in  order  to  replicate  itself  13 ,  which  it  does  slowly  in  a  stress-free   
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laboratory  environment  12 ;  useful  for  understanding  the  minimal  requirements  for  life,  but   
not  for  industry.   
  
Regardless  of  the  original  intent,  minimal  genome  reduction  strains  can  have  emergent   
beneficial  properties  88,89   in  addition  to  the  lower  metabolic  burden  and  increased   
metabolic  efficiency  produced  by  reducing  gene  numbers  90 .  The  reduced  internal   
biochemistry  may  also  provide  benefits  as  it  will  interfere  less  with  introduced  external   
pathways  91 ,  making  for  improved  chassis  cells.  Two  minimal  genome  reduction  strains   
have  been  subsequently  used  for  production  purposes  (Table  3).   
  
1.3.2.d.1 Laboratory  Techniques   
To  conduct  minimal  genome  research  in-vivo  you  can  either:  construct  bacterial   
genomes  from  scratch,  and  insert  them  to  replace  an  existing  genome,  or  remove   
sections  of  existing  natural  genomes.   
  
Synthetic  genome  construction  is  not  currently  possible  in  the  majority  of  bacteria  due   
to  economic  and  technological  constraints.  Economically,  bacterial  genome  production   
is  too  expensive  for  most  institutes.  Producing  JCVI-Syn1.0  was  estimated  to  cost   
~$40,000,000  92   and  E.coli  Syn61  72   cost  an  estimated  $322,000  (409  stretches  of  4  -   
15  kb  of  DNA,  at  7  cents  a  base  pair).  Technologically,  megabase  sized  genomes  can   
be  constructed  in  yeast  62,93 ,  however  successful  genome  transplantation  has  only  been   
demonstrated  in  a  few  Mycoplasmas  94–96   and  is  mutagenic  96 .  Genome  construction   
has  been  completed  in  E.coli  72   in  100  kbp  fragments.   
  
1.3.2.d.1.a In  E.coli   
The  E.coli  genome  has  a  long  history  of  being  reduced,  by:  7%  97 ,  29.7%  98 ,  15%  99 ,  
21%  71,88 ,  35%  22 ,  23%  100 ,  via  a  variety  of  methods,  all  with  the  intent  of  biotechnical   
applications  rather  than  true  minimisation.  An  exception  is  Zhou  93   who  constructed  a   
minimal  genome  of  E.coli  (MGE-01)  hosted  within  yeast,  which  is  only  1.03  mb  in  size,   
but  it  has  yet  to  be  reinserted  back  into  an  E.coli  cell.  In  the  majority  of  cases,  the  E.coli   
reductions  displayed  normal  growth  22,71,97,99,100 ,  with  added  benefits  including:   
comparable  electro-competency  to  E.coli  DH10B  and  better  maintenance  of  unstable   
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plasmids  99 ,  1.5  higher  cell  density  71 ,  or  better  cell  yield  22 .  However,  the  reductions   
carried  out  by  Hashimoto  98   resulted  in  unexpected  cell  shape,  nucleoid  size,  and   
nucleoid  location.  The  variety  of  techniques  used  in  these  reductions  include:  restriction   
enzyme  digestion,  transposon  insertion,  cre-meditated  recombination,  lambda-assisted   
homologous  recombination,  and  double  stranded  break  induced  homologous   
recombination.     
  
The  basis  for  modern  techniques  started  prior  to  the  millennium,  with  sequences   
encoding  Lambda  proteins  ( exo,  bet,  gam )  being  inserted  into  E.coli  for  the  first  time,   
giving  a  70  times  higher  rate  of  homologous  recombination  than  wild  type  E.coli  101 .   
This  rate  of  recombination  was  further  improved  by  removing  the  methyl-directed   
mismatch  repair  (MMR)  system,  resulting  in  25%  of  grown  cells  showing  the  intended   
mutation  102 .  An  overview  of  lambda  protein  mediated  homologous  recombination  is   
available  103 .  The  creation  of  the  modern  CRISPR-cas9  technique  started  with  the   
publication  of  cRNA  and  tracrRNA  fusion  in  2012  36,104 .  Subsequently,  the  lambda   
protein  system  was  enhanced  by  using  CRISPR-cas9  as  a  guidance  and  counter   
selection  system,  resulting  in  65%  of  grown  cells  carrying  the  desired  mutation  7 .     
  
Variations  of  this  system  have  been  produced  since:  Pyne  105   produced  a  three  plasmid   
system;  Reisch  106   standardised  the  two  plasmid  system;  Li  107   demonstrated  multiplex   
gene  editing  (as  did  Jiang  in  2015  108 )  and  demonstrated  a  100%  success  rate  for  some   
deletions;  Zhao  109   produced  a  single  plasmid  system;  and  Zerbini  9   created  a  more   
convenient  and  thoroughly  tested  two  plasmid  system.  These  CRISPR-cas9  -  lambda   
protein  plasmid  systems  offer  many  advantages  compared  to  previous  techniques   
including:  single  step  procedures,  reusable  plasmids,  elimination  of  selection  steps,   
absence  of  scar  sites,  and  greater  success  rates  across  prokaryotes.  Zerbini  9   targeted   
81  genes  using  a  CRISPR-cas9  -  lambda  protein  plasmid  system  with  double  stranded   
donor  DNA.  100%  of  the  genes  targeted  were  successfully  mutated,  with  10-100%  of   
the  colonies  grown  carrying  the  mutation  depending  on  the  gene  targeted  for  deletion.   
Due  to  the  plasmid  systems  being  "variations-of-the-theme"  these  robustness   




A  different  technique  using  CRISPR-cas9  was  demonstrated  by  Standage-Beier  110 ,   
who  used  single  strand  CRISPR-cas9  nicking  to  guide  homologous  recombination.   
There  are  also  CRISPR-cas9  enhanced  alternatives  to  homologous  recombination.  Su   
111   reintroduced  non  homologous  end  joining  into  E.coli  through  inserted  Mycoplasma   
genes,  in  combination  with  CRISPR-cas9.  Zheng  112   later  improved  this  with  a  different   
Mycoplasma  species  insert,  increasing  the  maximum  deletion  size  from  17,000  base   
pairs  to  123,000  base  pairs.  Zhou  93   established  a  new  technique  for  assembling   
megabase-sized  genomes  in  yeast,  taking  advantage  of  CRISPR-cas9.   
  
1.3.2.d.1.b In  Mycoplasmas   
The  development  of  Mycoplasma  techniques  is  in  reality  the  development  of  yeast   
hosted  genome  editing,  as  this  is  instrumental  for  editing  organisms  that  are  difficult  to   
culture  11 ,  which  includes  Mycoplasmas .  This  began  by  demonstrating  the  assembly  of   
a  M.genitalium  genome  within  yeast  62   and  the  subsequent  insertion  of  a  yeast   
assembled  Mycoplasma  genome  into  a  new  Mycoplasma  cell  11,95 .  This  has  been   
subsequently  improved  by  the  development  of  direct  cell-to-cell  transfer  of  bacterial   
genomes  into  yeast  113 ,  and  the  addition  of  CRISPR-cas9  within  yeast  for  Mycoplasma   
modification  114 .     
  
1.3.2.e Genome  Recoding   
Genome  recoding  research  substitutes  synonymous  codons,  encoding  the  same  amino   
acid,  across  an  entire  genome  resulting  in:  virus  resistance,  as  viral  replication  relies  on   
all  64  codons  23 ;  prevention  of  gene  transfer  115 ;  and  increased  translation  efficiency  21 .  It   
also  produces  a  blank  codon  that  can  be  repurposed  for  a  novel  function  not   
commonly  found  in  nature  such  as  a  non-standard  amino  acid  (NSAA)  21,23,116 .  This   
incorporation  of  NSAAs  additionally  acts  as  a  form  of  biocontainment  as  the  organism   
is  engineered  to  be  dependent  upon  the  presence  of  the  synthetic  NSAA  to  survive.  
  
Genome  recoding  is  possible  due  to  the  development  of  new  technologies:  MAGE,   
multiplex  automated  genome  engineering  117 ;  CAGE,  conjugative  assembly  genome   
engineering  21,118 ;  REXER,  replicon  excision  for  enhanced  genome  engineering  through   
programmed  recombination  119 ;  and  GENESIS,  genome  stepwise  interchange  synthesis   
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72 .  MAGE  cyclically  targets  many  genetic  locations  to  conduct  mismatches,  insertions,   
deletions  in  a  single  cell  or  across  a  population  of  cells,  maintaining  high  efficiency  up  to   
10  targets  at  a  time  117 .  This  leads  to  rapid  and  continuous  generation  of  genetic   
diversity  for  strain  and  pathway  engineering.  CAGE  is  a  complementary  method  to   
assemble  modified  genomic  modules  from  individual  cells  into  a  single  genome  through   
cell  to  cell  transfer,  and  has  been  used  in  combination  with  MAGE  to  systematically   
recode  codons  21,118 .  REXER  inserts  pieces  of  synthetic  E.coli  DNA  into  the   
chromosome  (within  the  E.coli  DNA  insertion  size  limitations)  using  CRISPR-cas9  to  cut   
both  the  plasmid  and  the  chromosome.  The  GENESIS  methodology  is  the  use  of   
REXER  for  sequential  stepwise  deletions,  allowing  the  entire  genome  to  be  replaced   
without  using  genome  transfer.  This  development  improves  the  outlook  of  building   




Genome  Reductions   
Microbe    Reduction    Benefits   
JCVI-syn3.0  12    50%     
Smallest  genome  of  any  autonomously  replicating  cell.  Has  a  doubling   
time  of  ~180  min,  four  -  five  times  faster  than  M.genitalium  (12  -  15   
hours  13 ).   
E.coli  Δ33a  87    39%      -   
E.coli  DGF-298  22    35%    Better  growth  fitness  and  cell  yield  in  a  rich  medium,  than  the  wild  type   
strain,  and  has  a  more  stable  genome.   
B.subtilis  PG10  and  PS38  86    36%     
Subsequently  used  for  production  purposes,  as  has  traits  that  are   
favorable  for  producing  ‘difficult-to-produce  proteins’  by  overcoming   
several  bottlenecks  (secretion  process  and  unstable  product)  120 .   
E.coli  Δ16  98    30%    -   
B.  subtilis  MGIM  121    24%    Little  reduction  in  growth  rate  and  comparable  enzyme  productivity.   
E.  coli  MGF-01  88    22%    Better  growth  rate  resulting  in  1.5-fold  cell  density  and  2.4-fold  greater   
threonine  production  compared  to  the  wild  type  strain.   
B.  subtilis  MBG874  122    20%   
Extracellular  cellulase  and  protease  production  were  1.7  and  2.5-fold   
higher.  Production  period  was  elongated  and  carbon  utilisation   
improved.   
E.coli  MS56  100    23  %   
Insertion  sequence  free,  making  it  more  genomically  stable,  predicted  to   
increase  production  of  recombinant  proteins.   
  
E.  coli  MDS43  99    15%   
Showed  genome  stabilization  and  increased  electroporation  efficiency,   
comparable  to  E.coli  DH10B.  Subsequently  used  for  production   
purposes:  83%  increase  in  L-threonine  production,  compared  to  E.  coli   
MG1655  using  the  same  metabolic  engineering  90 .   
Genome  Recoding   
Microbe    Modifications  
32  E.coli  strains  21    Replaced  314  UAG  (stop)  codons  with  UAA.   
E.coli  MG1655  24    Replaced  321  UAG  (stop)  codons  with  UAA.   
r E.coli -57  116    Replaced  62,214  instances  of  seven  codons  (UAG  (stop),  AGG  and  AGA  (Arg),  AGC  and   
AGU  (Ser),  UUG  and  UUA  (Leu)).   
E.coli  C123  123    Replaced  123  rare  AGA  and  AGG  (Arg)  codons  from  essential  genes  with  110  CGU   
conversions  and  13  optimized  codon  substitutions.     
E.coli  MDS42  119    Tested  1468  codon  changes  using  REXER  plasmids  and  GENESIS  method.   
S.cerevisiae  Sc2.0  124    Replaced  all  UAG  (stop)  codons  with  UAA.   
E.coli  Syn61  72    Replaced  18,214  codons,  UCG  with  AGC,  UCA  with  AGU,  UAG  with  UAA,  using  REXER   
plasmids  and  GENESIS  method.     




Combining  genome  engineering  research  efforts  together  can  give  insights  into  what  an   
“optimal”  cellular  chassis  could  look  like  (Table  4)  and  suggest  research  pathways  going   
forward.   
  
Feature    Description   
Genetically  Stable   
Removal  of  mobile  DNA  elements  (e.g.  insertion  elements,  transposases,  phages,  integrases,   
site-specific  recombinases)  125 .   
Genomically   
Recoded   
Substitute  codons  to  create  blank  codons  for  inclusion  of  new,  non-natural  amino  acids  21 ,  decreased   
likelihood  of  viral  infection  23 ,  and  horizontal  gene  transfer  115 .   
Genome  Minimised   
Removal  of  competing  and  unwanted  metabolic  pathways  that  divert  the  resources  of  the  cell  away  from   
desired  end  products  1 ,  resulting  in  increased  capacity  for  and  reduced  impact  of  cellular  burden  126,127 ,   
and  greater  robustness  and  energy  efficiency  128 .  Reduced  transcriptional  regulatory  interactions  also   
result  in  lower  resistance  to  engineering  efforts  125 .  Additionally,  creates  larger  and  more  optimal  precursor   
pools  129 .     
Efficient  Production    Simple  nutritional  needs,  fast  and  efficient  growth,  and  efficient  secretion  systems  19 .   
Robust   
Tolerance  for  extreme  conditions  19   i.e.  strength  of  cell  membrane  or  wall  and  appropriate  coping   
mechanisms  28 .   
Well  Understood   
Sufficient  knowledge  of  the  organism’s  genome  and  metabolism  to  produce  accurate  models,  and  allow   
modularisation  of  metabolic  pathways  28 .     
Developed  Tools   
A  range  of  established  genetic  tools  for  manipulation,  including  promoters  and  terminators  with  varying   
expression  levels,  and  well-characterised  plasmids,  to  enable  titre,  rate,  and  yield  improvements  and   
rapid  and  efficient  tuning  of  genetic  components  1 .   
Table  4.  Features  of  an  optimal  chassis  for  a  wide  range  of  applications.   
  
1.3.3 Metabolic  Engineering  in-silico   
Models  of  a  cell’s  metabolism  (known  in  the  literature  as  genome-scale  metabolic   
models,  abbreviated  to  GSMMs)  are  constructed  from  metabolic  networks,  which   
consist  of  all  known  metabolic  reactions  and  the  genes  which  encode  each  enzyme.   
These  models  produce  a  table  of  reactions,  substrates,  and  biologically  feasible   
constraints  from  the  metabolic  network,  and  form  a  solution  space  (all  the  possible   
outputs  given  all  the  possible  inputs)  by  analysing  each  reaction  in  the  model.  An   
algorithm  or  optimisation  process  (such  as  flux  balance  analysis  (FBA),  see  Orth  et  al.   
130   for  a  recent  review)  can  be  applied  to  the  model  to  find  a  solution  to  a  defined   
problem,  by  modifying  the  rate  of  reactions  in  the  model.     
  
University  of  California  San  Diego  maintain  a  database  of  published  GSMMs  which   
have  been  validated  against  experimental  data.  As  of  the  most  recent  update  (February   
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2018)  there  are  113  bacteria,  57  eukaryote  and  8  archaea  manually  curated  models  131 .   
GSMMs  can  also  be  generated  automatically  starting  from  available  biological   
databases  (e.g.  KEGG  132 )  or  generic  universal  networks  that  are  subsequently   
modified.  Automation  tools  include:  modelSEED  133 ,  Pathway  Tools  134 ,  AuReMe  135 ,   
Merlin  136 ,  MetaDraft  137 ,  Raven  138 ,  and  CarveMe  139 ,  which  have  been  recently   
reviewed  140 .   
  
Metabolic  models  can  be  used  to  predict  single  gene  essentiality,  using  the  lack  of   
biomass  production  as  a  proxy  for  cellular  death,  demonstrated  with  E.coli  MG1655   
(86%  accuracy)  141 ,  B.subtilis  142 ,  Saccharomyces  cerevisiae  143 ,  Helicobacter  pylori  144 ,   
and  Corynebacterium  glutamicum  145 .   
  
Although  referred  to  as  genome-scale,  these  models  only  account  for  the  metabolism   
and  no  other  systems  within  the  cell.  Recently  developed  models  have  begun  to  extend   
metabolic  models  to  include  transcription  and  translation  reactions  146 .  Metabolic   
models  might  not  be  appropriate  for  genome  engineering  as  they  cannot  predict  gene   
essentiality  in  the  genomic  context  of  the  entire  cell  (Section  1.3.2.a),  with  the  potential   
to  label  genes  that  are  essential  for  the  cells  correct  function  outside  metabolism   
incorrectly.      
  
1.3.4 Genome  engineering  in-silico   
The  M.genitalium  whole-cell  model  6   was,  at  the  time  of  publication,  the  only  existing   
model  that  included  the  function  of  every  known  gene  product  (401  of  the  525   
M.genitalium  genes),  making  it  capable  of  modelling  genes  in  their  genomic  context   
(Section  1.3.2.a).     
  
A  single  in-silico  M.genitalium  cell  is  simulated  from  random,  biologically  feasible  initial   
conditions  until  the  cell  divides  or  reaches  a  set  time  limit.  The  model  (implemented  in   
MATLAB)  combines  28  cellular  sub-models,  with  parameters  from  >900  publications   
and  >1,900  experimental  observations,  resulting  in  79%  accuracy  for  single  gene   




The  whole-cell  model  is  similar  to  metabolic  models,  with  reactions  and  biological   
constraints  implemented  as  equations  and  variables,  however  in  the  whole-cell  model   
the  equations  are  grouped  into  28  cellular  sub-models  (which  are  modelled   
independently  using  different  mathematics  and  experimental  data)  and  the  variables  are   
grouped  into  16  cellular  states.  The  whole-cell  model  integrates  the  28  cellular   
sub-models  using  time,  which  consists  of:   
● When  the  model  is  first  run,  the  variables  in  the  16  cellular  states  are  initialised   
and  allocated  among  the  28  sub-models.     
● The  cellular  sub-models  then  operate  for  one  second.     
● The  variables  in  the  16  cellular  states  are  updated  and  re-allocated  to  the  28   
sub-models.     
● This  repeats  until  the  cell  divides,  or  the  simulation  time  reaches  a  maximum   
value  (13.89  hours).     
There  are  six  categories  of  the  28  cellular  sub-models:  transport  and  metabolism,  DNA   
replication  and  maintenance,  RNA  synthesis  and  maturation,  protein  synthesis  and   
maturation,  cytokinesis,  and  host  interaction  (more  detail  is  provided  in  Table  5).     
  
Outside  of  single  gene  knockout  simulations,  it  has  been  used  to  investigate   
discrepancies  between  the  model  and  real-world  measurements  147 ,  design  synthetic   
genetic  circuits  in  the  context  of  the  cell  148 ,  and  make  predictions  about  the  use  of   
existing  antibiotics  against  new  targets  149 .     
  
Development  of  whole-cell  models  for  genome  engineering  is  time  and  cost  intensive.   
The  M.genitalium  whole-cell  model  took  ten-person  years  to  build  150 ,  resulting  in  the   
Karr  Lab,  Mount  Sinai  developing  automation  tools  (Datanator  and  WC-Lang  151 )  along   














Modelled  nutrient  import,   
conversion  and  recycling  of   
metabolic  building  blocks.   
The  interface  between  the   
environment  and  the  other   
27  sub-models.      
  FBA,  trained  using  the  observed   
growth  rate  of  M.genitalium   
Reconstructed  by  matching  M.genitalium  to   
E.coli  genes,  using  a  comprehensive  E.coli   
metabolic  model.  Used  observed  chemical   
compositions  from  other  species,   






Models  the  state  of  each   
RNA  polymerase,  initiation  at  
promoters,  elongation,  NTP   
allocation,  and  termination.    
Markov  chain  (RNA  polymerase),   
trained  using  M.genitalium   
observations.  Stochastic  process   
(initiation),  trained  using   
reconstructed  expression  and  decay  
rates.   
Chromosome  organisation  reconstructed  from  
M.pneumoniae .  Transcription  termination  not   
well-characterised,  modelled  deterministically,  
proceeding  based  on  presence  of  copies  of   







Models  the  binding  of   
transcriptional  regulators  to   
promoters,  and  the  effect   
(fold  change)  on  subsequent  
RNA  polymerase  binding.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step.  Trained  using  reported   
regulator  fold  change  effects.   
Not  well  characterised  in  M.genitalium .   
Reconstructed  using  DBTBS  database.   
Assumptions:  Transcriptional  regulators  bind   
promoters  proportionally  to  their  fold  change   
effect;  only  one  copy  of  each  regulator  can   
bind  at  each  promoter;  stable  binding  with   
DNA  (only  displaced  by  other  DNA-binding   
proteins);  regulator  impacts  multiply  as   







Models  the  cleavage  of   
polycistronic,  non-coding   
(operonic)  RNA.    
Algorithm,  with  mass-action   
kinetics,  that  runs  every  time  step.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
unprocessed  RNA.    
Reconstructed  based  on  E.coli  RNA   
cleavages  linked  to  M.genitalium  enzymes.   
Assumptions:  cleavage  occurs  in  a  single   
reaction,  in  a  single  time  step;  and  rate  is   
determined  by  copy  numbers  of  RNA,   







Models  the  base-specific   
modification  of  non-coding   
RNAs,  to  encode  the  triplet   
codes,  assist  folding,  and   
stabilise  products.   
Algorithm,  with  mass-action   
kinetics,  that  runs  every  time  step.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
unprocessed  RNA.     
Reconstructed  based  on  E.coli  RNA   
modifications.  Assumptions:  cleavage  occurs   
in  a  single  reaction,  in  a  single  time  step;  and   
rate  is  determined  by  copy  numbers  of  RNA,   







Models  the  aminoacylation   
of  tRNAs.   
Two  step  process:  1)  calculate  the   
maximum  number  of  reactions,  2)   
randomly  select  and  conduct  a   
reaction.  Restart  and  recalculate   
Step  1,  until  resources  are   
exhausted.   
Assumptions:  Intermediate  steps  are  not   
represented.  Reactions  are  randomly  selected  
using  a  probability  distribution,  weighted  by   
maximum  number  of  reactions  and  what  has   





RNA  Decay  
Models  the  decay  of  RNA,   
recycling  the  small  RNA  pool  
using  ribonuclease  R.     
5  step  process,  using  first-order   
Poisson  process  (rate  is  known,   
occurrence  is  random),  dependent   
on  ribonuclease  R  counts,  and   
selection  based  on  RNA  half-life.   
Uses  observed  decay  rates  from  E.coli .   
Assumptions:  RNA  degradation  is  an   
all-or-nothing  event  that  proceeds  to   






Models  the  assembly  of  70S  
ribosomes,  polymerisation,   
allocation  of  tRNAs  to   
ribosomes,  and  termination   
of  stalled  ribosomes.     
Three  processes  that  randomly   
select  targets.  Initiation:  dependent   
on  free  ribosomes,  initiation  factors,   
and  energy.  Elongation:  dependent   
on  copies  of  three  elongation   
factors.  Termination:  dependent  on   
copies  of  release  factor,  recycling   
factor,  elongation  factor,  and  energy.  
Assumptions:  ribosome  stalling  probability  is   
uncharacterised,  so  is  set  to  very  low.  Stalling   
is  a  fourth  process  that  is  only  triggered  by  a   







Models  the  first  steps  in   
protein  maturation.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
unprocessed  protein.   
Some  reconstruction  based  on  data  from   
Shewanella  oneidensis .  Assumptions:  protein   
cleaved  in  a  single  time  step,  in  a  single   
reaction;  and  rate  is  determined  by  copy   







Models  translocation  across  
and  in  the  cell  membrane.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
untranslocated  protein.   
Assumptions:  translocation  doesn’t  begin  until  
after  termination  and  processing;  occurs  in  a   
single  time  step,  in  a  single  reaction;  and  rate   
is  determined  by  copy  numbers  of  protein,   
metabolite,  and  enzyme.     
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Processing  2  
Models  lipoprotein   
adduction  and   
lipoprotein  cleavage.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
unprocessed  protein.     
Assumptions:  occurs  in  a  single  time  step,  in  a  
single  reaction;  and  rate  is  determined  by   
copy  numbers  of  protein,  metabolite,  and   





Protein  Folding   Models  folding  into  3D   structures.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  accumulation  of  unfolded   
protein.     
Reconstructed  based  on  proteome  studies  of   
E.coli  and  B.subtilis .  Assumptions:  As  not  well  
understood,  the  3D  configuration  is   
represented  as  a  two-state  –  folded,  unfolded  
–  Boolean  variable;  and  rate  is  determined  by   
copy  numbers  of  protein,  metabolite,  and   







Models  the  modification  of   
specific  amino  acids,   
regulating  structural   
diversity,  activity  and   
expression.   
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  accumulation  of   
unmodified  protein.     
Based  on  observations  from  M.genitalium  and  
M.pneumoniae .  Assumptions:  occurs  in  a   
single  time  step,  in  a  single  reaction;  and  rate   
is  determined  by  copy  numbers  of  protein,   








Models  the  formation  of   
protein  complexes.   
Algorithm,  with  mass-action   
kinetics,  that  runs  every  time  step,   
until  resources  are  exhausted.     
Assumptions:  as  poorly  understood,   
complexes  are  assumed  to  form   
spontaneously,  without  assistance;  completes  
in  a  single  time  step;  each  complex  forms  with  
the  same  specific  rate;  and  by  simultaneous   







Models  the  assembly  of  30S  
and  50S  ribosome  particles  
Algorithm,  with  stochastic   
processes,  that  runs  every  time   
step,  until  resources  are  exhausted.   
Expression  was  fit  to  prevent   
sustained  amino  acid  accumulation.  
Assumptions:  As  not  well  understood,  the   
sub-model  only  represents  rRNA  transcripts,   
protein  monomers  and  ribosomal  particles;   
completes  in  a  single  time  step;  and  rate  is   
determined  by  copy  numbers  of  RNA,  protein,  








Models  the  hierarchical   
assembly  of  the  eight   
terminal  organelle  proteins.  
Algorithm,  using  a  Boolean,   





Protein  Decay  
Models  the  cleavage  of   
proteins  and  protein   
misfolding  and  refolding.   
Algorithm  controlling  multiple   
processes.  Cleavage:  uses   
first-order  Poisson  process  (rate  is   
known,  occurrence  is  random).   
Misfolding:  uses  a  stochastic   
process.  Refolding:  uses  a   
deterministic,  single  Boolean  rule.   
Expression  was  fit  to  prevent   
sustained  accumulation  of  damaged  
proteins.   
Protein  half-life  was  predicted  using  N-end   
rule.  Assumptions:  membrane  and   
extracellular  proteins  are  not  vulnerable  to   
degradation;  degradation  occurs  in  a  single   
step;  occurs  immediately  if  proteases  and   
energy  available;  if  energy  or  enzyme  limited   
proteins  are  degraded  stochastically;   
cystol-localised  proteins  are  refolded;  proteins  
misfold  and  refold  at  the  same  rate,  with  no   







Models  the  chemical   
regulation  of  protein  activity.  
Boolean  network  of  the  effects  of   
small  molecules,  temperature,  and   
pH.   
Reconstructed  from  the  DrugBank  database.   
Assumptions:  proteins  with  no  known   







Models  the  binding  of  DNA   
polymerase  to  oriC,  starting   
chromosome  replication   
Algorithm,  with  deterministic  and   
stochastic  steps,  for  seven  stages.  
Reconstructed  from  E.coli ’s  DnaA  process.  All  
rate  constructs  were  obtained  from  previous   






Models  bidirectional  DNA   
replication  following   
initiation.   
Algorithm,  with  eight  deterministic   
stages,  evaluated  in  a  random  order  
to  allocate  shared  resources  fairly.   
Exact  mechanism  is  unknown.  Polymerisation  
is  limited  by  the  average  rate  in  Mycoplasmas .  
Assumptions:  RNA  polymerase  is  displaced   
upon  collision  with  DNA  polymerase,  but  will   
only  stall  DNA  polymerase  for  a  limited  time  if   







Models  chromosome   
segregation  post  replication.  
Immediate  segregation  event,  under  
four  conditions  being  met  (Boolean).  
Checked  at  each  timestep.     
Poorly  characterised,  as  M.genitalium  has   











Models  chromosome   
compaction.   
Two  step  process:  1)  calculate  the   
maximum  number  of  SMC   
complexes  that  can  bind,  2)   
randomly  select  binding  sites  using   
a  weighted  probability.   
Assumptions:  model  SMC  condensation   
separately  from  DNA  Supercoiling,  as   
unknown  impact  of  SMC  activity  on  DNA   
linking  number  (used  by  supercoiling);  SMC   
complexes  bind  to  random  locations;  and  rate  
is  determined  by  copy  numbers  of  SMC   







Models  chromosome   
compaction  also.   
Algorithm,  with  stochastic  or   
calculation  steps,  for  seven  stages,,  






DNA  Damage   Models  spontaneous  and   radiation  induced  damage.  
Reactions  are  triggered  randomly  at  
random  locations  (each  reaction   
treated  as  an  independent  Poisson   
process),  parameterised  by  reported  
data.   
Spontaneous  damage  is  calculated  from  the   
observed  rate,  whereas  radiation  damage  is   
calculated  from  the  observed  rate  and   
modelled  radiation  flux.  Chemically-induced   
damage  was  reconstructed  but  not  modelled   
(as  M.genitalium  is  not  commonly  cultured   





DNA  Repair   
Models  five  modes  of  DNA   
repair,  one  specific  to   
M.genitalium ,  and  the   
binding  of  DisA  to  DNA   
lesions.   
Damaged  locations  randomly   
selected,  independent  repair   
reactions  randomly  chosen,   
parameterised  by  observed  kinetic   
rates,  until  resources  are  exhausted.  
Assumptions:  each  step  is  a  separate  reaction  
and  independent;  the  rate  is  determined  by   
DNA  configuration  and  copy  numbers  of   
metabolites  and  enzymes   
Cytokinesis   FtsZ  Polymerisation  
Models  the  formation  of  FtsZ  
rings.   
Ordinary  differential  equations,   
evaluated  at  each  time  step.   
Equations  taken  from  the  literature,  and   
simplified.  Assumptions:  length  of  filament   
assumed  to  be  equivalent  of  C.crescentus ,   
and  all  filaments  are  of  the  same  length.     
Cytokinesis   Cytokinesis   
Models  the  contraction  of   
successively  smaller  FtsZ   
rings.   
Algorithm,  with  stochastic   
processes,  for  five  stages,   
parameterised  by  observed  rates.   
Uses  published  iterative  pinching  model,   
subsequently  modified.  Assumptions:  rates  of   
FtsZ  filaments  binding  and  dissociating  are   
uncharacterised,  so  set  to  rapid  rates  that   
would  not  limit  progress;  assume  FtsZ  ring  in   





Models  the  interaction  of   
M.genitalium  with  the  host   
human  urogenital  epithelium.  
Algorithm,  with  four  sequential  and   
dependent  conditional  statements   
(Boolean).   
Reconstructed  from  observed  terminal   
organelle  protein  compositions  and  reported   
host  interactions.  Poorly  characterised.   
Table  5 .  28  sub-models  that  comprise  the  M.genitalium  whole-cell  model.  The  inputs  and   
outputs  of  each  sub-model  are:  metabolite  and  macromolecule  numbers;  RNA,  protein  and   
DNA  polymers  configurations;  and  enzyme  configurations  and  capacity.      
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Of  the  prior  publications  using  the  M.genitalium  whole-cell  model,  one  in  particular   
(Sanghvi  et  al .  2013  147 )  is  deserving  of  more  discussion.  The  paper  itself  is  error-prone,   
and  overemphasises  its  results  and  implications;  but  the  supplementary  results  are   
remarkable.  This  supplementary  material,  by  itself,  is  inspirational  for  the  analysis   
conducted  in  this  thesis;  it  elaborates  on  the  model  implementation,  the  description  of   
biological  processes,  and  the  biological  implications.  This  analysis  is  the  precursor  to   
the  analysis  conducted  in  Chapter  4  and  5.     
  
The  methodology  for  using  the  M.genitalium  whole-cell  model  presented  in  the  paper  is   
good:  predict  cellular  behaviour  in-silico ,  compare  to  in-vivo ,  investigate  the   
discrepancies  to  make  discoveries,  and  update  the  model.     
  
However,  this  is  only  conducted  in  a  very  limited  manner  in  this  paper.  This  paper   
claims  to  investigate  86  single  gene  knockout  simulations  quantitatively.  This  number  is   
actually  53,  due  to  34  of  the  included  genes  being  unmodelled;  both  this  eand  the   
model  publication  paper  omit  any  quantitative  references  to  unmodelled  genes.  This   
paper  references  “seven  categories  …  two  of  which  (“annotation  insufficient”  and   
“quantitative  agreement,  annotation  insufficient”  )  are  dependent  on  ...  whether  a  gene’s   
function  was  well-enough  annotated  for  functional  inclusion  in  the  model”.  It  is  not  
clarified  in  the  paper  how,  if  a  gene  has  an  insufficient  annotation  to  be  modelled  it  is   
capable  of  yielding  quantitative  information  via  in-silico  simulation.  The  34  genes  in  the   
category  are  erroneously  included  in  the  count  of  the  86  single  gene  knockout   
simulations  (though  86  itself  is  a  miscount,  the  inclusion  of  the  34  genes  makes  it  87).     
  
It  focuses  on  two  of  these  seven  categories  to  select  14  genes  to  have  any,  albeit  brief,   
secondary  analysis.  The  paper,  however,  should  consider  28  genes  at  this  stage.  The   
paper  miscounts  one  category  (13  instead  of  14),  updates  the  results  of  9  genes  from   
the  model’s  publication  (Sanghvi  et  al .  Supplementary  Table  1  compared  to  Karr  et  al.   
Supplementary  Table  S2G  6 )  without  highlighting  this  or  giving  an  explanation  as  to  why   
(reducing  a  category  from  14  genes  to  5  genes),  and  excludes  the  genes  MG_011,   
MG_012,  MG_293,  MG_411,  MG_412  from  analysis  arbitrarily.  Of  these  14  genes,  only   
3  single  gene  knockout  simulations  are  investigated  in-depth.  
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The  paper  proposes  a  second,  good  methodology:  look  for  a  possible  mechanism  for   
the  model’s  inability  to  predict  the  experimental  data,  by  examining  the  ‘molecular   
pathology’  in  both  the  model  and  the  literature,  thereby  identifying  a  previously   
misrepresented  or  missing  function  in  the  model.      
  
However,  the  focus  of  the  paper  from  here  is  disappointing.  It  focuses  on  the  three   
single  gene  knockouts  due  to  the  quantitative  comparisons  it  can  make  rather  than   
qualitative  (the  alternative,  qualitative  comparisons  are  what  are  so  compelling  in  the   
supplementary  results).  This  would  be  understandable  from  the  perspective  of   
strengthening  the  research  with  laboratory  results,  except  that  these  experiments  occur   
as  plasmid  expressions  in  E.coli  (which  does  not  bolster  the  results  in  the  same  way).   
  
The  quantitative  focus  results  in  tweaking  parameter  values  to  change  metabolic  fluxes   
in  identified  compensatory  reactions,  to  produce  experimentally  predicted  growth  rates   
in  the  M.genitalium  whole-cell  model.  This  is  easier  to  implement  in  the  model  but   
dodges  really  questioning  the  model’s  implementation  of  biological  processes.  It  also   
allows  the  blame  for  these  irregularities  to  be  placed  on  the  lack  of  M.genitalium  in-vivo   
data  (as  explained  in  the  paper,  the  prior  implementation  relied  on  data  “approximated   
from  different  organisms”),  rather  than  decisions  made  by  the  model  developers.  Given   
this  is  a  paper  by  the  same  group,  a  year  later,  there  was  little  to  lose  by  confronting   
and  improving  their  own  work.  Otherwise,  the  biological  explanation  given  for  MG_039   
gets  the  closest  to  the  supplementary  result’s  analysis  and  is,  therefore,  the  more   
satisfactory.   
  
The  overemphasis  appears  twice  in  the  paper.  First,  the  paper  merges  its  quantitative   
results  with  the  previously  published  qualitative  results  from  the  model’s  publication  (for   
“all  525”  genes  -  as  previously  stated,  124  are  unmodelled),  in  an  unqualified  manner.   
This  enhances  the  scale  of  the  results,  which  they  state  more  truthfully  later  is  only   
“three  instances  of  validation”.  Secondly,  the  paper  states  that  the  results  were   
predictive.  As  the  paper  could  have  more  simply  adjusted  and  trialed  the  three  gene’s   
catalytic  efficiency,  given  the  known  quantitative  error  with  the  experimental  results,  the   
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use  of  the  model  to  predict  this  efficiency  is  unnecessary  and  overstates  the  impact  of   
this  result.   
  
This  thesis  differs  from  Sanghvi  et  al .  2013  147   by  focusing  on  qualitative  rather  than   
quantitative  analysis,  increasing  the  scale  of  the  genetic  modifications  past  single  gene   
knockouts,  and  conducting  thorough  analysis  across  the  largest  breadth  of  results  for   
as  long  as  possible;  while  emulating  the  analysis  conducted  in  the  supplementary   
results.   
  
1.3.4.a E.coli  in-silico   
The  E.coli  whole-cell  model  is  the  second  whole-cell  model,  under  review  for   
publication,  with  its  code  publicly  available  152 .  Currently,  it  has  1214  genes  modelled,   
with  the  ability  to  simulate  multiple  environments  and  growth  conditions,  and  match   
against  experimentally  verified  results  and  predictions.  The  model  is  implemented  in   
Python  and  uses  FireWorks,  a  workflow  management  tool,  to  organise  and  conduct   
simulations.  In  comparison  to  the  M.genitalium  whole-cell  model,  the  E.coli  whole-cell   
model  is  quicker  (15  minutes  to  simulate  a  life  cycle  of  a  cell),  can  simulate  multiple   
generations,  accounts  for  50  times  more  molecules,  and  is  built  using  species  specific   
data  (from  primary  literature  and  databases  (e.g.  EcoCyc)).  Most  of  this  data  comes   
from  three  strains  of  E.coli :  K-12  MG1655,  B/r,  and  BW25113,  making  the  model  a   
composite  strain.   
  
In  more  detail,  the  E.coli  whole-cell  can  simulate  cells  growing  at  different  rates  in   
response  to  changes  in  the  simulated  environment,  regulate  transcription  more   
accurately  by  including  the  function  of  22  transcription  factors  (that  regulate  355  genes),   
model  340  metabolic  reactions  in  greater  detail,  generate  metabolites  according  to   
resource  availability  rather  than  producing  metabolites  in  a  fixed  ratio  every  time  the   
cellular  states  are  updated,  and  has  greater  detail  in  the  translation  sub-model   
(translational  efficiency  data  is  included  to  inform  ribosome  binding  to  mRNA   
transcripts)  and  RNA  decay  sub-model  (decay  rates  for  both  endonuclease-mediated   
cleavage  and  digestion  by  exoRNases  are  included).  However,  the  E.coli  whole-cell   
does  not  currently  model  all  E.coli  genes  and  lacks  several  sub-models  implemented  in   
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the  M.genitalium  whole-cell  model.  These  missing  sub-models  can  be  grouped  into:   
DNA  (chromosome  condensation  and  segregation,  damage,  repair,  supercoiling);  RNA   
(processing,  modification,  aminoacylation);  protein  (processing,  translocation,  folding,   
modification);  ribosome  assembly  and  FtsZ  polymerization.  The  model  aims  to  support   
simulating  17  environmental  conditions,  though  only  five  have  been  fully  implemented   
and  tested  (wild  type,  nutrientTimeSeries,  condition,   
metabolism_kinetic_objective_weight,  and  param_sensitivity),  with  gene_knockout   
having  been  implemented  but  not  tested.  Other  environmental  conditions  and   
increased  numbers  of  modelled  genes  are  planned  to  be  added  to  the  model  over  time.   
Greater  detail  on  the  model  will  be  made  available  upon  publication.   
  
1.3.4.b Algorithms  for  Genome  Engineering   
Genome  design  algorithms  for  genome  engineering  are  rare;  only  one  algorithm  has   
been  identified  in  the  literature  outside  of  this  thesis.  MinGenome  153 ,  published  in  2018,   
identifies  all  dispensable  contiguous  sequences  (unbroken  stretches  of  non-essential   
genes)  in  the  E.coli  MG1655  genome.  By  identifying  these  large  multi-gene  deletions   
and  comparing  them  to  existing  E.coli  genome  reductions,  new  deletions  to  test  in-vivo   
are  highlighted,  which  when  tested  will  either  increase  the  current  genome  reductions   
or  highlight  low  essential  genes.      
  
1.3.5 Issues   
There  is  a  need  for  greater  species-specific  understanding  of  the  metabolism  and  the   
genome.  Even  well-studied  organisms  ( B.subtilis  and  E.coli )  have  genes  with  unknown   
functions  and  essentiality;  bacterial  genomes  have  on  average  33%  genes  of  unknown   
function  154 .  Of  the  genes  with  known  functions,  in  most  cases  we  only  understand   
essentiality  at  the  single  or  double  gene  knockout  level  68,69 .  Current  genome  reductions   
have  had  to  identify  synthetic  lethal  interactions  (particularly  low  essential  genes)  as  part   
of  their  reduction  efforts,  rather  than  being  able  to  design  around  them.  If  we  had  a   
greater  grasp  of  gene  product  interactions,  enabling  them  to  be  accurately  modelled,   
this  could  be  avoided.  We  would  also  be  taking  steps  towards  a  proposed  end  goal  of   
genome  design,  combining  modular  components  of  different  bacteria  in  a  novel  cell   
26,155 .     
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1.3.6 Next  Steps   
The  next  steps  for  genome  engineering  are:  (i)  the  production  and  publication  of  new   
whole-cell  models  156 ;  (ii)  the  implementation  of  computational  standards  to  keep  the   
field  cohesive  and  prevent  fragmentation  157 ;  (iii)  the  testing  of  in-silico  designs  in-vivo  56 ;   
(iv)  and  the  establishment  of  routine  procedures  for  in-vivo  genome  reductions  for   
species  that  will  soon  have  whole-cell  models.     
  
1.4 PhD  Aims     
Firstly,  to  create  a  genome  design  algorithm  for  use  with  whole-cell  models.  Secondly,   
to  produce  a  computational  minimal  genome  for  M.genitalium ,  using  the  M.genitalium   
whole-cell  model,  the  developed  genome  design  algorithm,  and  the  University  of   
Bristol’s  supercomputers.  Thirdly,  to  test  existing  and  currently  untested  minimal  gene   
sets  in-silico  using  the  M.genitalium  whole-cell  model.  Fourthly,  produce  a   
computational  minimal  genome  for  E.coli ,  using  the  developed  genome  design   
algorithm  and  the  E.coli  whole-cell  model  when  it  is  made  available  to  outside   
researchers.  Finally,  to  test  large-scale  reductions  of  the  E.coli  genome  as  predicted  by   
the  E.coli  whole-cell  model.  This  final  step  would  be  the  first  research  to  test  whole-cell   
model  results  in-vivo ,  and  the  first  use  of  in-silico  design  and  in-vivo  editing  for  entire   




Chapter  2  -  Methods   
2.1 Statement  of  Collaboration   
Sections  of  the  Methods  chapter  have  previously  been  published  with  the  author  of  this   
thesis  as  the  lead  author.  The  sections  reproduced  here  are  solely  this  author's  work.     
● Rees-Garbutt,  J.  et  al .  Designing  minimal  genomes  using  whole-cell  models.   
Nat.  Commun .  11 ,  836  (2020).   
○ Lead  author   
● Rees-Garbutt,  J.,  Grierson,  C.  &  Marucci,  L.  Testing  theoretical  minimal   
genomes  using  whole-cell  models.  bioRxiv.  doi:10.1101/2020.03.26.010363   
(2020).   
○ Lead  author     
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2.2 General  Methods   
2.2.1 Code  Availability   
All  code  created  as  part  of  this  thesis  is  available  on  Github  ( github.com/squishybinary ,   
github.com/GriersonMarucciLab )  under  a  GNU  General  Public  License  v3.0  (gpl-3.0).   
For  more  information  see  choosealicense.com/licenses/lgpl-3.0/ .   
  
2.2.2 Model  Availability   
The  M.genitalium  whole-cell  model  is  freely  available:  github.com/CovertLab/WholeCell .   
The  model  requires  a  single  CPU  and  can  be  run  with  8  GB  of  RAM.  I  run  the   
M.genitalium  whole-cell  model  on  Bristol’s  supercomputers  using  MATLAB  R2013b,   
with  the  model’s  standard  settings.  However,  I  use  my  own  version  of  the   
SimulationRunner.m.  MGGRunner.m   
( github.com/GriersonMarucciLab/Analysis_Code_for_Mycoplasma_genitalium_whole-c 
ell_model )  is  designed  for  use  with  supercomputers  that  start  hundreds  of  simulations   
simultaneously.  It  artificially  increments  the  starting  time-date  value  for  each  simulation,   
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as  this  value  is  subsequently  used  to  create  the  initial  conditions  of  the  simulation.  My   
research  copy  of  the  whole-cell  model  was  downloaded  10th  January  2017.   
  
The  E.coli  whole-cell  model  is  freely  available:   
github.com/CovertLab/WholeCellEcoliRelease .  I  run  the  model  on  Bristol’s  BlueCrystal   
supercomputer  using  the  standard  installation  requirements  and  settings.  My  research   
copy  of  the  model  is  up  to  date  with  the  current  release  snapshot,  which  was  released   
on  the  29th  October  2019.     
  
2.2.2.a M.genitalium  in-silico  Environmental  Conditions   
M.genitalium  is  grown  in-vivo  on  SP4  media.  The  in-silico  media  composition  is  based   
on  the  experimentally  characterized  composition,  with  additional  essential  molecules   
added  (nucleobases,  gases,  polyamines,  vitamins,  and  ions)  in  reported  amounts  to   
support  in-silico  cellular  growth.  Additionally,  the  M.genitalium  whole-cell  model   
represents  10  external  stimuli  including  temperature,  several  types  of  radiation,  and   
three  stress  conditions.  For  more  information  see  Karr  et  al.  Supplementary  Tables  S3F,   
S3H,  S3R  6 .   
  
2.2.3 Equipment   
For  the  M.genitalium  whole-cell  model  I  used  the  University  of  Bristol  Advanced   
Computing  Research  Centres’s  BlueGem,  a  900-core  supercomputer,  which  uses  the   
Slurm  queuing  system,  to  run  whole-cell  model  simulations.     
  
For  the  E.coli  whole-cell  model,  I  used  the  University  of  Bristol  Advanced  Computing   
Research  Centres’s  BlueCrystal,  a  3568-core  supercomputer,  which  uses  the  PBS   
queuing  system,  to  run  whole-cell  model  simulations.   
  
I  used  a  standard  office  desktop  computer,  with  8  GB  of  ram,  to  write  new  code,  and   
interact  with  the  supercomputer.  I  used  the  following  GUI  software  on  Windows  7:   
Notepad++  for  code  editing,  Putty  (ssh  software)  for  terminal  access  to  the   
supercomputer,  FileZilla  (ftp  software)  to  move  files  in  bulk  to  and  from  the   
supercomputer,  and  PyCharm  (IDE  software)  as  an  inbuilt  desktop  terminal  and  for   
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python  debugging.  The  command  line  software  used  included:  VIM  for  code  editing,   
and  SSH,  Rsync,  and  Bash  for  communication  and  file  transfer  with  the   
supercomputers.     
  
2.2.4 Data  Format   
For  the  M.genitalium  whole-cell  model  the  majority  of  output  files  are  state-NNN.mat   
files  (Figure  2),  which  are  logs  of  the  simulation  split  into  100-second  segments.  The   
data  within  a  state-NNN.mat  file  is  organised  into  the  16  cellular  variables.  These  are   
typically  arranged  as  3-dimensional  matrices  or  time  series,  which  are  flattened  to   
conduct  analysis.  The  other  file  types  contain  summaries  of  data  spanning  the   
simulation.  Each  wild  type  simulation  consists  of  300  files  requiring  0.3  GB.  Each  gene   
manipulated  simulation  can  consist  of  up  to  500  files  requiring  between  0.4  GB  and  0.9   
GB.  Each  simulation  takes  5  to  12  hours  to  complete  in  real  time,  7  -  13.89  hours  in   
simulated  time.     
  
The  E.coli  whole-cell  model  outputs  data  in  plain  text  files  and  automatically  plots  a   
range  of  graphs  from  the  data,  in  .png,  .pdf,  and  .svg  formats.     
  
2.2.5 Data  Analysis  Process  
For  the  M.genitalium  whole-cell  model,  the  raw  data  is  automatically  processed  as  the   
simulation  ends.  runGraphs.m  carries  out  the  initial  analysis,  while  compareGraphs.m   
overlays  the  output  on  collated  graphs  of  200  unmodified  M.genitalium  simulations.   
Both  outputs  are  saved  as  MATLAB  .fig  and  .pdfs,  though  the  .pdf  files  were  the  sole   
files  analysed.  The  raw  .mat  files  were  stored  in  case  of  further  investigation.   
For  the  single  gene  knockout  simulations  produced,  the  non-essential  simulations  were   
automatically  classified  and  the  essential  simulations  flagged.  Each  simulation  was   
investigated  manually  and  given  a  phenotype  using  the  decision  tree  (Figure  6).     
  
For  the  E.coli  whole-cell  model,  the  massFractionSummary.png,   
histogramDoublingTime.png,  and  replication.png  output  files  are  of  particular  interest  as   
these  provide  the  information  extracted  and  graphed  with  the  M.genitalium  whole-cell  
model  (Figure  4).  I  also  extract  a  metadata  file  (‘short-name’)  as  it  records  the  RNA  id  of   
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the  gene  knocked  out  in  the  simulation.  To  create  comparison  images  (Figure  17),  I  use   
Wand  158 ,  a  python  binding  of  ImageMagick  159 ,  to  make  the  .png  files  backgrounds   
transparent  and  overlay  the  images  on  top  of  each  other   
( github.com/squishybinary/Ecoli_whole-cell_model_analysis ).  The  model  outputs  and   
comparison  graphs  are  assessed  manually.   
  
2.2.6 Modelling  Scripts   
There  are  six  scripts  used  to  run  the  M.genitalium  whole-cell  model.  Three  are  the   
experimental  files  created  with  each  new  experiment  (the  bash  script,  gene  list,   
experiment  list),  and  three  are  stored  within  the  whole-cell  model  and  are  updated  only   
upon  improvement  (MGGrunner.m,  runGraphs.m,  and  compareGraphs.m).  The  bash   
script  is  a  list  of  commands  for  the  supercomputer(s)  to  carry  out.  Each  bash  script   
determines  how  many  simulations  to  run,  where  to  store  the  output,  and  where  to  store   
the  results  of  the  analysis.  The  gene  list  is  a  text  file  containing  rows  of  gene  codes  (in   
the  format  ‘MG_XXX’,).  Each  row  corresponds  to  a  single  simulation  and  determines   
which  genes  that  simulation  should  knockout.  The  experiment  list  is  a  text  file   
containing  rows  of  simulation  names.  Each  row  corresponds  to  a  single  simulation  and   
determines  the  final  location  of  the  simulation  output  and  analysis  results.     
  
There  is  only  one  script  used  to  run  the  E.coli  whole-cell  model.  The  bash  script  is   
created  with  each  new  experiment  and  contains  a  list  of  commands  for  the   
supercomputer  to  carry  out.  These  commands  prepare  the  supercomputer  to  execute   
two  main  tasks:  load  the  described  simulation  onto  the  external  database  as  a  series  of   
tasks,  and  then  execute  those  tasks  on  the  supercomputer  until  the  simulations  are   
complete.  The  genes  to  delete  are  defined  in  the  simulation  description  in  the  bash   
script.  The  analysis  is  automatically  conducted,  and  the  output  is  stored  automatically   




Figure  2.  Anatomy  of  a  state  file  ( M.genitalium  whole-cell  model).  The  data  within  a   
state-XXX.mat  file  is  organised  into  16  cellular  variables.  The  variables  graphed  in  my   
analysis  are:  Ploidy  as  DNA  replication,  Pinched  Diameter  as  Cell  Division,  Total  as   
Mass,  RnaWt  as  RNA  production,  ProteinWt  as  Protein  Production,  Growth  as  Growth.   
  
2.3 Running  the  M.genitalium  whole-cell  Model     
This  section  (and  Section  2.4.5)  were  written  by  myself  as  tutorials  for  training  other   
members  of  our  research  group  and  for  potential  future  users,  as  the  M.genitalium   
whole-cell  model  documentation  was  lacking  important  information  and  is  now  no   




2.3.1 Installing  the  M.genitalium  whole-cell  Model  on  a  Supercomputer      
1. Download  the  whole-cell  model  files  from  github.com/CovertLab/WholeCell   
2. Download  analysis  files  from  github.com/squishybinary/   
Analysis_Code_for_Mycoplasma_genitalium_whole-cell_model   
3. Create  the  following  directory  structure  on  your  institute’s  supercomputer:   
● /home/USER  folder   
● WholeCell-master   
● WholeCell-master     
● -[WholeCell  model  files]   
● -[runGraphs.m]     
● -[compareGraphs.m]     
● -[WildTypeBackground.fig]   
● src   
● +edu/+stanford/+covert/+cell/+sim   
● +runners     
● -[MGGrunner.m]   
● BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
● BlueGemScripts  -[*.sh]   
● KOLists  -[*_ko.list]   
● ExpLists  -[*_exp.list]   
● /projects  folder   
● GROUP  folder   
● USER  folder   
● Output  folder   
● PROJECTfolder   
● Name  of  *.sh  file  folder   
● 'simname'  (see  lines  of   
*_exp.list)  folder   
● 1  -[simulation  files]   
● n  (depending  on  number  
of  simulations,  see   
*_exp.list)   
● WildType  (stage  dependent)   
● n   
● Mutant  (stage  dependent)   
● n   
● pdfs   
● figs   
4. Upload  the  whole-cell  model  files  to  location  indicated     
5. Upload  runGraphs,  compareGraphs,  WildTypeBackground.fig,  MGGrunner   




2.3.2 Running  a  wild  type  M.genitalium  whole-cell  Model  Simulation   
In  brief,  to  manually  run  the  whole-cell  model:  a  new  bash  script,  gene  list,  and   
experiment  list  are  created  on  the  desktop  computer  to  answer  an  experimental   
question.  The  supercomputer  is  accessed  on  the  desktop  via  ftp  software,  where  the   
new  experimental  files  are  uploaded,  the  planned  output  folders  are  created,  and   
MGGRunner.m,  runGraphs.m,  compareGraphs.m  files  are  confirmed  to  be  present.  The   
supercomputer  is  then  accessed  on  the  desktop  via  ssh  software,  where  the  new  bash   
script  is  made  executable  and  added  to  the  supercomputer’s  queuing  system  to  be   
executed.  Once  the  experiment  is  complete,  the  supercomputer  is  accessed  on  the   
desktop  via  ssh  software,  where  the  results  of  the  analysis  are  moved  to  /pdf  and  /fig  
folders.  These  folders  are  accessed  on  the  desktop  via  ftp  software,  where  the  results   
of  the  analysis  are  downloaded.  More  detailed  instructions  are  contained  within  the   
template  bash  scripts.   
  
Detailed  steps:   
1. Download  the  wild  type  simulation  file  from:   
github.com/squishybinary/Supercomputer_Simulation_Files_for_Mycoplasma_g 
enitalium_whole-cell_model/blob/master/WildTypeSimulation.sh     
2. The  file  is  set  to  run  10  wild  type  simulations.  If  you  would  like  to  change  this:   
a. Modify  Line  54  (#SBATCH  --array=1-10)   
i. E.g.  for  one  simulation:  #SBATCH  --array=1   
ii. E.g  for  seven  simulations:  #SBATCH  --array=1-7   
3. In  the  .sh  file,  change  the  “USER”  name  and  the  “PROJECTfolder”  name  to  your  
preferred  project  name   
4. Upload  the  simulation  file  (*.sh)  to  the  supercomputer  (see  directory  structure)   
using  ftp  software   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   




6. Inside  your  project  folder  create  the  following  folders  in  the  displayed  structure:   
a. WildTypeSimulation     
i. 1   
ii. 2   
iii. …  (create  folders  equal  to  the  number  of  simulations  running)   
iv. pdfs   
v. figs   
7. Connect  to  the  supercomputer  using  a  terminal  /  shell  /  command  line  tool   
8. Run  the  simulation  files  on  the  supercomputer:   
a. Make  the  script  executable:     
chmod  u+x  WildTypeSimulation.sh   
b. Run  the  script  (if  your  supercomputer  uses  Slurm)   
sbatch  WildTypeSimulation.sh      
c. Check  it  is  running  (if  your  supercomputer  uses  Slurm)   
squeue  -u  [your_username]   
9. Once  the  simulations  have  completed,  the  resulting  files  will  appear  in  the   
respective  WildTypeSimulation/N  folders.   
10.   Copy,  paste,  and  run  lines  118  and  119  from  WildTypeSimulation.sh  separately   
into  the  terminal  /  shell  /  command  line  to  collect  all  analysis  files  into  the  /pdfs   
and  /figs  folders,  changing  the  username  and  projectfolder  name   
find  /projects/flex1/USER/output/PROJECTfolder/WildTypeSimulation  - type  f  -iname   
"*.pdf"  - exec  mv  -t   
/projects/flex1/USER/output/PROJECTfolder/WildTypeSimulation/pdfs  {}  +   
find  /projects/flex1/USER/output/PROJECTfolder/WildTypeSimulation  - type  f  -iname   
"*.fig"  - exec  mv  -t   
/projects/flex1/USER/output/PROJECTfolder/WildTypeSimulation/figs  {}  +   





2.3.3 Running  a  gene  knockout  M.genitalium  whole-cell  Model  Simulation   
Detailed  steps:   
1. Download  the  GeneKnockoutSimulation  files  (*.sh,  *_exp.list,  and  *_ko.list)  from:   
github.com/squishybinary/Supercomputer_Simulation_Files_for_Mycoplasma_g 
enitalium_whole-cell_model   
2. In  the  .sh  file,  change  the  “USER”  name  and  the  “PROJECTfolder”  name  to  your  
preferred  project  name   
3. Upload  simulations  files  (*.sh,  *_ko.list,  *_exp.list)  to  the  supercomputer  (see   
directory  structure  above):   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   
ii. KOLists  -[*_ko.list]   
iii. ExpLists  -[*_exp.list]   
4. Create  a  project  folder  matching  the  name  you  gave  it  Step  2   
5. Inside  your  project  folder  create  the  following  folders  in  the  displayed  structure:   
a. GeneKnockoutSimulation     
i. MG_007   
A. 1   
B. 2   
. .   
C. 10   
ii. WildType   
A. 11   
iii. Mutant   
A. 12   
iv. pdfs   
v. figs   
6. Connect  to  the  supercomputer  using  a  terminal  /  shell  /  command  line  tool   
7. Run  the  simulation  files  on  the  supercomputer:   
a. Make  the  script  executable:     
chmod  u+x  GeneKnockoutSimulation.sh   
b. Run  the  script  (if  your  supercomputer  uses  Slurm)   
sbatch  GeneKnockoutSimulation.sh      
c. Check  it  is  running  (if  your  supercomputer  uses  Slurm)   
squeue  -u  [your_username]   
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8. Once  the  simulations  have  completed,  the  resulting  files  will  appear  in  the   
respective  numbered  folders.   
9. Copy,  paste,  and  run  lines  118  and  119  from  GeneKnockoutSimulation.sh   
separately  into  the  terminal  /  shell  /  command  line  to  collect  all  analysis  files  into   
the  /pdfs  and  /figs  folders,  changing  the  username  and  projectfolder  name   
find  /projects/flex1/USER/output/PROJECTfolder/GeneKnockoutSimulation  -type  f  -iname   
"*.pdf"  -exec  mv  -t   
/projects/flex1/USER/output/PROJECTfolder/GeneKnockoutSimulation/pdfs  {}  +   
find  /projects/flex1/USER/output/PROJECTfolder/GeneKnockoutSimulation  -type  f  -iname   
"*.fig"  -exec  mv  -t   
/projects/flex1/USER/output/PROJECTfolder/GeneKnockoutSimulation/figs  {}  +   
10.   Download  the  analysis  files  from  the  /pdfs  and  /figs  folders  using  ftp  software.   
  
2.4 Chapter  4  and  5  Specific  Methods   
2.4.1 Code  Availability   
The  code  for  the  Minesweeper  genome  design  algorithm,  scripts  for  statistical  analysis,   
scripts  for  analysing  GO  terms,  my  custom  simulation  runner,  analysis  scripts,  a   
template  bash  script,  as  well  as  bash  scripts  and  text  files  used  to  generate  the   
simulations  are  available  on  Github  ( github.com/GriersonMarucciLab ).   
  
2.4.2 Statistics   
I  used  the  R  binom  package  ( rdocumentation.org/packages/binom )  to  conduct   
one-tailed  binomial  proportion  confidence  intervals  on  41  genes  showing  inconsistent   
results  (success  ranging  from  6  to  9  replicates,  out  of  a  total  of  10  replicates).  I  used   
binom.confit.exact  (Pearson-Klopper)  using  95%  CIs,  producing  for:  6/10  replicates   
[0.26,  0.87],  7/10  replicates  [0.34,  0.93],  8/10  replicates  [0.44,  0.97],  9/10   
replicates[0.55,  0.99]).  I  graphed  these  results  in  R  and  in  Python  using   
Seaborn  ( seaborn.pydata.org/ )  ,  the  exact  values,  code,  and  graphs  produced  are   





2.4.3 Data  Analysis  Process  
For  in-silico  experiments  conducted  using  Minesweeper,  simulations  were  automatically   
classified  solely  by  division,  which  can  be  analysed  from  cell  width  or  the  endtime  of  the   
simulation.  Further  analysis,  including:  cross-comparison  of  single  gene  knockout   
simulations,  comparison  to  Karr  et  al. ’s  6   results,  analysis  of  Minesweeper  and  GAMA   
genomes  (genetic  content  and  similarity,  behavioural  analysis,  phenotypic  penetrance,   
gene  ontology),  and  identification  and  investigation  of  high  and  low  essentiality  genes   
and  groupings,  were  completed  manually.     
The  GO  biological  process  terms  were  downloaded  from  Uniprot  160   (strain  ATCC   
33530/NCTC  10195),  processed  by  a  created  script   
( github.com/squishybinary/Gene_Ontology_Comparison_for_Mycoplasma_genitalium_ 
whole-cell_model ),  then  organised  manually  into  tables  of  GO  terms  that  were   
unaffected,  reduced,  or  removed  entirely  by  gene  deletions.   
  
2.4.4 Data  Availability   
The  databases  used  to  design  the  in-silico  experiments,  and  compare  the  results  to,   
includes  Karr  et  al.  6   and  Glass  et  al.  61   Supplementary  Tables,  and  Fraser  et  al.   
M.genitalium  G37  genome  58   interpreted  by  KEGG  132   and  UniProt  160   as  strain  ATCC  
33530/NCTC  10195.  The  output  .fig  files  for  all  simulations  referenced  in  Chapter  4  are   
available  from  the  group’s  Research  Data  Repository  (data-bris)  at  the  University  of   
Bristol,  with  the  identifier  doi.org/10.5523/bris.1jj0fszzrx9qf2ldcz654qp454  161 .  All  of  the   
Minesweeper  genome  simulations  require  4.2  TB  of  data.  These  are  stored  by  the   
group  to  be  available  for  request.     
  
2.4.5 Using  the  Minesweeper  Algorithm  with  the  M.genitalium  whole-cell  model   
Minesweeper  conducts  whole-cell  model  simulations  in  three  step  cycles:  design   
(algorithms  select  possible  gene  deletions);  simulate  (the  genome  minus  those   
deletions);  and  test  (analyse  resulting  cell).  Simulations  that  removed  the  most  genes   
from  the  in-silico  genome  and  produced  dividing  model  cells  proceed  to  the  next  cycle,   
increasing  the  number  of  gene  deletions  and  producing  progressively  smaller  genomes.     
Minesweeper  is  a  four-stage  algorithm  inspired  by  divide  and  conquer  algorithms  162 ,   
stages  one  to  three  are  sequential,  with  stage  four  repeating  until  Minesweeper  stops.  It   
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initially  deletes  genes  in  groups  but  eventually  deletes  individual  genes,  and  only  deletes   
non-essential  genes  (determined  by  single  gene  knockout  simulations).  It  uses  between   
8  and  359  CPUs  depending  on  the  stage,  with  data  storage  handled  by  user-submitted   
information  and  simulation  execution  conducted  manually.  It  is  written  in  Python3  and   
consists  of  four  scripts  (one  for  each  stage).  It  is  run  manually  on  a  non-dedicated   
desktop,  with  its  output  determining  which  simulations  to  be  run  on  the  supercomputer.   
It  uses  no  external  libraries,  so  should  be  able  to  be  run  on  any  modern  operating   
system  (as  they  come  with  Python  preinstalled)  via  a  terminal.  Each  stage/script   
requires  a  text  file(s)  as  input,  with  each  stage  outputting  simulation  files.  These  are  run   
on  a  supercomputer  and  the  automatically  produced  summary  file  is  used  as  input  for   
the  next  stage  on  the  desktop,  with  progress  recorded  in  the  deletion  log  in   
/OUTPUT_final.  See  Chapter  4  for  a  more  in-depth  explanation  of  the  Minesweeper   
algorithm.   
  
2.4.5.1 Minesweeper  Demo   
This  demo  was  produced  as  part  of  the  publication  process  for  Minesweeper.  It   
explains  a  step  by  step  process  for  completing  a  full  cycle  of  the  Minesweeper   
algorithm  using  the  M.genitalium  whole-cell  model.  For  code  and  equipment  required   
see  Section  2.2.2  Model  Availability  and  Section  2.2.3  Equipment.   
  
The  test  data  provided  with  the  demo  was  produced  by  completing  stages  one  to  four   
of  Minesweeper  using  the  averaged  single  gene  essentiality  data  from  Table  6  (Section   





2.4.5.2 Steps  to  Install  Minesweeper     
1. Download  /  unzip  Minesweeper  code  and  test  data   
a. github.com/GriersonMarucciLab/Minesweeper     
2. Make  a  copy  of  the  Minesweeper_0.9  folder,  rename  it  appropriate  to  your   
project,  and  place  it  in  your  preferred  location  on  your  local  desktop.   
3. Minesweeper  requires  Python3.  To  check  you  have  Python3  installed  on  your   
local  desktop,  type  into  your  terminal  /  IDE  (integrated  development   
environment):   
python  --version   
4. If  you  need  to  install  python3,  visit  python.org/downloads/  for  the  appropriate   
installer.   
  
2.4.5.3 First  Stage   
The  first  stage  of  Minesweeper  conducts  individual  protein-coding  gene  knockouts,   
removing  complete/high  essential  genes  as  deletion  candidates.  The  first  stage  of   
Minesweeper  is  optional,  if  you  already  have  single  gene  knockout  simulation  results   
you  can  proceed  to  the  second  stage.     
  
Detailed  Steps:   
1. Check  the  first  required  text  file  (genes.txt,  containing  the  protein-coding  gene   
codes  in  the  model)  is  already  present  in  a  preexisting  folder  structure   
(INPUT_script_1).   
2. Skip  this  step  if  this  is  your  first  time  running  the  algorithm  or  you  want  to  run   
using  the  default  settings:   
a. If  you  would  like  to  create  a  custom  file  of  genes  to  attempt  to  knockout   
from  the  M.genitalium  in-silico  genome:   
i. Format  (one  per  line):  MG_XXX   
ii. Save  as:  genes.txt   




b. If  there  are  genes  you  wish  to  be  excluded  from  deletion  (exclusion  starts   
from  the  second  stage):   
i. Format  (one  per  line):  MG_XXX   
ii. Save  as:  exclusionlist.txt     
iii. Save  to:  INPUT_script_2  folder  
c. If  this  is  your  second  time  running  the  algorithm  and  you  already  have   
single  gene  knockout  results  for  all  genes  (or  you  have  an  average   
phenotype  result  from  multiple  simulations  for  each  single  gene):   
i. Create  a  custom  output  file  for  the  first  stage  (see  templatescript   
folder  for  a  template)   
1. Format:  sim_number  [tab]  time  [tab]  outcome   
a. Time  values:  13.89  for  no  division   
b. Time  values:  11.01(or  another  random  value  less   
than  13.89)  for  divided   
c. Outcome  values:  nodivision  OR  divided  
d. Save  as:  inputko1_endtimes.txt     
e. Save  to:  INPUT_script_2  folder  
ii. You  also  need  to  create  a  false  experiment  list  for  the  first  stage   
(see  templatescript  folder  for  a  template):   
1. Format:     
a. lines  containing  'inputko'\n  *  number  of  genes   
b. and  two  lines  at  the  end:  'wild  type'\n,  'mutant'   
c. Save  as:  mineinputko1_exp.list   
d. Save  to:  OUTPUT_script_1  folder   
3. In  either  a  terminal  or  an  IDE:     
a. Change  the  directory  to  your  project  folder  in  your  preferred  location     
b. Run  the  code  by  typing:     





4. The  code  will  output  generated  simulation  files  and  save  actions  taken  to  the  log   
file.     
a. See  generated  simulation  files:  *.sh  ,  *_exp.list,  *_ko.list  in   
OUTPUT_script_1  folder   
b. Log  file:  deletionlog.txt  in  OUTPUT_final   
5. Upload  generated  simulation  files  (*.sh,  *_ko.list,  *_exp.list)  to  the  supercomputer   
(see  directory  structure  above):   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   
ii. KOLists  -[*_ko.list]   
iii. ExpLists  -[*_exp.list]   
6. Run  the  simulation  files  on  the  supercomputer  (if  it  uses  the  Slurm  queuing  
system  see  lines  10  -  35  of  *.sh  generated  simulation  file)   
7. Once  the  simulations  have  completed,  the  resulting  summary  files  will  appear  in   
the  name-of-.sh  folder  (see  directory  structure  above).  Download  the  file  and   
place  it  in  the  correct  folder:   
a. inputkoN_endtimes.txt   
b. inputkoN_endtimes.txt  in  /INPUT_script_2  folder   
2.4.5.4 Second  Stage   
The  second  stage  sorts  the  singly  non-essential  genes  into  26  deletion  segments   
(100%,  90%A,  90%B,  80%A,  80%B,  70%A,  70%B,  60%A,  60%B,  50%A,  50%B,   
33%A-C,  25%A-D,  12.5%A-H).  The  A  segments  start  from  the  top  of  the  list  of  genes,   
whereas  the  B  segments  start  from  the  bottom  of  the  gene  list.  Deletion  segments  that   
can  be  removed  and  still  produce  a  dividing  cell  are  carried  forward.   
Detailed  steps:     
1. In  either  a  terminal  or  an  IDE:     
a. Change  the  directory  to  your  project  folder  in  your  preferred  location     
b. Run  the  code  by  typing:     
python  script2.py   
2. The  code  will  output  generated  simulation  files  and  save  actions  taken  to  the  log   
file.     
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a. See  generated  simulation  files:  *.sh  ,  *_exp.list,  *_ko.list  in   
OUTPUT_script_1  folder   
b. Log  file:  deletionlog.txt  in  OUTPUT_final   
3. Upload  generated  simulation  files  (*.sh,  *_ko.list,  *_exp.list)  to  the  supercomputer   
(see  directory  structure  above):   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   
ii. KOLists  -[*_ko.list]   
iii. ExpLists  -[*_exp.list]   
4. Run  the  simulation  files  on  the  supercomputer  (if  it  uses  the  Slurm  queuing  
system  see  lines  10  -  35  of  *.sh  generated  simulation  file)   
5. Once  the  simulations  have  completed,  the  resulting  summary  files  will  appear  in   
the  name-of-.sh  folder  (see  directory  structure  above).  Download  the  file  and   
place  it  in  the  correct  folder:   
a. divideko_endtimes.txt     





2.4.5.5 Third  Stage   
The  third  stage  progresses  with  the  three  largest  deletion  segments  that  produced  a   
dividing  cell,  these  three  variants  are  referred  to  as  red,  yellow,  blue.  These  perform  as   
replicates  and  as  a  check  on  if  the  results  are  converging.  The  three  variants  are   
matched  with  smaller,  dividing,  non-overlapping  segments  using  a  list  of  allowed   
matches  (implementation  is  detailed  in  Section  4.3.7).  A  powerset  is  generated  (i.e.  a   
set  containing  all  possible  unique  combinations  of  the  matched  deletion  segments,   
including  zero  and  individual  deletion  segments)  and  each  of  the  deletion  combinations   
is  removed  from  an  individual  in-silico  cell  and  simulated.     
Detailed  steps:     
1. In  either  a  terminal  or  an  IDE:     
a. Change  the  directory  to  your  project  folder  in  your  preferred  location     
b. Run  the  code  by  typing:     
python  script3.py   
2. The  code  will  output  generated  simulation  files  and  save  actions  to  the  log  file.     
a. See  generated  simulation  files:  *.sh  ,  *_exp.list,  *_ko.list  in   
OUTPUT_script_1  folder   
b. Log  file:  deletionlog.txt  in  OUTPUT_final   
3. Upload  generated  simulation  files  (*.sh,  *_ko.list,  *_exp.list)  to  the  supercomputer   
(see  directory  structure  above):   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   
ii. KOLists  -[*_ko.list]   
iii. ExpLists  -[*_exp.list]   
4. Run  the  simulation  files  on  the  supercomputer  (if  it  uses  the  Slurm  queuing  
system  see  lines  10  -  35  of  *.sh  generated  simulation  file)   
5. Once  the  simulations  have  completed,  the  resulting  summary  files  will  appear  in   
the  name-of-.sh  folder  (see  directory  structure  above).  Download  the  file  and   
place  it  in  the  correct  folder:   
a. conquerko_COLOUR_0_endtimes     
b. conquerko_COLOUR_0_endtimes  in  /INPUT_script_4X      
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2.4.5.6 Fourth  Stage   
The  fourth  stage  is  cyclical.  The  largest  deletion  combination  from  the  third  stage   
generates  a  remaining  gene  list  (those  yet  to  be  deleted).  The  remaining  genes  are  split   
into  eight  groups  and  a  powerset  is  generated.  Each  deletion  combination  from  the   
powerset  is  individually  appended  to  the  current  largest  deletion  combination  and   
simulated.  The  simulation  results  update  the  largest  deletion  combination,  which  is   
used  to  generate  a  new  remaining  gene  list,  starting  the  next  cycle.  If  none  of  the   
deletion  combinations  produce  a  dividing  cell,  the  remaining  genes  are  singly  appended   
to  the  largest  deletion  combination,  removed  and  simulated.  The  individual  remaining   
genes  that  do  not  produce  a  dividing  cell  are  excluded  for  a  cycle  and  a  reduced   
remaining  gene  list  is  generated,  which  is  used  for  the  next  cycle.     
The  fourth  stage  continues  until  there  are  eight  or  fewer  remaining  genes  (where  a  final   
appended  powerset  is  run)  or  all  individually  appended  remaining  genes  do  not   
produce  a  dividing  cell.  Both  outcomes  result  in  a  list  of  deleted  genes  and  identified   
low  essential  genes.   
Repeat  these  steps  until  Minesweeper  finishes:   
1. In  either  a  terminal  or  an  IDE:     
a. Change  the  directory  to  your  project  folder  in  your  preferred  location     
b. Run  the  code  by  typing:     
python  script4X.py   
2. The  code  will  output  generated  simulation  files  and  save  actions  taken  to  the  log   
file.  Check  the  log  file  for  progress  and  whether  another  round  of  simulations  is   
required.     
a. See  generated  simulation  files:  *.sh  ,  *_exp.list,  *_ko.list  in   
OUTPUT_script_1  folder   
b. Log  file:  deletionlog.txt  in  OUTPUT_final   
3. Upload  generated  simulation  files  (*.sh,  *_ko.list,  *_exp.list)  to  the  supercomputer   
(see  directory  structure  above):   
a. /BlueGem  (or  NAME  OF  SUPERCOMPUTER)   
i. BlueGemScripts  -[*.sh]   
ii. KOLists  -[*_ko.list]   
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iii. ExpLists  -[*_exp.list]   
4. Run  the  simulation  files  on  the  supercomputer  (if  it  uses  the  Slurm  queuing  
system  see  lines  10  -  35  of  *.sh  generated  simulation  file)   
5. Once  the  simulations  have  completed,  the  resulting  summary  files  will  appear  in   
the  name-of-.sh  folder  (see  directory  structure  above).  Download  the  file  and   
place  it  in  the  correct  folder:   
a. Potential  file  names:   
i. gapko_COLOUR_1_endtimes     
ii. gapko_COLOUR_2_endtimes     
iii. gapko_COLOUR_N_endtimes   
b. gapko_COLOUR_N_endtimes  in  /INPUT_script_4X      
6. Repeat  Steps  1  to  5,  though  pay  attention  to  the  log  file  (Step  2)  which  will  tell   
you  when  Minesweeper  has  finished.     
The  reason  for  selecting  eight  groups  and  three  variants  is  that  a  powerset  of  eight   
produces  256  unique  combinations.  Three  variants  each  with  256  simulations  (768   
total)  represents  85%  of  the  capacity  of  BlueGem.  A  set  of  nine  groups  with  three   
variants  (1536  simulations  total)  is  170%  the  capacity  of  BlueGem.  Queueing  systems   
mean  that  you  do  not  require  this  total  number  of  CPUs  to  be  available,  but  the   
execution  time  is  multiplied  as  you  wait  for  the  simulations  to  process.  The  number  of   
variants  and  groups  can  be  lowered  or  increased  depending  on  the  number  of  CPUs   
available.  To  do  so,  change  the  calculation  and  list  generation  values  in  the   
eightPanelGroupingsGeneration  function  in  the  fourth  script.   
  
2.5 Chapter  6  Specific  Methods     
2.5.1 Installing  the  E.coli  whole-cell  Model  on  a  Supercomputer      
I  have  made  a  detailed  list  of  step  by  step  instructions  methods  for  installing  the  E.coli   
whole-cell  model  onto  a  PBS  based  supercomputer  (e.g.  BlueCrystal)  available  on   
Github  ( github.com/squishybinary/Ecoli_whole-cell_model_analysis ).  Special  thanks  are   
due  to  Dee  (Ms  Dianaimh  Greene)  of  the  Advanced  Computing  Research  Centre,  who   




In  brief,  the  main  steps  are:     
1. Download  the  whole-cell  model  files  from  
github.com/CovertLab/WholeCellEcoliRelease   
2. Upload  the  model  to  the  supercomputer  via  ftp   
3. Install  python  tools   
4. Modify  the  startup  process  to  load  specific  tools  from  the  supercomputer   
5. Create  a  “virtual  environment”,  a  separate,  enclosed  space  for  installing  tools,   
around  the  E.coli  whole-cell  model   
Within  the  virtual  environment:   
6. Install  python   
7. Install  a  common  linear  algebra  operations  tool   
8. Install  required  libraries  and  tools   
9. Test  installations   
10.Change  the  matplotlib  backend  to  enable  correct  graphing  by  the  model   
11.Compile  the  model's  code  
12.Run  tests  to  see  if  the  model  is  functioning  correctly   
  
2.5.2 Running  the  E.coli  whole-cell  Model  on  a  Supercomputer     
1. Upload  FireWorks  .yaml  files  using  FTP  (changing  the  capitalised  values)  to:   
a. /HOME/USER/Folder_containing_model/wcEcoli/wholecell/fireworks   
2. Create  and  upload  a  FireWorksBox  bash  script  (Section  6.2.4)  to  the   
supercomputer  via  FTP  (changing  the  capitalised  values):   
a. /HOME/USER/Folder_containing_model/wcEcoli/wholecell/fireworks   
3. Login  to  the  supercomputer  using  ssh   
4. Create  the  following  directories  in  /fireworks   
a. /logs   
i. /launchpad   
ii. /qadapter   
5. Make  the  FireWorksBox  executable  and  run  it:   
cd  wcEcoli/wholecell/fireworks   




Chapter  3  -  Developing  Analysis  For  and  Running  the  M.genitalium   
whole-cell  Model   
3.1 Statement  of  Collaboration   
I  received  initial  training  in  running  the  M.genitalium  whole-cell  model  on  University  of   
Bristol’s  BlueGem  supercomputer  from  PhD  student  Oliver  Chalkley.   
  
3.2 Aims   
The  M.genitalium  whole-cell  model  is  the  first  model  of  its  kind,  published  relatively   
recently,  and  requires  interdisciplinary  research  teams  to  implement  the  model  and   
analyse  the  resulting  data.  Due  to  this,  when  starting  this  work  in  2016,  the  number  of   
researchers  in  the  whole-cell  modelling  community  was  small,  documentation  was   
present  but  sparse,  and  standards  had  not  been  fully  finalised.  I  took  this  opportunity  to   
produce  an  analysis  process  for  our  group  and  to  standardise  our  running  of  the   
whole-cell  model  and  the  analysis  of  the  model’s  output.   
  
3.3 Developing  Analysis  for  M.genitalium  whole-cell  Model  Simulations   
Oliver  Chalkley,  the  first  PhD  student  in  the  group,  had  already  installed  the   
M.genitalium  whole-cell  model  on  the  University’s  supercomputers  (BlueGem  and   
BlueCrystal)  when  I  joined  the  group.  I  focused  my  efforts  on  developing  an  analysis   
process  for  the  simulation  data.  No  formalised  process  currently  existed  within  the   
group,  so  I  started  with  the  analysis  conducted  by  the  initial  publication  6 .  “Figure  6B”  in   
Karr  et  al. ’s  paper  (Figure  3)  shows  the  potential  range  of  in-silico  cell  phenotypes.   
Single  gene  knockout  simulations  were  conducted  and  classified  according  to   
behaviour  in  five  criteria  (growth,  protein  mass,  RNA  mass,  DNA  mass,  septum  size)  in   
comparison  to  wild  type  (non  gene  edited)  simulations,  over  the  length  of  the   
simulation.  Each  column  in  Figure  3  corresponds  to  a  different  phenotype  class  and   
shows  a  representative  gene  knockout,  with  the  criteria  for  that  classification   
highlighted  in  orange.  Two  categories,  quasi-essential  and  other,  were  indicative  of   
failures  over  multiple  generations,  which  were  simulated  using  only  the  growth   
sub-model;  the  M.genitalium  whole-cell  model  as  a  whole  is  not  capable  of  multiple   
generation  simulations.   
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Figure  3.  “Figure  6B”.  Figure  and  legend  replicated  from  Karr  et  al.  2012  6 .  Single  gene   
disruption  strains  were  grouped  into  phenotypes  (columns)  according  to  their  capacity   
to  grow,  synthesize  protein,  RNA,  and  DNA,  and  divide  (indicated  by  septum  length).   
Each  column  depicts  a  representative  in-silico  cell  for  each  phenotype.  Dynamics   
significantly  different  from  wild  type  are  highlighted  in  orange.  The  identity  of  the   
representative  cell  and  the  number  of  disruption  strains  in  each  category  are  indicated   
in  parentheses.   
  
The  code  used  to  create  “Figure  6B”  is  3392  lines  long  (SingleGeneDeletions.m)  163 .  To   
start  creating  an  analysis  process,  I  extracted  22  functions  from  this  file,  and  other  files   
within  the  model,  essential  to  loading,  processing,  classifying,  and  graphing  the   
simulation  data.  This  proved  difficult  due  to  the  lack  of  accompanying  documentation.   
For  example,  the  plotOverview  function  from  SingleGeneDeletions.m  did  correspond  to   
“Figure6B”.  But,  as  can  be  seen  in  the  code  below,  there  is  a  lack  of  explanatory  notes   
or  commentary  in  the  code  and  several  categories  (underlined)  are  not  present  in  the   
published  literature.  Substantial  work  was  required  to  understand  the  dependencies   






catLabels  =  {   
'WT'              SingleGeneDeletions.WILD_TYPE   
'Energy'          SingleGeneDeletions.DECOMPOSING   
'Metabolic'       SingleGeneDeletions.NON_GROWING   
'RNA'   
SingleGeneDeletions.DECAYING_GROWTH_NON_RNA_PROTEIN   
'Protein'         SingleGeneDeletions.DECAYING_GROWTH_NON_PROTEIN   
'Other'           SingleGeneDeletions.NON_PERPETUATING   
'DNA'             SingleGeneDeletions.NON_REPLICATIVE   
'Cytokinesis'     SingleGeneDeletions.NON_FISSIVE   
'Term  Org'        SingleGeneDeletions.NO_TERMINAL_ORGANELLE   
'Damaged'         SingleGeneDeletions.TOXIN_ACCUMULATION   
'Quasi-Ess'       SingleGeneDeletions.SLOW_GROWING   
'Non-Ess'         SingleGeneDeletions.NON_ESSENTIAL   
};   
propLabels  =  {   
{ 'NTP' }                  'ntps'   
{ 'Growth  (fg  h^{-1})' }   'growth'   
{ 'Protein  (fg)' }         'proteinWt'   
{ 'RNA  (fg)' }             'rnaWt'   
{ 'DNA  (fg)' }             'dnaWt'   
{ 'Septum  (nm)' }          'pinchedDiameter'   
{ 'Term  Org  (fg)' }        'terminalOrganelleWt'   
{ 'Damaged'  'Prot' }       'damagedProteins'   
};   
  
This  first  version  of  my  analysis  process  consisted  of  3  files:  runWholeCellAnalysis,   
processRawData,  and  MultiGeneOneExp   
( github.com/squishybinary/Original_whole-cell_analysis ),  calling  upon  the  22  extracted   
functions,  some  of  which  were  modified  to  function  independently.     
  
Two  problems  arose.  Firstly,  it  became  evident  that  the  files  that  SingleGeneDeletions.m   
were  manipulating  were  different  to  those  produced  by  processRawData.  A  processing   
step  was  missing.  This  was  later  confirmed  by  gaining  access  to  the  original   
publication’s  raw  data  ( archive.simtk.org/WholeCell/simulation/output/runSimulation/ ),   
where  it  appeared  multiple  simulations  of  each  gene  was  packaged  together  and   
averaged  (the  function  that  completed  this  processing  step  remained  elusive).   
69   
  
Secondly,  Karr  et  al. ’s  code  required  a  strict  naming  convention,  based  on  single  gene   
code  names  (e.g.  MG_006.mat),  implementing  deletions,  conducting  analysis,  and   
saving  files  based  on  the  specific  filename.  This  process  was  not  adaptable  to   
multi-gene  knockouts.     
  
This  led  me  to  develop  my  own  analysis  process  from  scratch,  recreating  the   
classification  by  pulling  the  required  data  directly  from  the  simulation  output  and   
creating  new  graphs  that  matched  “Figure  6B”.  This  analysis  process  consisted  of  three   
scripts:  runGraphs,  compareGraphs,  and  WildTypeBackgroundFig   
( github.com/squishybinary/Analysis_Code_for_Mycoplasma_genitalium_whole-cell_mo 
del ).   
  
runGraphs.m  carries  out  the  initial  analysis  of  a  M.genitalium  whole-cell  simulation,   
replicating  “Figure  6B”.  It  plots  growth,  protein  weight,  RNA  weight,  DNA  replication,   
cell  division,  and  records  several  experimental  details  (Figure  4).  Outputs  are  saved  as   




Figure  4.  Initial  analysis  of  a  single  gene  knockout.  This  particular  gene  is   
non-essential,  as  the  simulation  (in  red)  performs  as  expected  for  a  wild  type  cell  (200   
wild  type  simulations  in  black).  Simulation  specific  data  extracted  includes  seed   
number,  running  time,  last  file  created,  experiment  name,  simulation  number  and  date   
completed.     
  
compareGraphs.m  overlays  the  output  of  the  M.genitalium  whole-cell  simulation  on  the   
WildTypeBackground.fig,  the  collated  outputs  of  200  wild  type  M.genitalium   
simulations.  Outputs  are  saved  as  MATLAB  .fig  files  and  .pdfs.   
  
WildTypeBackgroundFig.m  produces  the  WildTypeBackground.fig  file  by  overlaying  the  
outputs  of  200  wild  type  M.genitalium  simulations.   
  
This  analysis  process  has  received  minor  updates  throughout  my  PhD  but  is  otherwise   
still  used  for  analysing  output  from  the  M.genitalium  whole-cell  model.  
  
3.4 Running  the  M.genitalium  whole-cell  Model   
The  M.genitalium  whole-cell  model  is  written  in  Matlab.  The  line  of  code  that  actually   
conducts  the  simulation  is:     
matlab  $options  -r  "diary( '${OutDir}/${Experiment}/${Sim}/diary.out' );   
addpath( '${Master}' );  setWarnings();  setPath();  runSimulation( 'runner' , 'MGGRunner' ,   
'logToDisk' ,true,  'outDir' ,  ${OutDir}/${Experiment}/${Sim}',  'seedIncrement' ,   
'${SeedInc}' );  diary  off;  exit;"   
This  can  be  translated  as:   
● Monitor  and  record  logs  of  the  simulation  as  it  is  running   
diary( '${OutDir}/${Experiment}/${Sim}/diary.out' );   
  
● Let  the  supercomputer  know  where  the  model  files  are   
addpath( '${Master}' );   
  






● Start  the  simulation  (with  the  following  variables):   
runSimulation(   
  
○ Use  my  custom  runner  file  to  increment  the  initial  conditions  correctly   
'runner' , 'MGGRunner' ,   
  
○ Save  the  output  of  the  simulation  
'logToDisk' ,true,     
  
○ To  this  location   
'outDir' , '${OutDir}/${Experiment}/${Sim}' ,   
  
○ Increment  the  initial  conditions   
'seedIncrement' , '${SeedInc}' )   
  
○ Finish  logging  once  runSimulation  is  complete   
;diary  off;exit;"     
  
Running  simulations  on  the  supercomputer  requires  creating  three  files:  a  bash  script,   
an  experiment  name  list,  and  a  gene  knockout  list.  Bash  scripts  contain  the  simulation   
command  (outlined  above)  and  Slurm  commands  (in  the  format  ‘${ . .}’).  Slurm  is  the   
queuing  system  used  on  BlueGem  and  the  commands  are  interpreted  to  control  the   
execution,  and  handle  the  output  of  the  model  (Figure  5).  The  experiment  name  list  and   
the  gene  knockout  list  contain  the  information  required  to  run  gene  knockout   
simulations,  which  are  extracted  by  the  bash  script  using  the  number  of  the  simulation   
as  a  line  number.   
#  A  Supercomputer  value  that  assigns  each  simulation  a  number,  that  doubles  as  a   
line  number  for  the  list  files   
Sim= ${Slurm_ARRAY_TASK_ID}   
 
#  Gene  Knockout  Variables   
#  Experiment  name  list  location   
experiment_list=/home/USER/BlueGem/ExpLists/GeneKnockoutSimulation_exp.list   
 
#  Extract  names  from  experiment  list   




#  Gene  knockout  list  location   
ko_list=/home/USER/BlueGem/KOLists/GeneKnockoutSimulation_ko.list   
 
#  Fetch  the  Gene  knockouts  from  the  knockout  list   
Gene=$(awk  NR== ${Slurm_ARRAY_TASK_ID}  ${ko_list} )   
  
An  additional  variable  is  added  to  runSimulation  command  to  conduct  gene  knockouts:   
'koList' ,{{${Gene}}});   
Although  the  code  says  ‘Gene’  it  can  refer  to  one  gene  or  hundreds  of  genes  to  be   
knocked  out.  Running  the  model  on  a  supercomputer  in  this  way  allows  for  simulating   
large  numbers  of  in-silico  cells  in  parallel.   
  
Figure  5.  My  first  M.genitalium  whole-cell  model  simulations.  These  three  wild  type   
simulations  were  run  on  BlueGem  and  graphed  manually  in  Matlab,  with  the  previously   




These  three  scripts  (the  bash  script  and  the  two  lists)  have  to  be  created  anew  for  each  
new  experimental  simulation  series.  Combined  with  the  three  analysis  scripts,  these  six   
scripts  produce  simulations  on  the  supercomputer  and  analysis  plots  of  the  resulting   
simulated  cells  (Figure  4).  More  detailed  information  is  provided  in  Section  2.3.2  and   
Section  2.3.3.     
  
Now  that  I  could  produce  comparable  analysis  plots,  I  generated  a  decision  tree  (Figure   
6)  to  classify  gene  knockouts  consistently  into  phenotypic  categories.  There  are  seven   
possible  phenotypes  caused  by  knocking  out  genes  in  M.genitalium  whole-cell  model   
simulations:  i)  non-essential,  if  a  dividing  cell  is  produced;  ii)  slow  growing,  if  a  dividing   
cell  has  started  the  process  of  division  but  has  not  completed  before  the  simulation   
ends;  and  essential  if  a  non-dividing  cell  is  produced  due  to  iii)  a  DNA  replication   
mutation,  iv)  a  RNA  production  mutation,  v)  a  protein  production  mutation,  vi)  a   
metabolic  mutation  (DNA,  RNA,  and  protein  production  are  all  affected),  or  vii)  a  division   





Figure  6.  Phenotypic  categorisation  decision  tree  for  simulations.  13.89  hours  is  the   
simulated  time  allowed  before  the  simulation  ends.  Cell  diameter  measures  whether  the   
cell  started  division:  yes  if  min  !=  max,  no  if  min  =  max.  Functioning  /  F  denotes  that  the   
cellular  function  is  within  the  range  of  behaviour  for  wild  type  cells.   
  
3.5 Issues  Running  the  M.genitalium  whole-cell  Model   
During  initial  testing  of  gene  deletion  simulations  I  discovered  an  error  in  one  of  the   
groups  previous  scripts  (koRunner.m).  This  error  was  preventing  the  simulations  from   
randomly  generating  initial  conditions  (“seeding”)  properly,  as  the  random  generation   
relied  on  using  the  current  time  and  date  to  the  hour.  BlueGem  can  spawn  upwards  of   
100  simulations  a  second.  I  created  MGGRunner.m  to  artificially  increment  date  time  by   
a  number  of  seconds  equal  to  the  number  assigned  to  the  simulation  by  the   





Figure  7.  Fixing  random  “seeding”.  (Upper)  200  wild  type  simulations  run  using   
KoRunner.m  without  working  random  “seeding”,  reducing  the  number  of  unique   
(plottable)  simulations.  (Lower)  200  wild  type  simulations  with  working  random   
“seeding”,  using  MGGRunner.m.  The  Chromosome  plot  had  been  replaced  with   




An  additional  investigation  identified  the  reason  behind  an  unexpectedly  high  incidence   
of  crashes  I  was  observing  for  M.genitalium  whole-cell  model  simulations.  Initially   
thought  to  be  the  number  of  gene  deletions  causing  problems,  the  gene  “MG_469”   
was  found  to  cause  the  simulation  to  crash  when  knocked  out  in-silico  (running  on   
BlueGem  using  Matlab  R2013b).  This  was  confirmed  by  re-running  simulations  while   
excluding  “MG_469”  from  being  deleted,  resulting  in  a  dramatic  reduction  in  the   
number  of  simulations  that  crashed.  It  was  later  discovered  that  “MG_254”  also  caused   
simulations  to  crash,  but  only  after  5  hours  of  simulation  time.  Both  “MG_469”  and   
“MG_254”  were  excluded  from  future  gene  deletions.  According  to  Jonathan  Karr,  the   
original  developers  and  other  users  reported  gene  deletions  that  caused  simulation   
crashes,  with  different  versions  of  Matlab  potentially  being  linked  to  different  causal   
gene  deletions.  However,  the  modelling  cause  for  this  was  not  discovered  ( personal   
communication ).     
  
To  confirm  the  status  of  unmodelled  genes  (which  were  not  originally  modelled  due  to   
unknown  function)  within  the  M.genitalium  whole-cell  model,  new  simulations  were  run.   
In  theory,  these  genes  are  listed  within  the  model  but  do  not  have  any  associated   
functions.  The  124  unmodelled  genes  were  knocked  out  within  the  model  and   
produced  a  successfully  dividing  cell  that  was  indistinguishable  from  a  wild  type  in-silico   
cell,  confirming  that  the  unmodelled  genes  were  not  functionally  implemented  within  the   
model.     
  
3.6 Discussion   
Having  established  a  repeatable  analysis  process  that  could  be  used  to  categorise  the   
phenotypes  of  the  in-silico  cells  reliably,  I  began  developing  a  genome  design  algorithm   
and  conducting  my  first  experimental  research,  attempting  to  produce  M.genitalium   











































Chapter  4  -  Minesweeper:  A  Minimal  Genome  Design  Algorithm   
4.1 Statement  of  Collaboration   
Sections  of  this  chapter  are  adapted  from  a  co-first  authored  paper  with  Oliver   
Chalkley.  We  worked  in  parallel,  Oliver  was  also  developing  a  genome  design  algorithm,   
named  GAMA  (Guess,  Add,  Mate  Algorithm)  and  producing  minimal  genome   
simulations.  However,  I  analysed  all  the  simulation  data  that  was  produced  and   
presented  here.  I  was  also  the  lead  author,  drafting  the  paper  and  managing  the  writing   
and  editing  process,  with  support  from  other  members  of  the  team  and  advice  from  my   
supervisors;  the  text  reproduced  below  is  my  own  work.  Oliver’s  work,  the   
development  of  GAMA  and  the  data  it  produced,  is  presented  in  his  thesis  and  is   
available  in  published  papers  56,164   and  will  not  be  discussed  here.     
● Rees-Garbutt,  J.  et  al .  Designing  minimal  genomes  using  whole-cell  models.   
Nat.  Commun .  11 ,  836  (2020)   
○ Lead  author   
● Rees-Garbutt,  J.,  Grierson,  C.  &  Marucci,  L.  Testing  theoretical  minimal   
genomes  using  whole-cell  models.  bioRxiv.  doi:10.1101/2020.03.26.010363   
(2020).   
○ Lead  author     
● Rees-Garbutt,  J.  Minesweeper  Genome  Design  Algorithm.  Github .   
https://github.com/squishybinary/Minesweeper  (2020).   
○ Lead  author   
  
4.2 Aims     
As  genome  design  algorithms  for  genome  engineering  are  rare  (Section  1.3.4.b),  I   
chose  to  start  developing  my  genome  design  algorithm  from  the  basis  of  genome   
segmentation  used  by  current  in-vivo  genome  engineering  efforts  (Section  1.3.2.d)  and   
to  focus  on  the  development  of  minimal  genomes.  Minimal  genomes  are  a  good  proof   
of  concept  for  genome  engineering  as  the  success  criteria  is  easy  to  assess  (did  the   
cell  divide  or  not)  and  it  does  not  require  a  large  amount  of  genetic  knowledge  (which   
we  currently  lack)  to  make  progress.  The  minimal  genome  design  algorithm  I  created   
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produced  1000s  of  in-silico  cells  on  the  University  of  Bristol’s  BlueGem  supercomputer,   
resulting  in  the  creation  of  an  M.genitalium  in-silico  minimal  genome  which,  if   
biologically  correct,  predicts  an  in-vivo  genome  smaller  than  JCVI-Syn3.0 ;  a  bacterium   
with,  currently,  the  smallest  genome  that  can  be  grown  in  pure  culture  60 .  
  
4.3 Algorithm  Development   
4.3.1 Rationale   
My  initial  thoughts  around  producing  a  genome  design  algorithm  were:  I  wanted  to   
produce  results  quickly  and  I  wanted  to  develop  an  algorithm  based  loosely  on  the   
practicalities  and  constraints  of  recent  genome  engineering  work  12   that  breaks   
genomes  down  into  workable  sizes  for  laboratory  manipulations  (Section  1.3.2.d).  The   
divide  and  conquer  methodology  165   I  settled  on  deals  with  both  of  these  requirements.   
It  involves  dividing  the  whole  problem  into  smaller  sub-problems,  solving  those   
sub-problems,  and  combining  the  solutions  to  solve  the  whole  problem;  very  similar  in   
concept  to  breaking  down  genomes  in  a  laboratory.  As  you  can  vary  the  size  of  the   
sub-problems,  it  also  allows  you  to  investigate  a  number  of  large-scale  deletions  in  the   
first  stages  of  the  algorithm  which  produces  results  quickly.  As  an  additional  design   
consideration,  I  decided  to  focus  on  genes  that  were  identified  as  non-essential  by   
in-silico  single  knockout  (i.e.  their  removal  did  not  prevent  cell  division)  to  make  as   
much  progress  as  possible  in  the  earlier  stages,  by  not  producing  a  large  percentage  of   
in-silico  cells  that  failed  to  divide.     
  
As  the  model  only  conducted  single  generation  simulations,  the  algorithm  would  have   
to  make  progress  using  a  design  (select  possible  gene  deletions),  simulate  (the  genome   
minus  those  deletions),  test  (analyse  the  in-silico  cell  produced)  cycle.  The  simulations   
that  produce  successfully  dividing  in-silico  cells  would  be  used  to  inform  the  next  cycle   
of  simulations.  The  aim  would  be  to  increase  the  number  of  gene  deletions  in  each   
subsequent  simulation  cycle  (while  maintaining  cellular  division),  thereby  producing  a   
smaller  and  smaller  genome.  This  approach  eventually  produced  the  published   





4.3.2 Initial  Development     
The  first  stage  of  an  early  version  of  the  algorithm  (Figure  8)  took  a  list  of  potential  gene   
knockouts  (singly  non-essential,  based  on  three  replicate  simulations  of  each  in-silico   
single  gene  knockout)  and  divided  them  into  groups  of  deletions  of  different  sizes.  This   
produced  an  in-silico  cell  that  deleted  72  genes  and  still  divided.  An  in-silico  cell  that   
removed  all  144  singly  non-essential  genes  produced  a  metabolic  mutant  phenotype   
and  failed  to  divide.  This  was  expected  due  to  the  likelihood  of  redundant  essential   
gene  relationships  between  the  deleted  genes,  resulting  in  synthetic  lethality  12,13,52   
(Section  1.3.2.a).      
  
The  second  stage  of  this  early  version  of  the  algorithm  combined  the  50%  (72  gene   
deletion)  with  non-overlapping  smaller  groups  of  deletions  (from  the  remaining  singly  
non-essential  genes)  that  still  produced  a  dividing  cell.  An  in-silico  cell  that  combined   
the  50%  deletion  segment  with  5  non-overlapping  6.5%  (8  gene)  segments  deleted   
132  genes  and  divided.  However,  the  132-gene-deletion  in-silico  cell  displayed  a  low   
phenotypic  penetrance  (the  occurrence  of  particular  phenotype  given  a  specific   





Figure  8.  An  early  version  of  stage  1  and  2.  In  the  first  stage,  B  and  C  are  gene   
deletion  simulations  that  produce  dividing  in-silico  cells,  whereas  A  does  not.  In  the   
second  stage,  B  and  C  deletion  groups  are  combined,  deleted,  and  simulated.     
  
4.3.3 Investigating  Deletions   
The  impact  of  particular  gene  deletions  on  phenotypic  penetrance  was  investigated   
in-silico .  Previously  a  group  of  genes  had  been  identified,  from  repeated  single  gene   
knockouts,  as  not  having  a  high  enough  phenotypic  penetrance  to  be  reliably   
considered  non-essential  (i.e.  they  produced  an  in-silico  dividing  cell  on  occasion,  but  
not  every  time).  Removing  8  of  these  genes  from  the  132  deletion  group,  resulted  in  a   
124  gene  deletion  set  where  the  resulting  cell  was  able  to  divide  86%  of  the  time.   
  
At  this  stage,  I  repeated  the  single  gene  knockout  simulations  and  increased  the   
number  of  repetitions  to  10  in  an  attempt  to  clarify  some  of  the  gene  knockouts   
presenting  different  phenotypes  or  having  low  phenotypic  penetrance.  19  additional   
genes  (Table  7,  Section  4.4.1)  were  reclassified  as  singly  non-essential,  as  defined  in   
Section  1.3.2.a,  and  determined  by  binominal  proportion  confidence  interval;  which   
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estimates  the  probability  of  success  for  experiments  with  only  two  possible  outcomes   
(success  /  failure),  when  only  the  past  number  of  experiments  and  number  of   
successes  are  known.  It  produces  two  scores  which  give  a  range  around  the  number   
of  observed  successful  experiments,  with  95%  confidence  that  the  true  number  of   
successful  experiments  lies  within  this  range.  For  example,  a  gene  knockout  produces   
a  dividing  cell  9  out  of  10  times  and  generates  the  score  0.55  and  0.99,  which  creates   
the  range  of  8.45  to  9.99  for  containing  the  true  value.  As  the  number  of  dividing  cells   
has  to  be  a  whole  number,  you  can  assume  that  the  true  number  is  9,  and  make  a   
reclassification  decision  from  there.  For  the  statistical  implementation,  see  Section   
2.4.2.     
  
These  were  iteratively  added  to  the  group  of  124  deletions,  as  well  as  two  non-essential   
genes  that  had  yet  to  be  removed,  increasing  the  number  of  gene  deletions  to  145,   
creating  a  dividing  cell  with  a  256  gene  genome  in-silico .     
  
4.3.4 Secondary  Development   
At  this  point  in  time,  the  later  stages  of  the  algorithm  lacked  definitive  steps.  The  third   
stage  continued  the  second  stage  using  smaller  groups  of  gene  deletions  (that  also   
produced  dividing  in-silico  cells  when  removed),  until  no  more  groups  could  be  added.   
The  fourth  stage  consisted  of  cross  comparing  simulation  results  manually  to  identify   
single  gene  deletions  that  were  still  candidates  for  gene  deletion.  However,  these   
stages  of  the  algorithm  would  have  to  be  codified  into  a  computational  algorithm,  a   
necessary  step  to  make  the  research  repeatable  and  publishable.  This  prompted  me  to   
revisit  and  formalise  these  later  stages,  making  them  specific  and  programmable.   
  
This  revisit  also  allowed  me  to  rectify  a  mistake  I  originally  made  in  designing  the  first   
stage.  Due  to  the  failure  of  the  100%  deletion  to  produce  a  dividing  cell,  I  made  an   
assumption  that  anything  larger  than  a  50%  deletion  segment  would  not  produce  a   
dividing  cell,  which  in  retrospect  is  not  defensible.  Later  research  that  discovered   
several  low  essential  genes  (Section  4.4.7)  allowed  me  to  quantify  the  impact  of  this   
assumption.  These  low  essential  genes  were  between  gene  positions  82  to  90,  roughly   
in  the  middle  of  the  original  deletion  set  (144  genes).  This  positioning  prevented  deletion   
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segments  larger  than  50%  from  producing  a  dividing  cell  in-silico ,  so  even  with  the  false   
assumption,  no  greater  progress  could  have  been  produced  in  stage  1.     
  
4.3.5 Stage  1  Implementation   
When  codifying  and  iterating  on  Minesweeper,  the  design  aim  became:  tracking,   
grouping,  and  combining  genes  in  a  comprehensive  and  failure-proof  way;  in  a   
transparent  manner  that  allows  progress  and  gene  combinations  to  be  checked  after   
the  fact;  and  working  within  the  computational  limitations  of  the  BlueGem   
supercomputer.  The  verbose  writing  style  of  the  code,  the  use  of  comments,  and  the   
lack  of  external  libraries  /  tools  aligns  with  this  transparency  and  hopefully  improves  the   
understanding  of  the  code  and  design  decisions  made.     
  
  
Figure  9.  Visualisation  of  Minesweeper  Stage  1     
  
Stage  1  (Figure  9)  produces  hundreds  of  single  protein-coding  (Section  1.3.2.c)  gene   
knockout  simulations  to  identify  low  and  no  essentiality  genes  (whose  knockout  does   
not  prevent  cell  division)  for  Stage  2.  It  was  designed  this  way  to  identify  complete  /   
high  essential  genes  (Section  1.3.2.a)  to  exclude  from  future  simulations,  in  an  attempt   
to  keep  the  number  of  dividing  cells  high.  The  code  creates  single  gene  knockout   
simulation  scripts  from  an  initial  list  of  genes.   
  
Functions:   
● userInput   
○ Ask  the  user  for  variables  which  are  required  by  the  supercomputer  to  run   
simulations  on  the  users  account,  which  are  later  used  to  modify  a  
template  script.   
● createGeneList   
○ Converts  a  given  text  file  into  the  correct  gene  format  making  it  usable.   
The  M.genitalium  whole-cell  model  processes  genes  in  the  specific   
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format  “  ‘MG_XXX’,  ”.  This  allows  the  user  to  work  with  the  whole   
genome,  subsets,  or  just  particular  genes.     
● createScripts   
○ Converts  a  template  script  using  user  input,  creating  simulation  scripts.   
This  automation  keeps  settings,  supercomputer  variables,  and  formatting   
consistent  between  simulations.   
○ Two  pathways  depending  on  the  number  of  genes:  <200  genes  creates   
one  script,  >200  genes  creates  multiple  scripts.  The  maximum  number  of   
simulations  a  user  can  start  with  one  script  on  BlueGem  is  256,  any   
further  simulations  are  automatically  cancelled.  Keeping  the  threshold  at   
200  simulations  safely  avoids  this.   
  
4.3.6 Stage  2  Implementation   
  
Figure  10.  Visualisation  of  Minesweeper  Stage  2   
  
Stage  2  (Figure  10)  produces  26  deletion  segments  to  be  simulated,  ranging  in  size   
from  100%  to  12.5%  of  the  identified  low  /  no  essentiality  genes.  This  is  to  create  the   
largest  possible  number  of  deletions  from  the  in-silico  genome  in  one  step.  The   
smallest  deletion  segment  size  is  set  by  supercomputer  limitations,  as  12.5%  creates  8   
groups  of  gene  deletions  (Section  2.4.5.6).  The  code  creates  deletion  segment   
simulation  scripts  from  the  results  of  Stage  1  simulations  (outputted  as   
inputko*_endtimes.txt).  Deletion  segments  that  can  be  removed  and  still  produce  a   
dividing  cell  are  carried  forward  to  Stage  3.     
  
A  way  to  improve  this  implementation,  instead  of  including  smaller  deletion  segments,   
could  be  to  implement  other  variants  of  the  deletion  segments.  Given  that  the  location   
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of  low  essential  genes  is  unknown  you  could  produce  variants  that  split  and  space  the   
deletions  over  the  genome  i.e.  the  50%  variant  could  delete  the  first  25%  of  the  low  /   
no  essentiality  genes,  not  delete  the  next  25%,  delete  the  third  25%  of  the  low  /  no   
essentiality  genes,  and  not  delete  the  final  25%.  This  would  increase  the  number  of   
combinations  to  match  and  track  but  has  the  potential  to  be  codifiable.     
  
Functions:   
● interpretResults   
○ Match  the  simulation  results  of  Stage  1  to  the  knocked  out  gene.   
● createNEList   
○ Filter  the  Stage  1  matched  results,  finding  those  that  divided,  and   
labelling  and  excluding  high  /  complete  essentiality  genes.   
● segmentGeneration   
○ Used  to  select  which  genes  to  include  in  the  26  deletion  segments.   
● outputToLists   
○ Used  to  save  the  26  deletion  segments  as  separate  files,  and  a  combined   
file  after  the  final  segment  is  generated.   
● createDivisionSegments   
○ Generates  the  26  deletion  segments,  using  the  functions   
segmentGeneration  and  outputToLists.   
● createScripts   
○ Converts  a  template  script  using  user  input  and  the  combined  file   
produced  in  this  stage,  creating  simulation  scripts  for  the  26  deletion   
segments.  The  same  automation  is  used  in  all  stages.   
  
The  use  of  text  files  to  record  information  rather  than  pass  the  information  dynamically   
to  functions  is  in  line  with  the  aim  of  transparency.  It  allows  the  user  to  track  genomic   
edits,  allows  the  current  stage  of  Minesweeper  to  locate  the  information  it  needs  to   
produce  simulation  scripts  in  a  known  location,  and  allows  future  stages  of   




4.3.7 Stage  3  Implementation   
  
Figure  11.  Visualisation  of  Minesweeper  Stage  3.  *  =  a  complete  powerset  also   
includes  a  set  with  zero  deletion  segments  that  is  not  shown  here.   
  
Stage  3  (Figure  11)  ranks  the  output  of  Stage  2,  progressing  with  the  largest  deletion   
segment  that  can  be  removed  and  produce  a  dividing  cell,  which  is  matched  with  other   
division-producing,  non-overlapping  deletion  segments.  This  filtering  of  segments   
increases  the  chances  of  success  and  lowers  the  total  number  of  segments  to  match   
and  combine  (see  computational  limitations,  Section  2.4.5.6).     
A  powerset  is  then  generated  (i.e.  a  set  containing  all  possible  unique  combinations  of   
the  matched  deletion  segments,  including  zero  and  individual  deletion  segments)  and   
each  of  the  deletion  combinations  is  removed  from  an  individual  in-silico  cell  and   
simulated.  This  ensures  that  all  possible  combinations  are  simulated.  Deletion   
segments  that  can  be  removed  and  still  produce  a  dividing  cell  are  carried  forward  to   
Stage  4.   
  
Functions:   
● alreadyRunCheck   
○ Checks  to  see  if  input  files  are  present  and  output  files  have  been   
previously  generated,  then  queries  the  user.  Both  Script  3  and  4  use   
powerset.  The  output  of  powerset  is  the  same  given  the  same  input,  but   
the  order  of  combinations  of  the  same  size  is  randomised.  As  matching   
of  the  simulation  results  is  by  order,  this  could  match  results  to  the  wrong   
simulation  if  rerun,  which  would  require  restarting  Minesweeper.  This   
function  prevents  files  previously  generated  using  powersets  being   
changed  and  overwritten,  requiring  input  from  the  user  before  continuing.     
● interpretResults   
○ Match  the  simulation  results  with  the  26  deletion  segments  from  Stage  2.   
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● successCheckAndVariants   
○ Check  26  deletion  segments  for  division  and  save  the  top  three  largest   
deletions.  These  top  three  are  assigned  to  colours  (red,  yellow,  blue)  and   
used  as  three  variants  /  avenues  of  deletion  going  forward.  This  is  a   
check  on  whether  the  results  are  converging,  and  allows  the  user  to   
continue  simulations  if  one  variant  reaches  a  “dead  end”  prematurely.   
Stage  4  should  avoid  this,  but  this  acts  as  a  failsafe.   
● powerset   
○ Generates  a  powerset,  all  possible  unique  combinations  of  a  set  e.g.   
1,2,3  =  ()  (1,)  (2,)  (3,)  (1,2)  (1,3)  (2,3)  (1,2,3).     
● outputToLists   
○ Uses  powerset  to  generate  combinations.  Records  the  powerset  
combinations  and  identifies  genes  to  be  deleted.   
● variantCombinations   
○ The  variants  (three  largest  deletion  segments)  are  matched  with  all  other   
dividing,  non-overlapping  segments,  using  combinational  logic  (outlined   
below).   
● createScripts   
○ Converts  a  template  script  using  user  input  and  the  powerset   
combinations,  creating  simulation  scripts.   
  
The  combinational  logic  is  based  on  visualising  the  genome  linearly  from  left  to  right,   
breaking  it  down  into  different  size  segments,  and  then  matching  those  segments  that   
do  not  overlap  or  overlap  only  by  a  few  percent  (Figure  12).  The  model  does  not   
penalise  deleting  the  same  gene  multiple  times,  so  slight  overlap  in  the  deleted   
powerset  combinations  ensures  coverage  of  the  genome  while  keeping  the  number  of   





Figure  12.  Combinational  logic  example.  If  the  50%a  deletion  produces  a  dividing   
in-silico  cell,  it  could  be  matched  with  33%c,  25%c,  25%d,  and  12.5%  e  -  h  if  they  also   
produce  dividing  in-silico  cells,  as  these  do  not  overlap.  When  potential  matches   
duplicate  genes  (25%c  -  d  vs  12.5%e  -  h),  only  the  smaller  segments  are  selected  for   
combination,  reducing  the  overall  number  of  segments  to  combine.   
  
● If  100  %  of  low  /  no  essentiality  genes  are  deleted:  Minesweeper  finishes.   
● If  90%  of  low  /  no  essentiality  genes  are  deleted:  Move  onto  Stage  4.   
● If  80%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '12.5%  g',  '12.5%  h'     
● If  70%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '12.5%  f',  '12.5%  g',  '12.5%  h'     
● If  60%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '33%  c',  '12.5%  e',  '12.5%  f',  '12.5%  g',  '12.5%  h'   
● If  50%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '33%  c',  '12.5%  e',  '12.5%  f',  '12.5%  g',  '12.5%  h'   
● If  33%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '33%  b',  '33%  c',  '12.5%  d',  '12.5%  e',  '12.5%  f',  '12.5%  g',   
'12.5%  h'   
● If  25%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '12.5%  c',  '12.5%  d',  '12.5%  e',  '12.5%  f',  '12.5%  g',  '12.5%  h'   
● If  12.5%  of  low  /  no  essentiality  genes  are  deleted,  potential  matches  for  the  A   
variant  are:  '12.5%  b',  '12.5%  c',  '12.5%  d',  '12.5%  e',  '12.5%  f',  '12.5%  g',   
'12.5%  h'      
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4.3.8 Stage  4  Implementation   
  
Figure  13.  Visualisation  of  Minesweeper  Stage  4.  *  =  a  complete  powerset  also   
includes  a  set  with  zero  deletion  segments  that  is  not  shown  here.     
  
Stage  4  (Figure  13)  is  cyclical.  It  ranks  the  results  from  Stage  3  and  identifies  the  largest   
deletion  segment  to  determine  the  remaining  low  /  no  essentiality  genes  that  have  not   
been  deleted.  This  is  done  for  each  variant.  The  remaining  genes  are  divided  into  eight   
groups  (the  number  of  groups  is  determined  by  computational  constraints,  Section   
2.4.5.6)  and  a  powerset  generated  for  these  eight  groups.  Each  combination  from  the   
powerset  is  individually  appended  to  the  current  largest  deletion  combination  for   
simulation.  The  simulation  results  update  the  largest  deletion  combination,  which  is   
used  to  generate  a  new  remaining  gene  list,  starting  the  next  cycle.   
If  none  of  the  simulations  produces  a  dividing  cell,  the  remaining  genes  are  singly   
appended  to  the  prior  largest  deletion  combination,  removed  and  simulated.  The   
individual  remaining  genes  that  do  not  produce  a  dividing  cell  are  excluded  for  a  cycle,   
a  reduced  remaining  gene  list  is  produced  and  used  for  the  subsequent  round  of  Stage  
4.   
Stage  4  continues  until  there  are  eight  or  fewer  remaining  genes  (where  a  final   
appended  powerset  is  run)  or  all  individually  appended  remaining  genes  do  not   
produce  a  dividing  cell.  Both  outcomes  result  in  a  list  of  deleted  genes  and  identified   






● alreadyRunCheck   
○ Checks  to  see  if  input  files  are  present  and  output  files  have  been   
generated,  then  queries  the  user.   
● interpretResults   
○ Match  the  simulation  results  of  Stage  3  /  Stage  4  to  the  specific  powerset   
combination.     
● remainingGenes   
○ Calculate  remaining  genes  from  dividing  results.  Three  outcomes:   
■ If  there  is  no  division,  return  to  prior  round’s  remaining  genes   
■ If  prior  round  contained  appended  single  knockouts,  create  a   
reduced  remaining  gene  set  from  those  that  divided   
■ If  there  is  division,  rank  results  and  select  the  smallest  number  of   
remaining  genes     
● powerset   
○ Generates  a  powerset,  all  possible  unique  combinations  of  a  set  e.g.   
1,2,3  =  ()  (1,)  (2,)  (3,)  (1,2)  (1,3)  (2,3)  (1,2,3).   
● outputToLists   
○ Uses  powerset  to  generate  combinations.  Records  the  names  of  eight   
groups  in  the  combinations,  and  matches  with  the  genes  within  the   
group.   
The  following  two  functions  are  unique  to  Stage  4  and  deal  with  splitting  the  remaining   
genes  into  eight  groups.   
● eightsegmentwrite   
○ Outputs  remaining  gene  lists  for  each  of  the  eight  groups.     
● eightPanelGroupingsGeneration   
○ Depending  on  the  number  of  remaining  genes,  the  size  of  the  group   
changes.  Groups  one  to  seven  are  equal  in  size,  with  group  eight  differing   
in  size  depending  on  if  the  number  of  remaining  genes  are  even  or  odd.   
Three  possible  options:   
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■ 15  genes  or  greater  =  divides  the  number  of  genes  into  the  eight   
groups  (minimum  two,  apart  from  final/eighth  group)  and  allocates   
them.   
■ 14  genes  to  8  genes  =  a  hard  coded  number  of  genes  selected,   
maintaining  eight  groups  by  transitioning  the  minimum  number  of   
genes  per  group  from  two  to  one.  This  was  created  to  prevent  
errors  where  1  to  4  groups  had  no  genes  allocated,  as  the   
minimum  gene  number  for  groups  was  previously  set  at  two.   
■ 7  genes  to  1  genes  =  number  of  groups  is  equal  to  the  number  of   
genes,  with  each  group  containing  one  gene.   
● runappendsingleKOS   
○ Single  gene  knockouts  are  appended  to  the  largest  deletion  with  a   
successful  dividing  cell,  to  be  simulated.     
● createScripts   
○ Converts  a  template  script  using  user  input,  creating  simulation  scripts.     
● endingDecision   
○ Given  the  outcome  of  createDividingTxt  and  remainingGenes,  determine   
next  step  for  remaining  variants  (e.g.  Red,  Yellow,  Blue).   
○ If  the  number  of  remaining  genes  was  less  than  or  equal  to  eight  in  the   
last  simulation  round  (triggering  the  final  round),  record  the  final  results  of   
the  variant.  If  all  three  variants  are  complete,  finish  Minesweeper.   
○ If  single  gene  knockouts  of  remaining  genes  individually  appended  to   
largest  deletion  were  conducted  in  the  last  simulation  round  and  none   
divided,  record  final  results.   
○ If  a  normal  eight  group  powerset  was  conducted  in  the  last  simulation   
round,  and  none  divided,  start  an  appended  single  gene  knockouts   
round.   
○ If  a  normal  eight  group  powerset  was  conducted  in  the  last  simulation   
round,  and  some  divided,  continue  to  another  round  or  the  final  round   




4.4 Results     
4.4.1 Initial  Input   
To  generate  an  initial  input  for  Minesweeper  and  GAMA  I  simulated  single  gene   
knockouts  in  an  unmodified  M.genitalium  in-silico  genome  (as  previously  reported  6 ,   
Table  6).  Of  the  401  in-silico  modelled  genes  42  are  RNA-coding,  which  were  not   
selected  for  knockout.  Gene  knockouts  in  each  of  the  359  protein-coding  genes  were   
simulated  individually  (10  replicates  each),  with  152  genes  classified  as  non-essential   
and  207  genes  classified  as  essential  (i.e.  producing  a  dividing  or  non-dividing  in-silico   





Gene    Decision    Gene    Decision    Gene    Decision    Gene    Decision    Gene    Decision   
MG_001   No  Division   MG_051    No  Division   MG_100    No  Division   MG_156    No  Division   MG_198    No  Division  
MG_003   No  Division   MG_052    Dividing    MG_101    Dividing    MG_157    No  Division   MG_200    Dividing   
MG_004   No  Division   MG_053    No  Division   MG_102    No  Division   MG_158    No  Division   MG_201    No  Division  
MG_005   No  Division   MG_055    Dividing    MG_476    Dividing    MG_159    No  Division   MG_203    No  Division  
MG_006   No  Division   MG_473    No  Division   MG_104    Dividing    MG_160    No  Division   MG_204    No  Division  
MG_007   No  Division   MG_058    No  Division   MG_105    Dividing    MG_161    No  Division   MG_205    Dividing   
MG_008   No  Division   MG_059    Dividing    MG_106    No  Division   MG_162    No  Division   MG_206    Dividing   
MG_009   Dividing    MG_061    Dividing    MG_107    No  Division   MG_163    No  Division   MG_208    Dividing   
MG_012   Dividing    MG_062    Dividing    MG_109    Dividing    MG_164    No  Division   MG_209    Dividing   
MG_013   No  Division   MG_063    Dividing    MG_110    Dividing    MG_165    No  Division   MG_210    Dividing   
MG_014   Dividing    MG_064    Dividing    MG_111    No  Division   MG_166    No  Division   MG_481    No  Division  
MG_015   Dividing    MG_065    Dividing    MG_112    No  Division   MG_167    No  Division   MG_482    Dividing   
MG_019   No  Division   MG_066    No  Division   MG_113    No  Division   MG_168    No  Division   MG_212    No  Division  
MG_020   Dividing    MG_069    No  Division   MG_114    No  Division   MG_169    No  Division   MG_213    Dividing   
MG_021   No  Division   MG_070    No  Division   MG_118    No  Division   MG_170    Dividing    MG_214    Dividing   
MG_022   No  Division   MG_071    No  Division   MG_119    Dividing    MG_171    No  Division   MG_215    No  Division  
MG_023   No  Division   MG_072    Dividing    MG_120    Dividing    MG_172    Dividing    MG_216    No  Division  
MG_026   No  Division   MG_073    Dividing    MG_121    Dividing    MG_173    No  Division   MG_217    Dividing   
MG_027   Dividing    MG_075    Dividing    MG_122    Dividing    MG_174    No  Division   MG_218    Dividing   
MG_029   Dividing    MG_077    No  Division   MG_123    Dividing    MG_175    No  Division   MG_221    No  Division  
MG_030   Dividing    MG_078    No  Division   MG_124    No  Division   MG_176    No  Division   MG_224    No  Division  
MG_031   No  Division   MG_079    No  Division   MG_126    No  Division   MG_177    No  Division   MG_225    Dividing   
MG_033   Dividing    MG_080    No  Division   MG_127    Dividing    MG_178    No  Division   MG_226    Dividing   
MG_034   No  Division   MG_081    No  Division   MG_128    No  Division   MG_179    No  Division   MG_227    Dividing   
MG_035   No  Division   MG_082    No  Division   MG_130    Dividing    MG_180    No  Division   MG_228    No  Division  
MG_036   No  Division   MG_083    Dividing    MG_132    Dividing    MG_181    No  Division   MG_229    No  Division  
MG_037   No  Division   MG_084    No  Division   MG_136    No  Division   MG_182    No  Division   MG_230    No  Division  
MG_038   No  Division   MG_085    Dividing    MG_137    No  Division   MG_183    Dividing    MG_231    No  Division  
MG_039   Dividing    MG_086    Dividing    MG_139    Dividing    MG_184    Dividing    MG_232    No  Division  
MG_040   Dividing    MG_087    No  Division   MG_141    No  Division   MG_186    Dividing    MG_234    No  Division  
MG_041   No  Division   MG_088    No  Division   MG_142    No  Division   MG_187    Dividing    MG_235    Dividing   
MG_042   No  Division   MG_089    No  Division   MG_143    Dividing    MG_188    Dividing    MG_236    Dividing   
MG_043   No  Division   MG_090    No  Division   MG_145    No  Division   MG_189    Dividing    MG_238    No  Division  
MG_044   No  Division   MG_091    No  Division   MG_149    Dividing    MG_190    Dividing    MG_239    Dividing   
MG_045   No  Division   MG_092    No  Division   MG_150    No  Division   MG_191    Dividing    MG_240    Dividing   
MG_046   Dividing    MG_093    No  Division   MG_151    No  Division   MG_192    Dividing    MG_244    Dividing   
MG_047   No  Division   MG_094    No  Division   MG_152    No  Division   MG_194    No  Division   MG_245    No  Division  
MG_048   Dividing    MG_097    Dividing    MG_153    No  Division   MG_195    No  Division   MG_249    No  Division  
MG_049   No  Division   MG_098    No  Division   MG_154    No  Division   MG_196    No  Division   MG_250    No  Division  







Gene    Decision    Gene    Decision    Gene    Decision    Gene    Decision   
MG_252    Dividing    MG_309    Dividing    MG_363    No  Division   MG_418    No  Division  
MG_253    No  Division   MG_310    Dividing    MG_522    No  Division   MG_419    No  Division  
MG_254    No  Division   MG_311    No  Division   MG_365    No  Division   MG_421    Dividing   
MG_257    No  Division   MG_312    Dividing    MG_367    No  Division   MG_424    No  Division  
MG_258    No  Division   MG_315    No  Division   MG_368    No  Division   MG_425    Dividing   
MG_259    Dividing    MG_316    Dividing    MG_369    Dividing    MG_426    No  Division  
MG_261    No  Division   MG_317    Dividing    MG_370    Dividing    MG_427    Dividing   
MG_262    Dividing    MG_318    Dividing    MG_372    No  Division   MG_428    Dividing   
MG_498    Dividing    MG_321    No  Division   MG_375    No  Division   MG_429    No  Division  
MG_264    Dividing    MG_322    No  Division   MG_376    Dividing    MG_430    No  Division  
MG_265    Dividing    MG_323    No  Division   MG_378    No  Division   MG_431    No  Division  
MG_266    No  Division   MG_324    Dividing    MG_379    No  Division   MG_433    No  Division  
MG_270    No  Division   MG_325    No  Division   MG_380    Dividing    MG_434    No  Division  
MG_271    No  Division   MG_327    Dividing    MG_382    No  Division   MG_435    No  Division  
MG_272    No  Division   MG_329    Dividing    MG_383    No  Division   MG_437    No  Division  
MG_273    No  Division   MG_330    No  Division   MG_384    No  Division   MG_438    Dividing   
MG_274    No  Division   MG_333    Dividing    MG_385    Dividing    MG_442    Dividing   
MG_275    No  Division   MG_334    No  Division   MG_386    Dividing    MG_444    No  Division  
MG_276    No  Division   MG_335    Dividing    MG_387    No  Division   MG_445    No  Division  
MG_277    Dividing    MG_517    No  Division   MG_390    Dividing    MG_446    No  Division  
MG_278    No  Division   MG_336    Dividing    MG_391    Dividing    MG_447    Dividing   
MG_282    No  Division   MG_339    Dividing    MG_392    Dividing    MG_448    Dividing   
MG_283    No  Division   MG_340    No  Division   MG_393    Dividing    MG_451    No  Division  
MG_287    No  Division   MG_341    No  Division   MG_394    No  Division   MG_453    No  Division  
MG_288    Dividing    MG_342    No  Division   MG_396    No  Division   MG_454    Dividing   
MG_289    Dividing    MG_344    Dividing    MG_398    Dividing    MG_455    No  Division  
MG_290    Dividing    MG_345    No  Division   MG_399    Dividing    MG_457    Dividing   
MG_291    Dividing    MG_346    Dividing    MG_400    Dividing    MG_458    No  Division  
MG_292    No  Division   MG_347    No  Division   MG_401    Dividing    MG_460    Dividing   
MG_293    Dividing    MG_349    Dividing    MG_402    Dividing    MG_462    No  Division  
MG_295    No  Division   MG_351    No  Division   MG_403    Dividing    MG_463    Dividing   
MG_297    Dividing    MG_352    Dividing    MG_404    Dividing    MG_464    Dividing   
MG_298    Dividing    MG_353    Dividing    MG_405    Dividing    MG_465    No  Division  
MG_299    No  Division   MG_355    Dividing    MG_407    No  Division   MG_466    No  Division  
MG_300    No  Division   MG_356    Dividing    MG_408    Dividing    MG_467    Dividing   
MG_301    No  Division   MG_357    No  Division   MG_409    Dividing    MG_468    Dividing   
MG_302    No  Division   MG_358    Dividing    MG_410    Dividing    MG_526    Dividing   
MG_303    No  Division   MG_359    Dividing    MG_411    Dividing    MG_469    No  Division  
MG_304    No  Division   MG_361    No  Division   MG_412    Dividing    MG_470    No  Division  




Table  6.  Simulating  protein-coding  M.genitalium  single  gene  knockouts.  A  published   
version  of  the  table  is  available  56 ,  as  is  the  simulation  data  161 .   
  
The  majority  of  genes  (58%)  are  essential;  this  was  expected,  as  M.genitalium  is  an   
obligate  parasite  with  reduced  genetic  redundancy  61 .  318  genes  showed  consistent   
phenotype  across  replicates,  with  41  showing  inconsistent  phenotypes.  Statistical   
analysis  (binomial  proportion  confidence  interval,  Pearson-Klopper,  95%  CIs  for:  a  6/10   
replicate  [5.74,  6.87],  7/10  replicates  [6.66,  7.93],  8/10  replicates  [7.56,  8.97],  9/10   
replicates  [8.45,  9.99])  resulted  in  assigning  the  most  common  phenotype  (Section   
2.4.2  and  Table  7).     
  
Overall,  my  results  agree  97%  with  Karr  et  al.  6   (Table  8),  disagreeing  on  nine  of  the  359   
protein-coding  genes.  From  reading  Karr  et  al. ’s  Supplementary  Information  6   and   
investigating  the  model’s  code  base,  I  believe  that  the  original  classifications  were   
based  on  five  simulations  per  gene,  with  the  results  then  averaged  together,  and  a   
classification  assigned  computationally  to  the  averaged  data.  By  comparison,  I   
completed  ten  simulations  per  gene  and  assigned  classifications  manually.  Our   
differences  may  be  due  to  edge  cases  that  were  misclassified  by  averaging  and   





Gene    Phenotypes    Consistency    Decision   
MG_084    Protein  Mutant  /  Dividing    6  out  of  10    No  Division   
MG_387    Septum  Mutant  /  Slow  Growing  Mutant  Mutant  /  Dividing    7  out  of  10    No  Division   
MG_049    Protein  Mutant  /  Septum  Mutant  /  Dividing    7  out  of  10    No  Division   
MG_250    DNA  Mutant  /  Slow  Growing  Mutant  /  Dividing    8  out  of  10    No  Division   
MG_470    Septum  Mutant  /  Dividing    8  out  of  10    No  Division   
MG_384    Septum  Mutant  /  Dividing    8  out  of  10    No  Division   
MG_008    Protein  Mutant  /  Dividing    8  out  of  9    No  Division   
MG_379    Protein  Mutant  /  Dividing    9  out  of  10    No  Division   
MG_445    Protein  Mutant  /  Dividing    9  out  of  10    No  Division   
MG_126    Protein  Mutant  /  Dividing    9  out  of  10    No  Division   
MG_295    Protein  Mutant  /  Dividing    9  out  of  10    No  Division   
MG_122    Dividing  /  Septum  Mutant    7  out  of  10    Dividing   
MG_104    Dividing  /  Metabolic  Mutant  /  Slow  Growing  Mutant  /  DNA  Mutant     7  out  of  10    Dividing   
MG_438    Dividing  /  DNA  Mutant    8  out  of  10    Dividing   
MG_425    Dividing  /  DNA  Mutant    8  out  of  9    Dividing   
MG_410    Dividing  /  DNA  Mutant  /  Slow  Growing  Mutant    9  out  of  10    Dividing   
MG_289    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_324    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_352    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_359    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_052    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_401    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_464    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_127    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_183    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_189    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_190    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_214    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_236    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
MG_265    Dividing  /  DNA  Mutant    9  out  of  10    Dividing   
Table  7.  Inspection  of  41  genes  that  produced  inconsistent  phenotypes.  A  published   





Gene    Karr  et  al.  2012    My  Results   
MG_019    No  Division  over  Two  Generations*    No  Division  (Septum  Mutation)  
MG_049    Dividing    No  Division  (Protein  Mutation)   
MG_051    Dividing    No  Division  (Protein  Mutation)   
MG_084    Dividing    No  Division  (Protein  Mutation)   
MG_122    No  Division    Dividing   
MG_126    Dividing    No  Division  (Protein  Mutation)   
MG_203    Dividing    No  Division  (Septum  Mutation)  
MG_384    No  Division  over  Two  Generations*    No  Division  (Septum  Mutation)  
MG_470    Dividing    No  Division  (Septum  Mutation)  
Table  8.  Differences  between  results  and  Karr  et  al.  2012.  A  published  version  of  the   
table  is  available  56 ,  as  is  the  simulation  data  161 .  *  =  growth  sub-model  only.     
  
4.4.2 Minesweeper  Results     
Minesweeper  (Sections  4.3.5  to  4.3.8)  produced  results  quickly;  within  two  days  the   
third  stage  removed  123  genes  (a  34%  reduction),  an  equivalent  size  reduction  to   
current  lab-based  efforts  in  other  species  22,86,87 .  In  total,  Minesweeper  deleted  145   
genes,  creating  an  in-silico  M.genitalium  cell  containing  256  genes  (named   
Minesweeper_256)  and  predicting  an  in-vivo  minimal  genome  of  380  genes.  The   
in-silico  cell  replicates  DNA,  produces  RNA  and  protein,  grows,  and  divides.     
  
4.4.3 GAMA  Method  and  Results   
This  work  is  presented  in  full  in  Oliver  Chalkley’s  thesis  and  is  available  in  published   
papers  56,164 .  In  summary,  GAMA  is  a  biased  genetic  algorithm  166 ,  conducting  two   
stages  (Guess  and  Add)  of  only  non-essential  gene  deletions,  before  including  essential   
genes  for  deletion  in  the  third  stage  (Mate).  The  smallest  GAMA-reduced  in-silico   
genome  deleted  165  genes,  creating  an  in-silico  M.genitalium  genome  of  236  genes   
(named  GAMA_236),  and  predicting  an  in-vivo  minimal  genome  of  360  genes.  GAMA   
removed  more  genes  than  Minesweeper,  while  still  producing  a  simulated  cell  which   





4.4.4 Comparison  of  GAMA  and  Minesweeper   
Minesweeper  and  GAMA  conduct  whole-cell  model  simulations  using  the  same  three   
step  design-simulate-test  cycle  (Section  4.3.1).   
  
Minesweeper  has  generated  4620  in-silico  genomes,  which  means  it  is  still  feasible  for   
each  genome  produced  to  be  manually  analysed.  It  initially  deletes  genes  in  groups  but   
eventually  deletes  individual  genes,  and  only  deletes  non-essential  genes.  It  produces   
large  gene  deletions  more  quickly.  Firstly,  as  it  excludes  essential  genes  from  being   
deleted  it  can  delete  a  larger  number  of  genes  with  a  lower  risk  of  producing   
non-dividing  in-silico  cells.  Secondly,  it  uses  between  8  and  359  CPUs  depending  on   
the  stage,  processing  through  the  supercomputer  queue  more  quickly.  This  allows  it  to   
produce  minimal  genome  size  reductions  within  two  days.  As  data  storage  is  handled   
by  user-submitted  information  and  simulation  execution  conducted  manually,  it  only   
requires  a  basic  understanding  of  common  computational  tools  (i.e.  terminals,  FTP   
software),  maintaining  the  possibility  of  biologists  being  able  to  use  it.      
  
GAMA  has  generated  53,451  in-silico  genomes,  with  deletions  varying  by  individual   
genes.  It  does  however  take  much  longer,  with  two  months  required  to  generate   
minimal  genome  size  reductions.  It  requires  greater  computational  power  and  time,   
using  between  400  and  3000  CPUs  depending  on  the  stage,  for  longer  periods  of  time   
than  is  allowed  on  available  supercomputers,  requiring  the  development  of  a  seperate   
tool  (the  genome  design  suite  164 )  to  implement  GAMA.  It  also  requires  greater   
computational  knowledge,  needing  a  good  knowledge  of  querying  SQL  databases,  and   
the  capacity  to  install  and  learn  to  use  the  genome  design  suite  164 .   
  
In  comparing  the  two  algorithms,  GAMA  is  more  comprehensive.  It  produces  greater   
numbers  of  simulations  that  cover  a  greater  amount  of  the  solution  space.  It  also   
attempts  to  remove  singly  essential  genes,  which  are  the  key  differences  between  the   
smallest  genomes  produced  by  Minesweeper  and  GAMA.  The  size  of  the  genome   
database  produced  by  GAMA  means  that  machine  learning  approaches  can  be   
applied,  which  is  attractive  to  other  research  disciplines.  Further  research  may  be  able   
to  identify  other  minima  that  have  yet  to  be  discovered  in  the  database  (the  number  of   
99   
  
genomes  produced  is  too  great  to  manually  analyse)  and  identify  key  features  shared   
by  the  10,000s  of  genomes  stored  there.  The  genome  design  suite  tool  may  also  be   
adaptable  to  other  genome  optimisation  problems,  but  that  requires  new  researchers  to   
learn  how  to  use  the  tool  and  further  develop  it  by  themselves.     
  
Minesweeper  is  the  solution  to  a  specific  problem,  which  it  executes  on  quickly,  and   
could  be  used  by  other  biologists  for  new  whole-cell  models.  GAMA,  the  genome   
dataset,  and  the  genome  design  suite  are  worthy  of  continued  development,  analysis,   
and  research,  as  they  could  be  key  to  solving  multiple  research  problems  in  the  future.     
  
4.4.5 Minesweeper_256,  GAMA_236  and  GAMA_237  Genomes     
I  investigated  our  two  minimal  genomes  for  their  consistency  in  producing  a  dividing   
in-silico  cell,  and  the  range  of  behaviour  they  displayed.  I  simulated  100  replicates  each   
of  an  unmodified  M.genitalium  in-silico  genome,  Minesweeper_256,  GAMA_236,  and  a   
single  gene  knockout  of  a  known  essential  gene  (MG_006)  to  provide  a  comparison   
(Table  9).  The  rate  of  division  (or  lack  of  in  the  MG_006  knockout  simulations)  was   
analysed  and  a  phenotype  penetrance  percentage  calculated  to  quantify  how  often  an   
expected  phenotype  occurred.  The  unmodified  M.genitalium  and  MG_006  knockout   
in-silico  genomes  demonstrated  consistent  phenotypes  (99%  and  0%  divided,   
respectively).  Minesweeper_256  was  slightly  less  consistent  (89%  divided),  while   
GAMA_236  was  substantially  less  consistent,  producing  a  dividing  in-silico  cell  18%  of   
the  time.  This  is  not  entirely  unexpected  given  the  presence  of  gene  deletions  that  have   
high  essentiality  (Section  4.4.8,  Table  19).  I  attempted  to  improve  the  division  rate  of   
GAMA_236  by  conducting  independent  single  knock-ins  of  its  unique  deletions  (Table   
10).  The  highest  division  rate  was  33%  (100  replicates,  Table  9)  due  to  the   
reintroduction  of  a  single  gene  (MG_270),  creating  the  in-silico  minimal  genome   
GAMA_237.  MG_270  (lipoate-protein  ligase  A)  modifies  the  enzyme  produced  by   
MG_272  (Karr  et  al.  Supplementary  mmc1,  pg  65)  6 ,  one  of  four  genes  (MG_271-274)   
that  produce  enzymes  that  form  the  pyruvate  dehydrogenase  complex.  This  provides   
acetyl-CoA  for  the  Krebs  cycle,  producing  ATP.  Reintroducing  MG_270  repairs  this   












GAMA_236    GAMA_237  
Phenotypic   
Penetrance   
99%    100%    89%    18.5%    33%   
1    Dividing    -    Dividing    Dividing    No  Division  
2    Dividing    -    Dividing    Dividing    No  Division  
3    Dividing    -    Dividing    No  Division   No  Division  
4    Dividing    -    Dividing    No  Division   No  Division  
5    Dividing    -    Dividing    No  Division   No  Division  
6    Dividing    -    Dividing    No  Division   No  Division  
7    Dividing    -    Dividing    Dividing    No  Division  
8    Dividing    -    Dividing    Dividing    No  Division  
9    Dividing    -    No  Division    No  Division   Dividing   
10    Dividing    No  Division    Dividing    Dividing    No  Division  
11    Dividing    No  Division    Dividing    No  Division   Dividing   
12    Dividing    No  Division    Dividing    No  Division   Dividing   
13    Dividing    No  Division    Dividing    No  Division   No  Division  
14    Dividing    No  Division    Dividing    No  Division   Dividing   
15    Dividing    No  Division    No  Division    No  Division   No  Division  
16    Dividing    No  Division    Dividing    No  Division   No  Division  
17    Dividing    No  Division    Dividing    No  Division   No  Division  
18    Dividing    No  Division    Dividing    No  Division   No  Division  
19    Dividing    No  Division    Dividing    Dividing    Dividing   
20    Dividing    No  Division    Dividing    No  Division   No  Division  
21    Dividing    No  Division    Dividing    No  Division   Dividing   
22    Dividing    No  Division    Dividing    No  Division   No  Division  
23    Dividing    No  Division    Dividing    No  Division   Dividing   
24    Dividing    No  Division    Dividing    No  Division   No  Division  
25    Dividing    No  Division    Dividing    No  Division   No  Division  
26    Dividing    No  Division    Dividing    Dividing    No  Division  
27    Dividing    No  Division    Dividing    No  Division   Dividing   
28    Dividing    No  Division    Dividing    No  Division   No  Division  
29    Dividing    No  Division    Dividing    No  Division   No  Division  
30    Dividing    No  Division    No  Division    Dividing    No  Division  
31    Dividing    No  Division    Dividing    No  Division   No  Division  
32    Dividing    No  Division    Dividing    No  Division   Dividing   
33    Dividing    No  Division    Dividing    No  Division   No  Division  
34    Dividing    No  Division    Dividing    Dividing    Dividing   
35    Dividing    No  Division    Dividing    No  Division   No  Division  
36    Dividing    No  Division    Dividing    Dividing    No  Division  
37    Dividing    No  Division    Dividing    No  Division   No  Division  
38    Dividing    No  Division    Dividing    No  Division   No  Division  
39    Dividing    No  Division    No  Division    No  Division   No  Division  
40    Dividing    No  Division    Dividing    Dividing    Dividing   
41    Dividing    No  Division    Dividing    No  Division   No  Division  










GAMA_236    GAMA_237  
43    Dividing    No  Division    Dividing    No  Division   No  Division  
44    Dividing    No  Division    Dividing    No  Division   Dividing   
45    Dividing    No  Division    Dividing    No  Division   Dividing   
46    Dividing    No  Division    No  Division    No  Division   Dividing   
47    Dividing    No  Division    Dividing    No  Division   No  Division  
48    Dividing    No  Division    Dividing    No  Division   No  Division  
49    Dividing    No  Division    Dividing    No  Division   No  Division  
50    Dividing    No  Division    Dividing    No  Division   Dividing   
51    Dividing    No  Division    Dividing    No  Division   Dividing   
52    Dividing    No  Division    Dividing    No  Division   Dividing   
53    Dividing    No  Division    Dividing    Dividing    No  Division  
54    Dividing    No  Division    Dividing    No  Division   No  Division  
55    Dividing    No  Division    Dividing    Dividing    No  Division  
56    Dividing    No  Division    Dividing    No  Division   Dividing   
57    Dividing    No  Division    Dividing    No  Division   No  Division  
58    Dividing    No  Division    Dividing    No  Division   No  Division  
59    Dividing    No  Division    Dividing    No  Division   Dividing   
60    Dividing    No  Division    Dividing    No  Division   No  Division  
61    Dividing    No  Division    Dividing    No  Division   No  Division  
62    Dividing    No  Division    Dividing    No  Division   Dividing   
63    Dividing    No  Division    Dividing    No  Division   No  Division  
64    Dividing    No  Division    Dividing    No  Division   Dividing   
65    Dividing    No  Division    No  Division    No  Division   No  Division  
66    Dividing    No  Division    Dividing    Dividing    Dividing   
67    Dividing    No  Division    Dividing    No  Division   No  Division  
68    Dividing    No  Division    Dividing    No  Division   No  Division  
69    Dividing    No  Division    Dividing    No  Division   No  Division  
70    Dividing    No  Division    No  Division    Dividing    No  Division  
71    Dividing    No  Division    No  Division    No  Division   No  Division  
72    Dividing    No  Division    Dividing    No  Division   No  Division  
73    Dividing    No  Division    Dividing    No  Division   Dividing   
74    Dividing    No  Division    Dividing    No  Division   Dividing   
75    Dividing    No  Division    Dividing    No  Division   No  Division  
76    Dividing    No  Division    No  Division    No  Division   No  Division  
77    Dividing    No  Division    Dividing    No  Division   Dividing   
78    Dividing    No  Division    Dividing    No  Division   Dividing   
79    Dividing    No  Division    Dividing    No  Division   No  Division  
80    Dividing    No  Division    Dividing    Dividing    No  Division  
81    Dividing    No  Division    Dividing    No  Division   No  Division  
82    Dividing    No  Division    Dividing    No  Division   No  Division  
83    Dividing    No  Division    Dividing    No  Division   Dividing   
84    Dividing    No  Division    Dividing    No  Division   No  Division  
85    Dividing    No  Division    Dividing    No  Division   Dividing   
86    Dividing    No  Division    Dividing    No  Division   No  Division  
                 
102   
  








GAMA_236    GAMA_237  
87    Dividing    No  Division    Dividing    No  Division   No  Division  
88    Dividing    No  Division    Dividing    Dividing    Dividing   
89    Dividing    No  Division    Dividing    No  Division   No  Division  
90    Dividing    No  Division    No  Division    No  Division   No  Division  
91    Dividing    No  Division    Dividing    No  Division   No  Division  
92    Dividing    No  Division    Dividing    Dividing    No  Division  
93    Dividing    No  Division    No  Division    No  Division   No  Division  
94    Dividing    No  Division    Dividing    No  Division   No  Division  
95    Dividing    No  Division    Dividing    No  Division   No  Division  
96    Dividing    No  Division    Dividing    No  Division   Dividing   
97    Dividing    No  Division    Dividing    No  Division   No  Division  
98    Dividing    No  Division    Dividing    -    Dividing   
99    Dividing    No  Division    Dividing    -    Dividing   
100    No  Division    -    Dividing    -    No  Division  
Table  9.  Phenotypic  penetrance  of  an  unmodified  M.genitalium  genome,  MG_006   
deletion  (known  essential  gene),  Minesweeper_256,  GAMA_236,  and  GAMA_237.  A   
published  version  of  the  table  is  available  56 ,  as  is  the  simulation  data  161 .  -  =  a  failed   





MG_    008   022   084   141   177   182    249    270    282    295    340    341    347    367    372    379    445    465   
%    20    19    17    22    28    21    25    33    16    23    18    15    27    13    22    18    16    19   
1    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D   
2    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
3    ND    D    ND    ND    ND    D    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND   
4    ND    D    ND    ND    D    D    ND    ND    ND    ND    ND    D    ND    ND    ND    D    ND    ND   
5    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND   
6    D    ND    ND    D    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND   
7    ND    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    D    D   
8    ND    ND    ND    D    ND    D    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND   
9    ND    ND    ND    ND    ND    D    D    D    ND    ND    ND    ND    ND    ND    D    ND    D    ND   
10    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND   
11    ND    ND    ND    ND    ND    ND    D    D    ND    D    ND    ND    ND    ND    ND    ND    ND    D   
12    ND    ND    ND    ND    D    D    ND    D    ND    ND    ND    ND    ND    D    D    D    ND    ND   
13    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
14    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    D   
15    ND    ND    ND    D    ND    ND    D    ND    ND    ND    D    D    D    ND    ND    ND    D    D   
16    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    D    D    ND    ND    ND    D    ND   
17    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND   
18    ND    D    D    ND    ND    ND    ND    ND    ND    D    D    D    ND    ND    D    D    ND    ND   
19    ND    ND    ND    D    D    ND    ND    D    D    ND    ND    ND    ND    ND    ND    ND    ND    ND   
20    ND    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND   
21    ND    ND    D    ND    ND    ND    D    D    ND    ND    D    ND    ND    D    D    ND    ND    ND   
22    D    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND   
23    ND    ND    ND    ND    ND    D    D    D    ND    D    ND    ND    ND    ND    D    ND    D    ND   
24    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
25    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND   
26    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    D   
27    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND   
28    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    D    ND    ND    ND   
29    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
30    ND    ND    ND    D    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND   
31    ND    ND    ND    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND   
32    ND    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND   
33    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND   
34    D    ND    ND    ND    D    ND    ND    D    ND    ND    D    ND    ND    ND    ND    D    ND    ND   
35    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND   
36    ND    ND    D    ND    ND    D    ND    ND    ND    D    D    ND    ND    ND    ND    ND    ND    ND   
37    ND    ND    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND   
38    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
39    ND    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND   
40    D    ND    ND    ND    ND    ND    ND    D    ND    D    ND    ND    D    ND    ND    ND    ND    D   
41    ND    ND    ND    D    D    ND    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND   
42    ND    D    ND    D    ND    ND    D    D    ND    ND    ND    ND    ND    D    ND    ND    ND    ND   
43    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    D   
104   
  
MG_    008   022   084   141   177   182    249    270    282    295    340    341    347    367    372    379    445    465   
44    ND    D    ND    ND    D    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    ND   
45    ND    D    D    ND    ND    ND    D    D    D    ND    ND    ND    D    ND    ND    ND    ND    ND   
46    ND    D    ND    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
47    ND    ND    ND    ND    ND    D    ND    ND    ND    D    ND    ND    D    ND    ND    ND    D    ND   
48    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    D    D    ND    ND    ND    ND    ND   
49    ND    ND    ND    D    D    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    D    ND   
50    D    ND    ND    D    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    D   
51    ND    ND    ND    ND    ND    ND    ND    D    D    D    ND    ND    D    D    D    ND    ND    ND   
52    ND    D    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND   
53    ND    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    D    ND    D    D    ND    ND   
54    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    D    ND    D    ND    D    D    ND    D   
55    D    D    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    D    ND    D    ND    ND    ND   
56    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    D    ND    D    ND    ND    ND    D    ND   
57    D    ND    D    D    ND    ND    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND   
58    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    D   
59    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND   
60    D    D    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    D   
61    -    ND    D    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND   
62    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    D    ND    ND    ND    D    ND   
63    ND    D    ND    ND    ND    ND    D    ND    ND    D    D    ND    ND    ND    ND    ND    D    D   
64    ND    ND    ND    D    D    ND    ND    D    ND    ND    ND    D    ND    ND    D    D    ND    ND   
65    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    D    ND    D   
66    ND    ND    ND    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
67    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND   
68    ND    ND    D    ND    ND    D    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
69    D    ND    ND    ND    ND    D    D    ND    ND    D    ND    ND    ND    ND    D    ND    ND    D   
70    D    ND    ND    ND    D    ND    ND    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND   
71    ND    D    ND    ND    ND    D    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    D   
72    D    D    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    D    D   
73    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    D    ND    ND    D    ND   
74    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    ND   
75    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
76    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    D    D   
77    ND    D    D    ND    ND    ND    D    D    D    D    ND    D    ND    ND    D    ND    ND    ND   
78    D    ND    ND    ND    D    D    ND    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND   
79    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND   
80    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
81    D    ND    D    D    ND    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND    ND   
82    ND    ND    ND    D    ND    ND    ND    ND    D    D    ND    ND    D    ND    ND    ND    D    ND   
83    D    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND    D    D    ND    ND    D   
84    ND    D    ND    ND    D    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND   
85    ND    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    D    ND    ND   
86    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND    ND   
87    ND    ND    D    ND    ND    D    ND    ND    ND    ND    D    ND    D    ND    D    ND    ND    ND   
88    ND    ND    D    ND    D    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    D    ND    ND   
105   
  
MG_    008   022   084   141   177   182    249    270    282    295    340    341    347    367    372    379    445    465   
89    ND    D    D    ND    ND    D    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND   
90    ND    D    ND    D    ND    ND    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND   
91    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    D    ND    ND   
92    ND    ND    ND    ND    D    ND    ND    ND    ND    D    D    ND    D    ND    D    ND    D    ND   
93    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND   
94    ND    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND   
95    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND    D    ND    ND    ND    ND    ND    ND   
96    ND    ND    ND    ND    ND    ND    D    D    ND    ND    ND    ND    ND    ND    D    ND    ND    ND   
97    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    ND    D    ND    ND   
98    ND    ND    ND    ND    D    ND    ND    D    D    ND    D    ND    ND    ND    D    D    ND    ND   
99    ND    D    ND    ND    D    ND    ND    D    D    D    ND    ND    ND    ND    ND    ND    ND    ND   
100    ND    ND    ND    ND    ND    ND    D    ND    ND    ND    D    ND    ND    ND    ND    ND    ND    ND   
Table  10.  Improving  the  phenotypic  penetrance  of  GAMA_236  by  reintroducing   
individual  genes,  creating  GAMA_237.  ND  =  No  Division,  D  =  Dividing.  A  published   
version  of  the  table  is  available  56 ,  as  is  the  simulation  data  161 .  -  =  a  failed  simulation   
due  to  supercomputer  error.   
  
While  exploring  further  deletions  for  Minesweeper_256,  another  individual  gene  was   
found  that  impacted  the  division  rate.  Deleting  MG_104  (ribonuclease  R)  decreased  the   
division  rate  to  a  1/9  of  its  original  value.  M.genitalium  has  a  very  small  pool  of  RNAs   
(Karr  et  al.  Supplementary  mmc1,  pg  85)  6 ,  relying  on  ribonucleases  to  recycle  RNAs   
for  other  cellular  processes.  Without  ribonuclease  R  (the  only  modeled  ribonuclease),   
the  RNA  decay  sub-model  cannot  function  in-silico ,  decreasing  the  amount  of  available   
RNAs.     
  
The  100  replicates  for  each  of  the  unmodified  M.genitalium  genome,   
Minesweeper_256,  and  GAMA_237  were  plotted  to  assess  the  range  of  behaviour   
(Figure  14).  The  unmodified  M.genitalium  whole-cell  model  (Figure  14,  top  row)  shows   
the  range  of  expected  behaviour  for  a  dividing  cell  (in  line  with  previous  results  6 ).   
Growth,  protein  production,  and  cellular  mass  increase  over  time,  with  the  majority  of   
cells  dividing  within  10  hours  (see  cell  diameter  change).  RNA  production  fluctuates  but   
increases  over  time.  DNA  replication  follows  a  characteristic  shape,  with  some   
simulations  delaying  the  initiation  of  DNA  replication  past  ~9  hours.     
  
By  comparison,  Minesweeper_256  (Figure  14,  middle  row)  displays  slower,  and  in   
some  cases  decreasing,  growth  over  time  which  is  capped  at  a  lower  maximum.   
106   
  
Protein  and  cellular  mass  are  generated  more  slowly,  lower  amounts  are  produced,  and   
some  erratic  behaviour  is  present.  The  range  of  RNA  production  is  narrower  compared   
to  the  unmodified  M.genitalium  whole-cell  model.  DNA  replication  takes  longer  and   
initiation  can  occur  later  (at  11  hours).  Cell  division  occurs  later,  between  8  and  13.9   
hours.  A  number  of  simulations  can  be  seen  failing  to  replicate  DNA  and  divide.   
  
Compared  to  the  other  genomes,  GAMA_237  (Figure  14,  bottom  row)  shows  a  much   
greater  range  of  growth  rates.  Some  grow  as  fast  as  the  unmodified  genome,  some  are   
comparable  to  Minesweeper_256,  and  some  show  very  low  or  decreasing  growth  (this   
can  also  be  seen  in  cellular  mass).  Observable  protein  levels  appear  between  2  and  5   
hours,  followed  by  a  slower  rate  of  protein  production  in  some  simulations.  The  range  of   
RNA  production  is  reduced  and  the  rate  of  RNA  production  is  slower.  Some  simulations   
replicate  DNA  at  a  rate  comparable  to  the  unmodified  genome,  others  replicate  more   
slowly,  and  some  do  not  complete  DNA  replication.  Cell  division  occurs  across  a   
greater  range  of  time  (6  -  13.9  hours).  A  number  of  simulations  showing  metabolic   








Figure  14.  Behavioural  comparison  of  the  whole-cell  model,  Minesweeper_256,  and   
GAMA_237.  One  hundred  in-silico  replicates,  with  second-by-second  values  plotted  for   
6  cellular  variables  over  13.89  hours  (the  default  endtime  of  the  simulations).  The  top   
row  shows  the  expected  cellular  behaviour  (previously  shown  by  Karr  et  al.  6 )  and  is   
used  for  comparison.  Minesweeper_256  and  GAMA_237  show  deviations  in  phenotype   
caused  by  gene  deletions.  Simulation  data  is  available  161 .   
  
4.4.6 Genome  Analysis  using  Gene  Ontology  terms     
I  investigated  what  cellular  processes  were  altered  in  the  creation  of  Minesweeper_256   
using  gene  ontology  (GO)  biological  process  terms  160 ,  standardised  labels  that   
describe  a  gene’s  function.  In  the  baseline  M.genitalium  whole-cell  model  259/401   
genes  (72%  coverage)  have  GO  terms  on  UniProt  160   (Table  11).     
  
Minesweeper_256  has  186  (73%)  genes  with  GO  terms  and  70  genes  without.  The  145   
gene  deletions  reduced  22  (14%)  GO  categories  and  removed  42  (27%)  GO  categories   
entirely,  of  which  30  were  associated  with  a  single  gene  (Table  12).     
  
The  GO  categories  reduced  include:  DNA  (repair,  replication,  topological  change,   
transcription  regulation  and  initiation);  protein  (folding  and  transport);  RNA  processing;   
creation  of  lipids;  cell  cycle;  and  cell  division.  As  the  in-silico  cells  continue  to  function,   
we  can  assume  that  these  categories  could  withstand  low-level  disruption.     
  
Removed  GO  categories  that  involved  multiple  genes  include:  proton  transport;  host   
interaction;  DNA  recombination;  protein  secretion  and  targeting  to  membrane;  and   
response  to  oxidative  stress.  Removed  GO  categories  that  contain  single  genes   
include:  transport  (carbohydrate,  phosphate  and  protein  import,  protein  insertion  into   
membrane);  protein  modification  (refolding,  repair,  targeting);  chromosome   
(segregation,  separation);  biosynthesis  (coenzyme  A,  dTMP,  dTTP,  lipoprotein);   
breakdown  (deoxyribonucleotide,  deoxyribose,  mRNA,  protein);  regulation  (phosphate,   
carbohydrate,  and  carboxylic  acid  metabolic  processes,  cellular  phosphate  ion   
homeostasis);  cell-cell  adhesion;  foreign  DNA  cleavage;  SOS  response;  sister   




Gene    Name      GO  Biological  Process  Labels   
MG_001    dnaN    DNA  replication   
MG_003    gyrB    DNA  topological  change   
MG_004    gyrA    DNA  topological  change   
MG_005    serS    selenocysteinyl-tRNA(Sec)  biosynthetic  process,  seryl-tRNA  aminoacylation   
MG_006    tmk    dTDP  biosynthetic  process   
MG_008    mnmE    tRNA  modification   
MG_012         cellular  protein  modification  process   
MG_013    folD    histidine  biosynthetic  process,  methionine  biosynthetic  process,  purine  nucleotide  biosynthetic  process     
MG_019    dnaJ    DNA  replication,  protein  folding,  response  to  heat     
MG_021    metG    methionyl-tRNA  aminoacylation   
MG_022    rpoE    regulation  of  transcription,  DNA-templated,  transcription,  DNA-templated   
MG_023    fba    fructose  1,  6-bisphosphate  metabolic  process,  glycolytic  process   
MG_030    upp    UMP  salvage,  uracil  salvage   
MG_031    polC    DNA  replication   
MG_033    glpF    glycerol  metabolic  process   
MG_034    tdk   DNA  biosynthetic  process   
MG_035    hisS    histidyl-tRNA  aminoacylation   
MG_036    aspS    tRNA  aminoacylation  for  protein  translation   
MG_037         NAD  biosynthetic  process   
MG_038    glpK    glycerol-3-phosphate  metabolic  process,  glycerol  catabolic  process,  glycerol  metabolic  process     
MG_041    ptsH    phosphoenolpyruvate-dependent  sugar  phosphotransferase  system,  regulation  of  transcription,  DNA-templated,  
transcription,  DNA-templated     
MG_043    potB    transport   
MG_044    potC    transport   
MG_046    tsaD    tRNA  threonylcarbamoyladenosine  modification   
MG_047    metK    one-carbon  metabolic  process,  S-adenosylmethionine  biosynthetic  process   
MG_048    ffh    SRP-dependent  cotranslational  protein  targeting  to  membrane   
MG_049    deoD    nucleoside  metabolic  process   
MG_050    deoC    deoxyribonucleotide  catabolic  process,  deoxyribose  phosphate  catabolic  process   
MG_051    deoA    pyrimidine  nucleobase  metabolic  process,  pyrimidine  nucleoside  metabolic  process   
MG_053    manB    carbohydrate  metabolic  process   
MG_055         protein  secretion   
MG_058    prs   5-phosphoribose  1-diphosphate  biosynthetic  process,  nucleoside  metabolic  process,  nucleotide  biosynthetic   
process     
MG_062    fruA    phosphoenolpyruvate-dependent  sugar  phosphotransferase  system   
MG_066    tkt    metabolic  process   
MG_069    ptsG    phosphoenolpyruvate-dependent  sugar  phosphotransferase  system   
MG_070    rpsB    translation   
MG_072    secA    protein  import,  protein  targeting   
MG_073    uvrB    nucleotide-excision  repair,  SOS  response   
MG_077    oppB    protein  transport   
MG_078    oppC    protein  transport   
MG_079    oppD    protein  transport   
MG_080    oppF    protein  transport   
MG_081    rplK    translation   
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MG_082    rplA    regulation  of  translation,  translation   
MG_084    tilS    tRNA  processing   
MG_085    hprK    carbohydrate  metabolic  process,  regulation  of  carbohydrate  metabolic  process   
MG_086    lgt    lipoprotein  biosynthetic  process,  protein  lipoylation   
MG_087    rpsL    translation   
MG_088    rpsG    translation   
MG_090    rpsF    translation   
MG_092    rpsR    translation   
MG_093    rplI    translation   
MG_094    dnaB    DNA  replication,  synthesis  of  RNA  primer   
MG_097    ung    base-excision  repair   
MG_098         regulation  of  translational  fidelity   
MG_099    gatA    translation   
MG_100    gatB    translation   
MG_101         transcription,  DNA-templated   
MG_102    trxB    removal  of  superoxide  radicals   
MG_106    def    translation   
MG_110    rsgA    ribosome  biogenesis   
MG_111    pgi    gluconeogenesis,  glycolytic  process   
MG_112    rpe    carbohydrate  metabolic  process   
MG_113    asnS    asparaginyl-tRNA  aminoacylation   
MG_114    pgsA    phosphatidylglycerol  biosynthetic  process   
MG_118    galE    galactose  metabolic  process   
MG_119         carbohydrate  transport   
MG_120         transport   
MG_121         transport   
MG_122    topA    DNA  topological  change   
MG_124    trxA    cell  redox  homeostasis,  glycerol  ether  metabolic  process   
MG_126    trpS    tryptophanyl-tRNA  aminoacylation   
MG_128    nadK    NAD  metabolic  process,  NADP  biosynthetic  process   
MG_130    rny    mRNA  catabolic  process   
MG_136    lysS    lysyl-tRNA  aminoacylation   
MG_139    rnj    rRNA  processing   
MG_141    nusA    DNA-templated  transcription,  termination,  transcription  antitermination   
MG_143    rbfA    rRNA  processing   
MG_145    ribF    FAD  biosynthetic  process,  FMN  biosynthetic  process,  riboflavin  biosynthetic  process     
MG_150    rpsJ    translation   
MG_151    rplC    translation   
MG_152    rplD    translation   
MG_153    rplW    translation   
MG_154    rplB    translation   
MG_155    rpsS    translation   
MG_156    rplV    translation   
MG_157    rpsC    translation   
MG_158    rplP    translation   
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MG_159    rpmC    translation   
MG_160    rpsQ    translation   
MG_161    rplN    translation   
MG_162    rplX    translation   
MG_163    rplE    translation   
MG_164    rpsZ    translation   
MG_165    rpsH    translation   
MG_166    rplF    translation   
MG_167    rplR    translation   
MG_168    rpsE    translation   
MG_169    rplO    translation   
MG_170    secY    protein  transport   
MG_171    adk    AMP  salvage   
MG_174    rpmJ    translation   
MG_175    rpsM    translation   
MG_176    rpsK    translation   
MG_177    rpoA    transcription,  DNA-templated   
MG_178    rplQ    translation   
MG_179    ecfA1    transport   
MG_180    ecfA2    transport   
MG_182    truA    pseudouridine  synthesis,  tRNA  processing   
MG_188         transport   
MG_189         transport   
MG_191    mgpA    cytoadherence  to  microvasculature,  mediated  by  symbiont  protein   
MG_192         cell  adhesion   
MG_194    pheS    phenylalanyl-tRNA  aminoacylation   
MG_195    pheT    phenylalanyl-tRNA  aminoacylation   
MG_197    rpmI    translation   
MG_198    rplT    translation   
MG_201    grpE    protein  folding   
MG_203    parE    DNA  topological  change   
MG_204    parC    DNA  topological  change   
MG_205    hrcA    regulation  of  transcription,  DNA-templated,  transcription,  DNA-templated   
MG_206    uvrC    DNA  repair,  SOS  response   
MG_208         tRNA  threonylcarbamoyladenosine  modification   
MG_209         pseudouridine  synthesis   
MG_212    plsC    CDP-diacylglycerol  biosynthetic  process   
MG_213    scpA    cell  cycle,  cell  division,  chromosome  segregation     
MG_214    scpB    cell  division,  chromosome  separation   
MG_215    pfkA    fructose  6-phosphate  metabolic  process   
MG_218    hmw2    cytoadherence  to  microvasculature,  mediated  by  symbiont  protein,  pathogenesis   
MG_221    mraZ    transcription,  DNA-templated   
MG_224    ftsZ    cell  cycle,  cell  division   
MG_227    thyA    dTMP  biosynthetic  process,  dTTP  biosynthetic  process   
MG_228    folA    glycine  biosynthetic  process,  nucleotide  biosynthetic  process,  one-carbon  metabolic  process     
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MG_229    nrdF    deoxyribonucleotide  biosynthetic  process,  DNA  replication   
MG_231    nrdE    DNA  replication   
MG_232    rplU    translation   
MG_234    rpmA    translation   
MG_235    nfo    DNA  repair   
MG_238    tig    cell  cycle,  cell  division,  protein  folding     
MG_239    lon    protein  catabolic  process   
MG_240         biosynthetic  process   
MG_244    uvrD    DNA  repair,  DNA  replication   
MG_249    sigA    DNA-templated  transcription,  initiation   
MG_251    glyQS    glycyl-tRNA  aminoacylation   
MG_252         RNA  processing   
MG_253    cysS    cysteinyl-tRNA  aminoacylation   
MG_254    ligA    DNA  repair,  DNA  replication   
MG_257    rpmE    translation   
MG_261    dnaE    DNA  replication   
MG_264    coaE    coenzyme  A  biosynthetic  process   
MG_266    leuS    leucyl-tRNA  aminoacylation   
MG_270    lplA    protein  lipoylation   
MG_271    pdhD    cell  redox  homeostasis,  glycolytic  process   
MG_272    pdhC    glycolytic  process   
MG_273    pdhB    glycolytic  process   
MG_274    pdhA    glycolytic  process   
MG_275    nox    cell  redox  homeostasis   
MG_276    apt    adenine  salvage,  AMP  salvage,  purine  ribonucleoside  salvage     
MG_278    spoT    guanosine  tetraphosphate  biosynthetic  process   
MG_282    greA    regulation  of  DNA-templated  transcription,  elongation,  transcription,  DNA-templated  
MG_283    proS    prolyl-tRNA  aminoacylation   
MG_287         fatty  acid  biosynthetic  process   
MG_289    p37    transport   
MG_291    p69    transport   
MG_292    alaS    alanyl-tRNA  aminoacylation   
MG_293         lipid  metabolic  process   
MG_295    mnmA    tRNA  processing   
MG_297    ftsY    SRP-dependent  cotranslational  protein  targeting  to  membrane   
MG_298    smc    chromosome  condensation,  sister  chromatid  cohesion   
MG_299    pta    acetyl-CoA  biosynthetic  process   
MG_300    pgk    glycolytic  process   
MG_301    gapA    adhesion  of  symbiont  to  host  cell,  glucose  metabolic  process,  glycolytic  process     
MG_305    dnaK    protein  folding   
MG_311    rpsD    translation   
MG_312    hmw1    cytoadherence  to  microvasculature,  mediated  by  symbiont  protein,  pathogenesis   
MG_315         DNA  replication   
MG_317    hmw3    cytoadherence  to  microvasculature,  mediated  by  symbiont  protein,  pathogenesis   
MG_318         cytoadherence,  heterophilic  cell-cell  adhesion  via  plasma  membrane  cell  adhesion  molecules,  pathogenesis     
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MG_323         potassium  ion  transport   
MG_325    rpmG1    translation   
MG_329    der    ribosome  biogenesis   
MG_334    valS    valyl-tRNA  aminoacylation   
MG_335    engB    cell  cycle,  cell  division   
MG_339    recA    DNA  recombination,  DNA  repair,  SOS  response     
MG_340    rpoC    transcription,  DNA-templated   
MG_341    rpoB    transcription,  DNA-templated   
MG_345    ileS    isoleucyl-tRNA  aminoacylation   
MG_346         tRNA  processing   
MG_351    ppa    phosphate-containing  compound  metabolic  process   
MG_352    recU   DNA  recombination,  DNA  repair   
MG_357    ackA    acetyl-CoA  biosynthetic  process,  organic  acid  metabolic  process   
MG_358    ruvA    DNA  recombination,  DNA  repair,  SOS  response     
MG_359    ruvB    DNA  recombination,  DNA  repair,  SOS  response     
MG_361    rplJ    ribosome  biogenesis,  translation   
MG_362    rplL    translation   
MG_363    rpmF    translation   
MG_367    rnc    mRNA  processing,  rRNA  catabolic  process,  rRNA  processing     
MG_368    plsX    fatty  acid  biosynthetic  process,  phospholipid  biosynthetic  process   
MG_369         glycerol  metabolic  process   
MG_370         pseudouridine  synthesis   
MG_372    thiI    thiamine  biosynthetic  process,  thiamine  diphosphate  biosynthetic  process,  tRNA  thio-modification     
MG_375    thrS    threonyl-tRNA  aminoacylation   
MG_378    argS    arginyl-tRNA  aminoacylation   
MG_379    mnmG    tRNA  wobble  uridine  modification   
MG_382    udk    CTP  salvage,  UMP  salvage   
MG_383    nadE    NAD  biosynthetic  process   
MG_385         lipid  metabolic  process   
MG_386         cytoadherence  to  microvasculature,  mediated  by  symbiont  protein   
MG_387    era    ribosome  biogenesis   
MG_392    groL    protein  refolding   
MG_393    groS    protein  folding   
MG_394    glyA    glycine  biosynthetic  process,  tetrahydrofolate  interconversion   
MG_396    rpiB    carbohydrate  metabolic  process,  pentose-phosphate  shunt,  non-oxidative  branch   
MG_398    atpC    ATP  synthesis  coupled  proton  transport   
MG_399    atpD    ATP  synthesis  coupled  proton  transport   
MG_400    atpG    ATP  synthesis  coupled  proton  transport   
MG_401    atpA    ATP  synthesis  coupled  proton  transport   
MG_402    atpH    ATP  synthesis  coupled  proton  transport   
MG_403    atpF    ATP  synthesis  coupled  proton  transport   
MG_404    atpE    ATP  hydrolysis  coupled  proton  transport,  ATP  synthesis  coupled  proton  transport   
MG_405    atpB    ATP  synthesis  coupled  proton  transport   
MG_407    eno    glycolytic  process   
MG_409         cellular  phosphate  ion  homeostasis,  negative  regulation  of  phosphate  metabolic  process   
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MG_411    pstA    phosphate  ion  transmembrane  transport   
MG_417    rpsI    translation   
MG_418    rplM    translation   
MG_419    dnaX    DNA  replication   
MG_421    uvrA    nucleotide-excision  repair,  SOS  response   
MG_424    rpsO    translation   
MG_426    rpmB    translation   
MG_428         DNA-templated  transcription,  initiation   
MG_429    ptsI    phosphoenolpyruvate-dependent  sugar  phosphotransferase  system   
MG_430    gpmI    glucose  catabolic  process,  glycolytic  process   
MG_431    tpiA    gluconeogenesis,  glycolytic  process,  pentose-phosphate  shunt     
MG_434    pyrH    'de  novo'  CTP  biosynthetic  process   
MG_435    frr    translation   
MG_437    cdsA    CDP-diacylglycerol  biosynthetic  process   
MG_438         DNA  restriction-modification  system   
MG_442    rbgA    ribosome  biogenesis   
MG_444    rplS    translation   
MG_446    rpsP    translation   
MG_448    msrB    protein  repair,  response  to  oxidative  stress   
MG_453    galU    biosynthetic  process,  UDP-glucose  metabolic  process   
MG_454         response  to  oxidative  stress   
MG_455    tyrS    tyrosyl-tRNA  aminoacylation   
MG_458    hpt    IMP  salvage,  purine  ribonucleoside  salvage   
MG_460    ldh    carbohydrate  metabolic  process,  carboxylic  acid  metabolic  process   
MG_462    gltX    glutamyl-tRNA  aminoacylation   
MG_464    yidC    protein  insertion  into  membrane,  protein  transport   
MG_465    rnpA    tRNA  processing   
MG_466    rpmH    translation   
MG_469    dnaA    DNA  replication  initiation,  regulation  of  DNA  replication   
MG_473    rpmG2    translation   
MG_476    secG    protein  secretion   
MG_481    rpsU    translation   
MG_482    acpS    fatty  acid  biosynthetic  process   
MG_498    mutM    base-excision  repair,  nucleotide-excision  repair   
MG_517         enterobacterial  common  antigen  biosynthetic  process,  glycerol  metabolic  process,  membrane  lipid  biosynthetic   
process     
MG_522    rpsT    translation   
Table  11.  259  modelled  M.genitalium  genes  with  GO  (Biological  Process)  terms.  A   










Unaffected  GO  Term  Categories    Baseline  GO  N   Minesweeper_256  GO  N  
translation    56    56   
glycolytic  process    11    11   
cell  redox  homeostasis    3    3   
acetyl-CoA  biosynthetic  process    2    2   
AMP  salvage    2    2   
CDP-diacylglycerol  biosynthetic  process    2    2   
gluconeogenesis    2    2   
glycine  biosynthetic  process    2    2   
NAD  biosynthetic  process    2    2   
nucleoside  metabolic  process    2    2   
nucleotide  biosynthetic  process   2    2   
one-carbon  metabolic  process    2    2   
phenylalanyl-tRNA  aminoacylation    2    2   
purine  ribonucleoside  salvage    2    2   
5-phosphoribose  1-diphosphate  biosynthetic  process    1    1   
adenine  salvage    1    1   
adhesion  of  symbiont  to  host  cell    1    1   
alanyl-tRNA  aminoacylation    1    1   
arginyl-tRNA  aminoacylation    1    1   
asparaginyl-tRNA  aminoacylation    1    1   
CTP  salvage    1    1   
cysteinyl-tRNA  aminoacylation    1    1   
de  novo'  CTP  biosynthetic  process    1    1   
deoxyribonucleotide  biosynthetic  process    1    1   
DNA  biosynthetic  process    1    1   
DNA  replication  synthesis  of  RNA  primer      1    1   
DNA  replication  initiation    1    1   
DNA-templated  transcription  termination      1    1   
dTDP  biosynthetic  process    1    1   
enterobacterial  common  antigen  biosynthetic  process    1    1   
FAD  biosynthetic  process    1    1   
FMN  biosynthetic  process    1    1   
fructose  1 6-bisphosphate  metabolic  process      1    1   
fructose  6-phosphate  metabolic  process    1    1   
galactose  metabolic  process    1    1   
glucose  catabolic  process    1    1   
glucose  metabolic  process    1    1   
glutamyl-tRNA  aminoacylation    1    1   
glycerol  catabolic  process    1    1   
glycerol  ether  metabolic  process    1    1   
glycerol-3-phosphate  metabolic  process    1    1   
glycyl-tRNA  aminoacylation    1    1   
guanosine  tetraphosphate  biosynthetic  process    1    1   
histidine  biosynthetic  process    1    1   
histidyl-tRNA  aminoacylation    1    1   
116   
  
Unaffected  GO  Term  Categories    Baseline  GO  N   Minesweeper_256  GO  N  
IMP  salvage    1    1   
isoleucyl-tRNA  aminoacylation    1    1   
leucyl-tRNA  aminoacylation    1    1   
lysyl-tRNA  aminoacylation    1    1   
membrane  lipid  biosynthetic  process    1    1   
metabolic  process    1    1   
methionine  biosynthetic  process    1    1   
methionyl-tRNA  aminoacylation    1    1   
mRNA  processing    1    1   
NAD  metabolic  process    1    1   
NADP  biosynthetic  process    1    1   
organic  acid  metabolic  process    1    1   
pentose-phosphate  shunt    1    1   
pentose-phosphate  shunt  non-oxidative  branch      1    1   
phosphate-containing  compound  metabolic  process    1    1   
phosphatidylglycerol  biosynthetic  process    1    1   
phospholipid  biosynthetic  process    1    1   
potassium  ion  transport    1    1   
prolyl-tRNA  aminoacylation    1    1   
purine  nucleotide  biosynthetic  process    1    1   
pyrimidine  nucleobase  metabolic  process    1    1   
pyrimidine  nucleoside  metabolic  process    1    1   
regulation  of  DNA  replication    1    1   
regulation  of  DNA-templated  transcription  elongation      1    1   
regulation  of  translation    1    1   
regulation  of  translational  fidelity    1    1   
removal  of  superoxide  radicals    1    1   
response  to  heat    1    1   
riboflavin  biosynthetic  process    1    1   
rRNA  catabolic  process    1    1   
S-adenosylmethionine  biosynthetic  process    1    1   
selenocysteinyl-tRNA(Sec)  biosynthetic  process    1    1   
seryl-tRNA  aminoacylation    1    1   
tetrahydrofolate  interconversion    1    1   
thiamine  biosynthetic  process    1    1   
thiamine  diphosphate  biosynthetic  process    1    1   
threonyl-tRNA  aminoacylation    1    1   
transcription  antitermination    1    1   
tRNA  aminoacylation  for  protein  translation    1    1   
tRNA  modification    1    1   
tRNA  thio-modification    1    1   
tRNA  wobble  uridine  modification    1    1   
tryptophanyl-tRNA  aminoacylation    1    1   
tyrosyl-tRNA  aminoacylation    1    1   
UDP-glucose  metabolic  process    1    1   
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valyl-tRNA  aminoacylation    1    1   
Reduced  GO  Term  Categories    Baseline  GO  N   Minesweeper_256  GO  N  
DNA  replication    10    9   
protein  folding    5    4   
tRNA  processing    5    4   
DNA  topological  change    5    4   
Transcription  DNA-templated      9    7   
phosphoenolpyruvate-dependent  sugar  phosphotransferase  system    4    3   
protein  transport    6    4   
fatty  acid  biosynthetic  process    3    2   
regulation  of  transcription  DNA-templated      3    2   
transport    10    6   
carbohydrate  metabolic  process    5    3   
cell  cycle    4    2   
glycerol  metabolic  process    4    2   
biosynthetic  process    2    1   
DNA-templated  transcription  initiation      2    1   
protein  lipoylation    2    1   
UMP  salvage    2    1   
cell  division    5    2   
ribosome  biogenesis    5    2   
pseudouridine  synthesis    3    1   
rRNA  processing    3    1   
DNA  repair    8    1   
Removed  GO  Term  Categories    Baseline  GO  N   Minesweeper_256  GO  N  
ATP  synthesis  coupled  proton  transport    8    0   
cytoadherence  to  microvasculature  mediated  by  symbiont  protein      6    0   
SOS  response    6    0   
DNA  recombination    4    0   
pathogenesis    4    0   
nucleotide-excision  repair    3    0   
base-excision  repair    2    0   
lipid  metabolic  process    2    0   
protein  secretion    2    0   
response  to  oxidative  stress    2    0   
SRP-dependent  cotranslational  protein  targeting  to  membrane    2    0   
tRNA  threonylcarbamoyladenosine  modification    2    0   
ATP  hydrolysis  coupled  proton  transport    1    0   
carbohydrate  transport    1    0   
carboxylic  acid  metabolic  process    1    0   
cell  adhesion    1    0   
cellular  phosphate  ion  homeostasis    1    0   
cellular  protein  modification  process    1    0   
chromosome  condensation    1    0   
chromosome  segregation    1    0   
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Removed  GO  Term  Categories    Baseline  GO  N   Minesweeper_256  GO  N  
chromosome  separation    1    0   
coenzyme  A  biosynthetic  process    1    0   
deoxyribonucleotide  catabolic  process    1    0   
deoxyribose  phosphate  catabolic  process    1    0   
DNA  restriction-modification  system    1    0   
dTMP  biosynthetic  process    1    0   
dTTP  biosynthetic  process    1    0   
heterophilic  cell-cell  adhesion  via  plasma  membrane  cell  adhesion   
molecules   
1    0   
lipoprotein  biosynthetic  process    1    0   
mRNA  catabolic  process    1    0   
negative  regulation  of  phosphate  metabolic  process    1    0   
phosphate  ion  transmembrane  transport    1    0   
protein  catabolic  process    1    0   
protein  import    1    0   
protein  insertion  into  membrane    1    0   
protein  refolding    1    0   
protein  repair    1    0   
protein  targeting    1    0   
regulation  of  carbohydrate  metabolic  process    1    0   
sister  chromatid  cohesion    1    0   
RNA  processing    1    0   
uracil  salvage    1    0   
Table  12.  Minesweeper_256  gene  deletions  impact  on  GO  terms.  A  published  version   
of  the  table  is  available  56 .   
  
I  conducted  further  analysis,  as  some  of  these  removals  could  be  of  concern  to  the   
longevity  of  the  in-silico  cell.  The  GO  term  proton  transport  applies  to  the  genes   
MG_398-405,  which  form  ATP  synthase,  an  enzyme  that  generates  ATP  using  energy   
from  protons  transferring  across  the  cell  membrane.  This  removes  one  pathway  for   
producing  ATP,  but  the  minimal  genome  still  contains  intact  phosphoglycerate  kinase   
(MG_300)  and  pyruvate  kinase  (MG_216)  that  both  produce  ATP  as  part  of  glycolysis.   
Additionally,  there  are  13  reversible  reactions  that  produce  ATP  in  the  reverse  reaction   




Enzyme    Reaction    Genes   
ATP  synthase  (four  protons  for  one  ATP)   
(periplasm)   
ADP[c]  +  (4)  H[e]  +  H[c]  +  PI[c]  <==>   
ATP[c]  +  (4)  H[c]  +  H2O[c]   
MG_398_399_400_401_402_403_ 
404_405_22MER   
phosphoglycerate  kinase    [c]:  ADP  +  DPG  <==>  ATP  +  G3P    MG_300_MONOMER   
pyruvate  kinase    [c]:  ADP  +  H  +  PEP  <==>  ATP  +  PYR    MG_216_TETRAMER   
acetate  kinase    [c]:  ACTP  +  ADP  <==>  AC  +  ATP    MG_357_DIMER   
deoxyadenylate  kinase  (dADP)    [c]:  ATP  +  DAMP  <==>  ADP  +  DADP    MG_171_MONOMER   
choline  kinase    [c]:  ATP  +  CHOL  ==>  ADP  +  H  +  pCHOL   MG_356_MONOMER   
cytidylate  kinase  (dCMP)    [c]:  ATP  +  DCMP  <==>  ADP  +  DCDP    MG_330_MONOMER   
cytidylate  kinase  (CMP)    [c]:  ATP  +  CMP  <==>  ADP  +  CDP    MG_330_MONOMER   
UMP  kinase    [c]:  ATP  +  UMP  <==>  ADP  +  UDP    MG_434_HEXAMER   
methylenetetrahydrofolate  cyclohydrase   
[c]:  ATP  +  FTHF10  +  (3)  H  <==>  ADP  +   
METTHF  +  PI   
MG_245_MONOMER   
guanylate  kinase  (GMP:ATP)    [c]:  ATP  +  GMP  <==>  ADP  +  GDP    MG_107_DIMER   
deoxyguanylate  kinase  (dGMP:ATP)    [c]:  ATP  +  DGMP  <==>  ADP  +  DGDP    MG_107_DIMER   
NAD  kinase    [c]:  ATP  +  NAD  <==>  ADP  +  NADP    MG_128_HEXAMER   
phosphoribosylpyrophosphate  synthetase    [c]:  ATP  +  R5P  <==>  AMP  +  H  +  PRPP    MG_058_HEXAMER   
thiamine-phosphate  kinase    [c]:  ATP  +  THMP  <==>  ADP  +  TPP    MG_372_DIMER   
thiamine  kinase    [c]:  ATP  +  DTMP  <==>  ADP  +  DTDP    MG_006_DIMER   
Table  13.  ATP  producing  reactions  in  the  M.genitalium  whole-cell  model.  Data  from   
Karr  et  al.  Supplementary  Table  mmc4-O  6 .  A  published  version  of  the  table  is  available   
56 .   
  
The  GO  term  DNA  recombination  applies  to  the  genes  MG_339,  MG_352,  MG_358,   
MG_359,  which  conduct  half  of  the  steps  in  homologous  recombination  double  strand   
break  repair.  This  process,  as  well  as  nucleotide  excision  repair  and  base  excision   
repair  are  removed  from  the  cell.  However,  direct  damage  reversal  (MG_254)  and  DNA   
polymerase  (MG_001)  are  still  present.  DisA  (MG_105),  the  DNA  damage  sensor,  has   
currently  been  deleted  but  I  believe  this  is  due  the  single-generation  nature  of  the   
M.genitalium  whole-cell  model;  the  cell  can  survive  without  successful  DNA  repair  for  a   
single  generation  in-silico ,  whereas  it  cannot  for  multiple  generations  in-vivo ;  evidenced   
by  Karr  et  al.  Supplementary  Table  S2G  6   labelling  the  single  knockout  as  a  false   
non-essential.     
  
DisA  is  the  only  dedicated  process  for  recognising  DNA  damage  in  M.genitalium ,  and  is   
believed  to  signal  lack  of  damage  by  producing  a  secondary  messenger  molecule,   
which  it  stops  producing  when  it  binds  to  damaged  DNA  (Karr  et  al.  Supplementary   
mmc1,  pg  40))  6 .  Most  knowledge  in  how  it  functions  comes  from  other  species   
( B.subtilis ),  but  M.genitalium  appears  to  lack  the  rest  of  the  signalling  system  present  in   
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other  species.  This  lack  of  knowledge  simplifies  what  can  be  implemented  in  the   
model.  The  DNA  damage  sub-model  models  random  and  radiation-induced  DNA   
damage,  while  the  DNA  repair  sub-model  models  the  binding  of  free  DisA  to  DNA   
lesions  (Karr  et  al.  Supplementary  mmc1,  pg  42))  6 ,  depending  on  enzyme  availability.   
For  the  actual  DNA  repair  functions  to  occur,  the  model  conducts  a  series  of  general   
steps:   
1. Identify  chromosomes  sites  that  are  substrates  for  the  repair  system.   
a. i.e.  areas  of  DNA  damage  bound  by  DisA   
2. Eliminate  sites  that  neighbor  damage,  or  which  are  occupied  by  proteins  (other  
than  the  DNA  damage  scanning  protein  DisA ).  
3. Compute  maximum  number  of  repair  reactions  that  can  occur  based  on   
metabolite  and  enzyme  availability,  and  kinetics.   
4. Randomly  select  among  eligible  repair  sites  for  repair.   
5. Update  state  of  DNA  and  update  metabolites.   
6. Free  any  DisA  that  was  previously  bound  to  the  repaired  site.   
It  appears  there  is  little  to  be  altered  or  updated  in  the  model  to  better  capture  the   
biological  function  of  DisA  until  more  is  known  of  how  it  functions  in  M.genitalium   
in-vivo .  The  incorrect  essentiality  classification  from  its  single  gene  knockout  can,  I   
believe,  only  be  solved  by  implementing  multi-generational  simulations  in  the   
M.genitalium  whole-cell  model.   
  
The  GO  term  chromosome  segregation  applies  only  to  MG_213,  where  it  is  listed  as  its   
tertiary  function.  The  genes  in  the  model  that  actually  conduct  chromosome   
segregation  (MG_470,  MG_221,  MG_387,  MG_384,  MG_203,  MG_204,  MG_224  (Karr   
et  al.  Supplementary  mmc1,  pg  34))  6   are  all  present  in  the  minimal  genome,  but  do  not   
have  an  associated  GO  term.  This  underlines  the  use  of  caution  when  using  GO  terms   
and  the  need  for  secondary  analysis.   
  
The  gene  deletions  in  Minesweeper_256  reduce  the  ability  of  the  in-silico  cell  to  interact   
with  the  environment  and  defend  against  external  forces.  They  also  cause  a  reduction   
in  control,  from  transport  to  regulation  to  genome  management,  and  prune  metabolic   
processes  and  metabolites.  This  leaves  the  in-silico  cell  alive,  but  more  vulnerable  to   
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external  and  internal  pressures,  less  capable  of  responding  to  change,  and  more  reliant   
on  internal  processes  occurring  by  chance.     
  
In  comparison,  GAMA_237  has  163  genes  (69%  coverage)  with  GO  terms  on  UniProt   
160 ,  with  73  genes  with  no  GO  terms.  The  165  genes  deleted  reduced  18  (11%)  GO   
categories  and  removed  54  (35%)  GO  categories,  38  of  which  were  associated  with  a   
single  gene  (Table  14).  The  gene  deletions  unique  to  GAMA_237  can  be  seen  in  Table   
15,  17,  and  18.   
  
One  reduced  GO  category  was  less  affected  compared  to  Minesweeper_256  (glycerol   
metabolic  process)  and  one  unaffected  GO  category  was  unique  to  GAMA_237   
(phosphate  ion  transmembrane  transport).  Three  GO  categories  were  reduced  further  in   
GAMA_237:  DNA  transcription,  DNA  transcription  regulation,  and  transport  (ABC   
transporters)  (Table  18).    
  
Categories  that  were  removed  solely  in  GAMA_237  include:  DNA  transcription   
(termination,  regulation,  elongation,  antitermination,  initiation);  tRNA  (processing,   





Unaffected  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
translation    56    56   
glycolytic  process    11    11   
cell  redox  homeostasis    3    3   
acetyl-CoA  biosynthetic  process    2    2   
AMP  salvage    2    2   
CDP-diacylglycerol  biosynthetic  process    2    2   
gluconeogenesis    2    2   
glycine  biosynthetic  process    2    2   
NAD  biosynthetic  process    2    2   
nucleoside  metabolic  process    2    2   
nucleotide  biosynthetic  process   2    2   
one-carbon  metabolic  process    2    2   
phenylalanyl-tRNA  aminoacylation    2    2   
purine  ribonucleoside  salvage    2    2   
5-phosphoribose  1-diphosphate  biosynthetic  process    1    1   
adenine  salvage    1    1   
adhesion  of  symbiont  to  host  cell    1    1   
alanyl-tRNA  aminoacylation    1    1   
arginyl-tRNA  aminoacylation    1    1   
asparaginyl-tRNA  aminoacylation    1    1   
CTP  salvage    1    1   
cysteinyl-tRNA  aminoacylation    1    1   
de  novo'  CTP  biosynthetic  process    1    1   
deoxyribonucleotide  biosynthetic  process    1    1   
DNA  biosynthetic  process    1    1   
DNA  replication  synthesis  of  RNA  primer      1    1   
DNA  replication  initiation    1    1   
dTDP  biosynthetic  process    1    1   
enterobacterial  common  antigen  biosynthetic  process    1    1   
FAD  biosynthetic  process    1    1   
FMN  biosynthetic  process    1    1   
fructose  1 6-bisphosphate  metabolic  process      1    1   
fructose  6-phosphate  metabolic  process    1    1   
galactose  metabolic  process    1    1   
glucose  catabolic  process    1    1   
glucose  metabolic  process    1    1   
glutamyl-tRNA  aminoacylation    1    1   
glycerol  catabolic  process    1    1   
glycerol  ether  metabolic  process    1    1   
glycerol-3-phosphate  metabolic  process    1    1   
glycyl-tRNA  aminoacylation    1    1   
guanosine  tetraphosphate  biosynthetic  process    1    1   
histidine  biosynthetic  process    1    1   
histidyl-tRNA  aminoacylation    1    1   
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Unaffected  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
IMP  salvage    1    1   
isoleucyl-tRNA  aminoacylation    1    1   
leucyl-tRNA  aminoacylation    1    1   
lysyl-tRNA  aminoacylation    1    1   
membrane  lipid  biosynthetic  process    1    1   
metabolic  process    1    1   
methionine  biosynthetic  process    1    1   
methionyl-tRNA  aminoacylation    1    1   
NAD  metabolic  process    1    1   
NADP  biosynthetic  process    1    1   
organic  acid  metabolic  process    1    1   
pentose-phosphate  shunt    1    1   
pentose-phosphate  shunt  non-oxidative  branch      1    1   
phosphate  ion  transmembrane  transport    1    1   
phosphate-containing  compound  metabolic  process    1    1   
phosphatidylglycerol  biosynthetic  process    1    1   
phospholipid  biosynthetic  process    1    1   
potassium  ion  transport    1    1   
prolyl-tRNA  aminoacylation    1    1   
purine  nucleotide  biosynthetic  process    1    1   
pyrimidine  nucleobase  metabolic  process    1    1   
pyrimidine  nucleoside  metabolic  process    1    1   
regulation  of  DNA  replication    1    1   
regulation  of  translation    1    1   
regulation  of  translational  fidelity    1    1   
removal  of  superoxide  radicals    1    1   
response  to  heat    1    1   
riboflavin  biosynthetic  process    1    1   
S-adenosylmethionine  biosynthetic  process    1    1   
selenocysteinyl-tRNA(Sec)  biosynthetic  process    1    1   
seryl-tRNA  aminoacylation    1    1   
tetrahydrofolate  interconversion    1    1   
threonyl-tRNA  aminoacylation    1    1   
tRNA  aminoacylation  for  protein  translation    1    1   
tRNA  modification    1    1   
tryptophanyl-tRNA  aminoacylation    1    1   
tyrosyl-tRNA  aminoacylation    1    1   
UDP-glucose  metabolic  process    1    1   
valyl-tRNA  aminoacylation    1    1   
Reduced  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
DNA  replication    10    9   
DNA  topological  change    5    4   
protein  folding    5    4   
glycerol  metabolic  process    4    3   
phosphoenolpyruvate-dependent  sugar  phosphotransferase  system    4    3   
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Reduced  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
protein  transport    6    4   
protein  lipoylation    2    1   
fatty  acid  biosynthetic  process    3    2   
carbohydrate  metabolic  process    5    3   
cell  cycle    4    2   
biosynthetic  process    2    1   
UMP  salvage    2    1   
transport    10    4   
cell  division    5    2   
ribosome  biogenesis    5    2   
regulation  of  transcription   DNA-templated      3    1   
transcription   DNA-templated      9    2   
DNA  repair    8    1   
Removed  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
ATP  synthesis  coupled  proton  transport    8    0   
cytoadherence  to  microvasculature  mediated  by  symbiont  protein      6    0   
SOS  response    6    0   
tRNA  processing    5    0   
DNA  recombination    4    0   
pathogenesis    4    0   
nucleotide-excision  repair    3    0   
pseudouridine  synthesis    3    0   
rRNA  processing    3    0   
base-excision  repair    2    0   
DNA-templated  transcription  initiation      2    0   
lipid  metabolic  process    2    0   
protein  secretion    2    0   
response  to  oxidative  stress    2    0   
SRP-dependent  cotranslational  protein  targeting  to  membrane    2    0   
tRNA  threonylcarbamoyladenosine  modification    2    0   
ATP  hydrolysis  coupled  proton  transport    1    0   
carbohydrate  transport    1    0   
carboxylic  acid  metabolic  process    1    0   
cell  adhesion    1    0   
cellular  phosphate  ion  homeostasis    1    0   
cellular  protein  modification  process    1    0   
chromosome  condensation    1    0   
chromosome  segregation    1    0   
chromosome  separation    1    0   
coenzyme  A  biosynthetic  process    1    0   
deoxyribonucleotide  catabolic  process    1    0   
deoxyribose  phosphate  catabolic  process    1    0   
DNA  restriction-modification  system    1    0   
DNA-templated  transcription  termination      1    0   
dTMP  biosynthetic  process    1    0   
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Removed  GO  Term  Categories    Baseline  GO  N   GAMA_237  GO  N  
dTTP  biosynthetic  process    1    0   
heterophilic  cell-cell  adhesion  via  plasma  membrane  cell  adhesion   
molecules   
1    0   
lipoprotein  biosynthetic  process    1    0   
mRNA  catabolic  process    1    0   
mRNA  processing    1    0   
negative  regulation  of  phosphate  metabolic  process    1    0   
protein  catabolic  process    1    0   
protein  import    1    0   
protein  insertion  into  membrane    1    0   
protein  refolding    1    0   
protein  repair    1    0   
protein  targeting    1    0   
regulation  of  carbohydrate  metabolic  process    1    0   
regulation  of  DNA-templated  transcription  elongation      1    0   
RNA  processing    1    0   
rRNA  catabolic  process    1    0   
sister  chromatid  cohesion    1    0   
thiamine  biosynthetic  process    1    0   
thiamine  diphosphate  biosynthetic  process    1    0   
transcription  antitermination    1    0   
tRNA  thio-modification    1    0   
tRNA  wobble  uridine  modification    1    0   
uracil  salvage    1    0   
Table  14.  GAMA_237  gene  deletions  impact  on  GO  terms.  A  published  version  of  the   
table  is  available  56 .   
  
The  GO  analysis  of  GAMA_237,  when  compared  to  that  of  Minesweeper_256,   
suggests  a  further  reduction  of  both  internal  control  and  reactivity  to  the  external   
environment.  These  reductions  are  discussed  further  below.   
  
4.4.7 Low  Essential  Genes     
I  analysed  Minesweeper_256  and  GAMA_237  to  determine  whether  these  were   
different  minimal  genomes  or  GAMA_237  was  an  extension  of  Minesweeper_256.  I   
compared  unmodified  M.genitalium ,  Minesweeper_256,  and  GAMA_237  genomes   
(Figure  15),  which  highlighted  141  shared  deletions  and  gene  deletions  unique  to  each   





     Shared  Deletions   
Unique  to   
  GAMA_237   
Unique  to   
Minesweeper_256   
1    MG_009    MG_008    MG_033   
2    MG_012    MG_022    MG_410   
3    MG_014    MG_039    MG_411   
4    MG_015    MG_084    MG_412   
5    MG_020    MG_104      
6    MG_027    MG_141      
7    MG_029    MG_177      
8    MG_030    MG_182      
9    MG_040    MG_249      
10    MG_046    MG_282      
11    MG_048    MG_289      
12    MG_050    MG_290      
13    MG_052    MG_291      
14    MG_055    MG_295      
15    MG_059    MG_340      
16    MG_061    MG_341      
17    MG_062    MG_347      
18    MG_063    MG_367      
19    MG_064    MG_372      
20    MG_065    MG_379      
21    MG_072    MG_427      
22    MG_073    MG_445      
23    MG_075    MG_465      
24    MG_083           
25    MG_085           
26    MG_086           
27    MG_097           
28    MG_101           
29    MG_476           
30    MG_105           
31    MG_109           
32    MG_110           
33    MG_119           
34    MG_120           
35    MG_121           
36    MG_122           
37    MG_123           
38    MG_127           
39    MG_130           
40    MG_132           
41    MG_139           
42    MG_143           





     Shared  Deletions         Shared  Deletions         Shared  Deletions   
44    MG_170    88    MG_316    132    MG_447   
45    MG_172    89    MG_317    133    MG_448   
46    MG_183    90    MG_318    134    MG_454   
47    MG_184    91    MG_324    135    MG_457   
48    MG_186    92    MG_327    136    MG_460   
49    MG_187    93    MG_329    137    MG_463   
50    MG_188    94    MG_333    138    MG_464   
51    MG_189    95    MG_335    139    MG_467   
52    MG_190    96    MG_336    140    MG_468   
53    MG_191    97    MG_339    141    MG_526   
54    MG_192    98    MG_344         
55    MG_200    99    MG_346         
56    MG_205    100    MG_349         
57    MG_206    101    MG_352         
58    MG_208    102    MG_353         
59    MG_209    103    MG_355         
60    MG_210    104    MG_356         
61    MG_482    105    MG_358         
62    MG_213    106    MG_359         
63    MG_214    107    MG_369         
64    MG_217    108    MG_370         
65    MG_218    109    MG_376         
66    MG_225    110    MG_380         
67    MG_226    111    MG_385         
68    MG_227    112    MG_386         
69    MG_235    113    MG_390         
70    MG_236    114    MG_391         
71    MG_239    115    MG_392         
72    MG_240    116    MG_393         
73    MG_244    117    MG_398         
74    MG_252    118    MG_399         
75    MG_259    119    MG_400         
76    MG_262    120    MG_401         
77    MG_498    121    MG_402         
78    MG_264    122    MG_403         
79    MG_265    123    MG_404         
80    MG_277    124    MG_405         
81    MG_288    125    MG_408         
82    MG_293    126    MG_409         
83    MG_297    127    MG_421         
84    MG_298    128    MG_425         
85    MG_309    129    MG_428         
86    MG_310    130    MG_438         
87    MG_312    131    MG_442         
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Table  15.  Shared  and  unique  gene  deletions  of  Minesweeper_256  and  GAMA_237.  A   




Figure  15.  Genome  comparison  of  the  whole-cell  model,  Minesweeper_256,  and   
GAMA_237.  This  figure  was  created  by  co-author  Sophie  Landon  for     
our  paper  56   using  data  produced  by  myself  (Minesweeper_256)  and  Oliver  Chalkley   
(GAMA_237).  The  outer  ring  displays  the  M.genitalium  genome  (525  genes  in  total),   
with  modelled  genes  (401)  in  navy  and  unmodelled  genes  (124,  with  unknown  function)   
in  grey.  The  middle  ring  displays  the  reduced  Minesweeper_256  (256  genes)  genome  in   
light  blue,  with  genes  present  in  Minesweeper_265  but  not  in  GAMA_237  in  dark  blue.   
The  inner  ring  displays  the  reduced  GAMA_237  (237  genes)  genome  in  light  yellow,   
with  genes  present  in  GAMA_237  but  not  in  Minesweeper_265  in  dark  yellow.  Figure   
produced  from  published  M.genitalium  genetic  data  6,58 ,  with  genetic  data  for   




Our  genome  comparison  found  that  Minesweeper_256  removed  four  genes,  and   
GAMA_237  removed  five  genes  (Table  16),  that  could  not  be  removed  from  the  other   
genome  (either  individually  or  as  a  group)  without  preventing  cellular  division.  An   
additional  gene,  MG_305,  could  not  be  removed  in  either  GAMA_237  or   
Minesweeper_256.  I  confirmed  that  these  ten  genes  were  individually  non-essential   
(Table  6)  and  that  nine  of  the  genes  have  low  essentiality  10 .  To  identify  the  cause  of  this   
synthetic  lethality  I  attempted  to  match  the  functions  of  the  low  essential  genes   
together,  anticipating  redundant  essential  gene  pairs  or  groups.     
  
Gene    Annotation    Function    Removed  In    Present  In   
MG_039    Uncharacterised   Probable  catalyst  of  redox  reactions.    GAMA_237    Minesweeper_256   
MG_289    p37    High-affinity  transport  system  protein  attached  to  cell   
membrane.   
GAMA_237    Minesweeper_256   
MG_290    p29    Probable  ATP-binding  cassette  (ABC)  transporter.      GAMA_237    Minesweeper_256   
MG_291    p69    Permease  (ABC  membrane  transporter)  protein.    GAMA_237    Minesweeper_256   
MG_427    Unnamed    Reduces  peroxides,  protecting  against  oxidative   
stress.     
GAMA_237    Minesweeper_256   
MG_033    glpF    Facilitates  glycerol  across  the  membrane.    Minesweeper_256    GAMA_237   
MG_410    pstB    Imports  phosphate  (part  of  PstSACB  ABC  complex).     Minesweeper_256    GAMA_237   
MG_411    pstA    Permease  protein  for  phosphate  transport  system.      Minesweeper_256    GAMA_237   
MG_412    Uncharacterised   Probable  phosphate  ion  binding  attached  to  cell   
membrane.   
Minesweeper_256    GAMA_237   
MG_305    dnaK    Chaperone  protein  involved  in  refolding  mis/unfolded   
heat  shock  proteins.   
M.g*  whole-cell   
model   
GAMA_237  and   
Minesweeper_256   
Table  16.  Low  essential  genes  from  Minesweeper_256  and  GAMA_237  genomic   
contexts.  Protein  annotation  and  function  obtained  from  UniProt  160 ,  based  on  Fraser  et   





I  found  two  genes  in  GAMA_237  (MG_289,  MG_291)  that  had  matching  GO  terms  with   
the  gene  MG_411  in  Minesweeper_256.  These,  and  three  other  adjacent  genes  on  the   
genome,  were  tested  by  combinatorial  gene  knockouts  in  an  unmodified  M.genitalium   
whole-cell  model  genome  (Table  17).  MG_289,  MG_290,  MG_291  were  found  to  form   
a  functional  group,  as  were  MG_410,  MG_411,  MG_412.  These  genes  could  be   
deleted  individually  and  in  functional  groups  from  an  otherwise  unmodified  M.genitalium   
whole-cell  genome  and  produce  a  dividing  in-silico  cell.  However,  any  double  gene   
deletion  combination  that  involved  one  gene  from  each  functional  group  resulted  in  a   






   Gene  Knockouts      Outcome   
1    MG_289,    Dividing   
2    MG_289,    Dividing   
3    MG_289,    Dividing   
4    MG_290,    Dividing   
5    MG_290,    Dividing   
6    MG_290,    Dividing   
7    MG_291,    Dividing   
8    MG_291,    Dividing   
9    MG_291,    Dividing   
10    MG_410,    Dividing   
11    MG_410,    Dividing   
12    MG_410,    Dividing   
13    MG_411,    Dividing   
14    MG_411,    Dividing   
15    MG_411,    Dividing   
16    MG_412,    Dividing   
17    MG_412,    Dividing   
18    MG_412,    Dividing   
19    MG_289,  MG_291,    Dividing   
20    MG_289,  MG_291,    Dividing   
21    MG_289,  MG_291,    Dividing   
22    MG_290,  MG_291,    Dividing   
23    MG_290,  MG_291,    Dividing   
24    MG_290,  MG_291,    Dividing   
25    MG_290,  MG_289,    Dividing   
26    MG_290,  MG_289,    Dividing   
27    MG_290,  MG_289,    Dividing   
28    MG_410,  MG_411,  MG_412,    Dividing   
29    MG_410,  MG_411,  MG_412,    Dividing   
30    MG_410,  MG_411,  MG_412,    Dividing   
31    MG_289,  MG_410,    No  Division  
32    MG_289,  MG_410,    No  Division  
33    MG_289,  MG_410,    No  Division  
34    MG_289,  MG_411,    No  Division  
35    MG_289,  MG_411,    No  Division  
36    MG_289,  MG_411,    No  Division  
37    MG_289,  MG_412,    No  Division  
38    MG_289,  MG_412,    No  Division  
39    MG_289,  MG_412,    No  Division  
40    MG_291,  MG_410,    No  Division  
41    MG_291,  MG_410,    No  Division  
42    MG_291,  MG_410,    No  Division  
43    MG_291,  MG_411,    No  Division  
44    MG_291,  MG_411,    No  Division  
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   Gene  Knockouts      Outcome   
45    MG_291,  MG_411,    No  Division  
46    MG_291,  MG_412,    No  Division  
47    MG_291,  MG_412,    No  Division  
48    MG_291,  MG_412,    No  Division  
49    MG_290,  MG_410,    No  Division  
50    MG_290,  MG_410,    No  Division  
51    MG_290,  MG_410,    No  Division  
52    MG_290,  MG_411,    No  Division  
53    MG_290,  MG_411,    No  Division  
54    MG_290,  MG_411,    No  Division  
55    MG_290,  MG_412,    No  Division  
56    MG_290,  MG_412,    No  Division  
57    MG_290,  MG_412,    No  Division  
58    MG_289,  MG_291,  MG_410,    No  Division  
59    MG_289,  MG_291,  MG_410,    No  Division  
60    MG_289,  MG_291,  MG_410,    No  Division  
61    MG_289,  MG_291,  MG_411,    No  Division  
62    MG_289,  MG_291,  MG_411,    No  Division  
63    MG_289,  MG_291,  MG_411,    No  Division  
64    MG_289,  MG_291,  MG_412,    No  Division  
65    MG_289,  MG_291,  MG_412,    No  Division  
66    MG_289,  MG_291,  MG_412,    No  Division  
67    MG_290,  MG_291,  MG_410,    No  Division  
68    MG_290,  MG_291,  MG_410,    No  Division  
69    MG_290,  MG_291,  MG_410,    No  Division  
70    MG_290,  MG_291,  MG_411,    No  Division  
71    MG_290,  MG_291,  MG_411,    No  Division  
72    MG_290,  MG_291,  MG_411,    No  Division  
73    MG_290,  MG_291,  MG_412,    No  Division  
74    MG_290,  MG_291,  MG_412,    No  Division  
75    MG_290,  MG_291,  MG_412,    No  Division  
76    MG_289,  MG_290,  MG_410,    No  Division  
77    MG_289,  MG_290,  MG_410,    No  Division  
78    MG_289,  MG_290,  MG_410,    No  Division  
79    MG_289,  MG_290,  MG_411,    No  Division  
80    MG_289,  MG_290,  MG_411,    No  Division  
81    MG_289,  MG_290,  MG_411,    No  Division  
82    MG_289,  MG_290,  MG_412,    No  Division  
83    MG_289,  MG_290,  MG_412,    No  Division  
84    MG_289,  MG_290,  MG_412,    No  Division  
85    MG_410,  MG_411,  MG_289,    No  Division  
86    MG_410,  MG_411,  MG_289,    No  Division  
87    MG_410,  MG_411,  MG_289,    No  Division  
88    MG_410,  MG_411,  MG_291,    No  Division  
89    MG_410,  MG_411,  MG_291,    No  Division  
133   
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90    MG_410,  MG_411,  MG_291,    No  Division  
91    MG_410,  MG_412,  MG_289,    No  Division  
92    MG_410,  MG_412,  MG_289,    No  Division  
93    MG_410,  MG_412,  MG_289,    No  Division  
94    MG_410,  MG_412,  MG_291,    No  Division  
95    MG_410,  MG_412,  MG_291,    No  Division  
96    MG_410,  MG_412,  MG_291,    No  Division  
97    MG_411,  MG_412,  MG_289,    No  Division  
98    MG_411,  MG_412,  MG_289,    No  Division  
99    MG_411,  MG_412,  MG_289,    No  Division  
100    MG_411,  MG_412,  MG_291,    No  Division  
101    MG_411,  MG_412,  MG_291,    No  Division  
102    MG_411,  MG_412,  MG_291,    No  Division  
103    MG_410,  MG_411,  MG_290,    No  Division  
104    MG_410,  MG_411,  MG_290,    No  Division  
105    MG_410,  MG_411,  MG_290,    No  Division  
106    MG_410,  MG_412,  MG_290,    No  Division  
107    MG_410,  MG_412,  MG_290,    No  Division  
108    MG_410,  MG_412,  MG_290,    No  Division  
109    MG_411,  MG_412,  MG_290,    No  Division  
110    MG_411,  MG_412,  MG_290,    No  Division  
111    MG_411,  MG_412,  MG_290,    No  Division  
112    MG_410,  MG_411,  MG_412,  MG_289,    No  Division  
113    MG_410,  MG_411,  MG_412,  MG_289,    No  Division  
114    MG_410,  MG_411,  MG_412,  MG_289,    No  Division  
115    MG_410,  MG_411,  MG_412,  MG_290,    No  Division  
116    MG_410,  MG_411,  MG_412,  MG_290,    No  Division  
117    MG_410,  MG_411,  MG_412,  MG_290,    No  Division  
118    MG_410,  MG_411,  MG_412,  MG_291,    No  Division  
119    MG_410,  MG_411,  MG_412,  MG_291,    No  Division  
120    MG_410,  MG_411,  MG_412,  MG_291,    No  Division  
121    MG_410,  MG_411,  MG_412,  MG_289,  MG_291,    No  Division  
122    MG_410,  MG_411,  MG_412,  MG_289,  MG_291,    No  Division  
123    MG_410,  MG_411,  MG_412,  MG_289,  MG_291,    No  Division  
124    MG_410,  MG_411,  MG_412,  MG_289,  MG_290,    No  Division  
125    MG_410,  MG_411,  MG_412,  MG_289,  MG_290,    No  Division  
126    MG_410,  MG_411,  MG_412,  MG_289,  MG_290,    No  Division  
127    MG_410,  MG_411,  MG_412,  MG_290,  MG_291,    No  Division  
128    MG_410,  MG_411,  MG_412,  MG_290,  MG_291,    No  Division  
129    MG_410,  MG_411,  MG_412,  MG_290,  MG_291,    No  Division  
130    MG_410,  MG_411,  MG_412,  MG_289,  MG_290,  MG_291,    No  Division  
Table  17.  Testing  potentially  redundant  functional  groups  using  combinatorial  gene   
knockouts.  A  published  version  of  the  table  is  available  56 ,  as  is  the  simulation  data  161 .   
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M.genitalium  only  has  two  external  sources  of  phosphate,  inorganic  phosphate  and   
phosphonate.  MG_410,  MG_411,  and  MG_412  transport  inorganic  phosphate  into  the   
cell,  and  MG_289,  MG_290,  and  MG_291  transport  phosphonate  into  the  cell  (Glass  et   
al.  Supplementary  Table  6  61 ).  These  phosphate  sources  proved  to  be  a  key  difference   
between  the  minimal  genomes.  Minesweeper_256  removed  the  phosphate  transport   
genes,  relying  on  phosphonate  as  the  sole  phosphate  source.  GAMA_237  removed  the   
phosphonate  transport  genes,  relying  on  inorganic  phosphate  as  the  sole  phosphate   
source.  This  can  be  seen  in  the  GO  term  analysis,  the  phosphate  ion  transmembrane   
transport  is  still  present  in  GAMA_237  but  not  in  Minesweeper_256  (Table  12  and  13).   
  
It  has  previously  been  theorised  that  individual  bacterial  species  will  have  multiple   
minimal  genomes  167,168 ,  with  different  gene  content  depending  on  the  environment,  and   
which  evolutionarily  redundant  cellular  pathways  were  selected  during  reduction.  The   
results  I  reported  above  suggest  that  one  of  these  selections  is  the  sourcing  of   
phosphate,  with  minimal  genomes  differing  by  choice  of  phosphate  transport  genes   
and  associated  processing  stages,  equivalent  to  the  phn  gene  cluster  in  Escherichia   
coli  169 .  However,  I  could  not  find  any  annotated  phosphonate  processing  genes  that   
had  been  removed  in  GAMA_237,  following  GAMA_237  removing  the  phosphonate   
transport  genes.  I  suspect  that  further  “pivot  points”  (the  selection  of  one  redundant   
cellular  pathway  over  another  during  genome  reduction)  will  be  identified  in  future   
in-vivo  and  in-silico  bacterial  reductions,  increasing  the  number  of  minimal  genomes  per   
bacterial  species.   
  
I  additionally  investigated  MG_305  ( DnaK ),  the  gene  that  neither  Minesweeper_256  or   
GAMA_237  could  remove  (Table  16).  This  shares  the  protein  folding  GO  term  with  four   
other  genes:  MG_019,  MG_201,  MG_238,  and  MG_393.  Three  were  unmodified  in   
either  genome,  but  MG_393  ( GroES )  was  removed  by  both  Minesweeper_256  and   
GAMA_237,  indicating  a  potential  redundant  essential  relationship.  However,  knocking   
in  MG_393  and  knocking  out  MG_305  still  produces  a  non-dividing  cell  in  both  GAMA   
and  Minesweeper  (Table  18).  At  this  stage,  I  thought  that  MG_305  had  additional   
redundant  pair  relationships  that  have  already  suffered  one  deletion  shared  by  both   
GAMA_237  and  Minesweeper_256  (Table  15).     
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Further  investigation  identified  MG_392  ( GroEL ).  This  is  a  protein  chaperone,  which   
similar  to  DnaK  is  believed  to  assist  in  late  protein  folding  (Karr  et  al.  Supplementary   
mmc1,  pg  62)  6 .  It  was  not  immediately  identified,  as  it  is  the  only  gene  in  the   
M.genitalium  whole-cell  model  genome  with  the  protein  refolding  GO  term.  GroES   
(MG_393)  acts  as  a  co-chaperone  for  MG_392,  forming  the  GroEL-GroES  chaperonin   
complex.  This  was  simulated  using  comparative  gene  knockouts  to  see  if  it  explained   
the  additional  redundant  essential  relationships  of  MG_305  (Table  18).  However,   
deleting  pairs  or  triplets  of  genes  resulted  in  a  non-dividing  in-silico  cell  and   
Minesweeper_256  with  MG_392  and  MG_393  deleted  and  MG_305  restored  produces   
a  non-dividing  in-silico  cell.     
  
It  appears  that  these  genes  contribute  to  a  threshold  level  that  is  required  for  the  cell  to   
divide,  where  removing  too  many  of  them  prevents  division.  It  could  be  that  the  removal   
of  these  proteins  that  are  involved  in  late  protein  folding  (Karr  et  al.  Supplementary   
mmc1,  pg  63)  6   prevents  the  cell  from  producing  the  required  threshold  of  abundance   
for  FtsZ  protein  to  start  division  (Karr  et  al.  Supplementary  mmc1,  pg  21)  6 ,  or  perhaps   
earlier  in  the  cell  cycle,  a  lack  of  each  of  the  required  five  chromosome  segregation   






   Gene  Deletion    Outcome    Gene  Deletion    Outcome   
1    MG_305    Dividing    MG_305    Dividing   
2    MG_305    Dividing    MG_305    Dividing   
3    MG_305    Dividing    MG_305    Dividing   
4    MG_305    Dividing    MG_305    Dividing   
5    MG_305    Dividing    MG_305    Dividing   
6    MG_305    Dividing    MG_305    Dividing   
7    MG_305    Dividing    MG_305    Dividing   
8    MG_305    Dividing    MG_305    Dividing   
9    MG_305    No  Division    MG_305    Dividing   
10    MG_305    Dividing    MG_305    Dividing   
11    MG_393    Dividing    MG_392,  MG_393    No  Division   
12    MG_393    Dividing    MG_392,  MG_393    Dividing   
13    MG_393    Dividing    MG_392,  MG_393    Dividing   
14    MG_393    Dividing    MG_392,  MG_393    Dividing   
15    MG_393    No  Division    MG_392,  MG_393    Dividing   
16    MG_393    Dividing    MG_392,  MG_393    Dividing   
17    MG_393    Dividing    MG_392,  MG_393    Dividing   
18    MG_393    Dividing    MG_392,  MG_393    Dividing   
19    MG_393    Dividing    MG_392,  MG_393    Dividing   
20    MG_393    Dividing    MG_392,  MG_393    Dividing   
21    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
22    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
23    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
24    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
25    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
26    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
27    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
28    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
29    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
30    MG_305  and  MG_393    No  Division    MG_305,  MG_392,  MG_393    No  Division   
31    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
32    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
33    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
34    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
35    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
36    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
37    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
38    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
39    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
40    Minesweeper_MG305    No  Division    Minesweeper_MG305    No  Division   
41    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
42    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
43    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
44    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
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45    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
46    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
47    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
48    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
49    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
50    GAMA_MG305    No  Division    GAMA_MG305    No  Division   
Table  18.  Testing  potentially  redundant  genes  using  comparative  gene  knockouts.   
MG_305,  MG_393,  MG_305  and  MG_393,  MG_305  and  MG_392  and  MG_392  are   
triple,  double,  and  single  gene  knockouts  in  an  otherwise  unmodified  in-silico  cell.   
Minesweeper_MG305  and  GAMA_MG305  are  Minesweeper_256  and  GAMA_237  with   
MG_393  reintroduced  (MG_392  and  MG_393  in  the  second  set)  and  MG_305  deleted.   
  
4.4.8 High  Essential  Genes     
Our  comparison  of  the  genomes  also  found  17  genes  knocked  out  in  GAMA_237  that   
have  high  essentiality  10   (Table  19).  They  were  defined  as  essential  by  single  knockout  in   
an  unmodified  M.genitalium  whole-cell  model  (Table  6)  but  could  be  removed  in  the   
genomic  context  of  GAMA_237  without  preventing  division  (Table  15).  I  also  found  that   
four  of  these  17  genes  (MG_084,  MG_295,  MG_379,  MG_445)  could  be  removed  as  a   
group  in  the  genomic  context  of  Minesweeper_256,  but  doing  so  greatly  increased  the   
number  of  non-dividing  cells  produced  (74%,  simulation  data  is  available  161 ).     
  
These  17  genes  can  be  grouped  into  either  transcription-related  or  translation-related   
functions.  The  transcription-related  genes  produce  enzymes  required  for  transcription  in   
the  model  (Karr  et  al.  Supplementary  mmc1,  pg  93  6 ),  all  of  which  have  been  removed   
in  the  GAMA_237  minimal  genome.  In  addition,  I  found  that  the  five  modelled   
transcriptional  regulators  (Karr  et  al.  Supplementary  Table  S3P  col  D  6 )  were  removed   
from  GAMA_237.  This  removes  the  process  of  transcription  from  the  in-silico  cell.      
The  translation-related  genes  are  involved  in  the  two  parts  of  the  core  translation   
machinery  (consisting  of  ribosome  synthesis,  tRNA  maturation,  and  tRNA   
aminoacylation  170 ),  with  only  tRNA  aminoacylation  being  conserved  in  GAMA_237  (Karr   
et  al.  Supplementary  mmc1,  pg  104  6 ).  Nine  genes  involved  in  tRNA  maturation  are   
removed  (Karr  et  al.  Supplementary  Table  S3AB  6 ),  and  a  key  gene  in  ribosome   
synthesis  (MG_367)  is  deleted  (Karr  et  al.  Supplementary  mmc1,  pg  89  6 )  from   




Gene    Annotation    Function   
  Transcription-related   
MG_022    rpoE    DNA-directed  RNA  polymerase  subunit  delta.  Presence  causes  increased  specificity  of  transcription,  a   
decreased  affinity  for  nucleic  acids,  and  enhanced  recycling.   
MG_141    nusA    Transcription  termination/antitermination  protein.  Participates  in  both.   
MG_177    rpoA    DNA-directed  RNA  polymerase  subunit  alpha.  Catalyzes  the  transcription  of  DNA  into  RNA  using  the  four  
ribonucleoside  triphosphates  as  substrates.   
MG_249    sigA    RNA  polymerase  sigma  factor.  The  primary  initiation  factor  during  exponential  growth,  promoting  the   
attachment  of  RNA  polymerase  to  specific  sites.     
MG_282    greA    Transcription  elongation  factor.  Cleaves  the  fraction  of  nascent  transcripts  that  get  trapped  at  arresting   
sites,  resuming  elongation  and  allowing  efficient  RNA  polymerase  transcription.   
MG_340    rpoC    DNA-directed  RNA  polymerase  subunit  beta.  Catalyzes  the  transcription  of  DNA  into  RNA  using  the  four   
ribonucleoside  triphosphates  as  substrates.   
MG_341    rpoB    Additional  part  of  DNA-directed  RNA  polymerase  subunit  beta.   
  Translation-related   
MG_008    mnmE   tRNA  modification  GTPase.  Addition  of  a  carboxymethylaminomethyl  group  to  certain  tRNAs.   
MG_084    tilS    tRNA(Ile)-lysidine  synthase.  Ligates  lysine  to  the  AUA  codon-specific  tRNA,  changing  the  amino  acid   
specificity  from  methionine  to  isoleucine.   
MG_182    truA    tRNA  pseudouridine  synthase  A.  Forms  pseudouridine  in  the  anticodon  stem  and  loop  of  tRNAs.   
MG_295    mnmA    tRNA-specific  2-thiouridylase.  Catalyzes  2-thiolation  of  uridine  in  tRNAs.   
MG_347    trmB    tRNA  methyltransferase.  Catalyzes  the  formation  of  N7-methylguanine  in  tRNA.   
MG_367    rnc   
Ribonuclease  3.  Produces  ribosome  large  and  small  RNAs  (23S  and  16S).     
Processes  some  mRNAs  and  tRNAs.  Digests  double-stranded  RNA.  Other  rRNA  processing  genes:   
MG_110,  MG_139,  MG_425  also  removed  in  GAMA_237.   
MG_372    thiI    tRNA  sulfurtransferase.  Catalyzes  the  transfer  of  sulfur  to  tRNAs  to  produce  4-thiouridine,  and  catalyzes   
the  transfer  of  sulfur  to  carrier  protein  ThiS  (a  step  in  the  synthesis  of  thiazole).   
MG_379    mnmG    Forms  a  tetramer  with  MG_008.  Addition  of  a  carboxymethylaminomethyl  group  to  certain  tRNAs.   
MG_445    trmD    tRNA  methyltransferase.  Specifically  methylates  guanosine-37  in  various  tRNAs.   
MG_465    rnpA    Ribonuclease  P  protein  component.  Produces  mature  tRNAs  (catalyzes  removal  of  5'-leader  sequence).   
Additionally  broadens  the  substrate  specificity  of  the  ribozyme  through  binding.   
Table  19.  High  essential  genes  from  GAMA_237  genomic  context.  Protein  annotation   
and  function  obtained  from  UniProt  160 ,  based  on  Fraser  et  al. ’s  M.genitalium  G37   
genome  58 .        
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It  is  likely  that  that  the  lower  in-silico  division  rate  for  GAMA_237  (33%)  is  due  to  the  cell   
being  reliant  on  favourable  random  initial  conditions  (i.e.  already  present  RNAs  and   
proteins),  within  the  biologically  feasible  conditions  allowed,  to  survive  a  single   
generation.  This  underlines  a  problem  with  using  in-silico  models  in  genome  design.  To   
the  best  of  my  knowledge,  the  M.genitalium  whole-cell  model  is  modelled  correctly,   
including  the  implementation  of  deleting  genes  (Karr  et  al.  Supplementary  mmc1,  pg   
117  6 ;  Simulation.m,  lines  194-350  163 ).  However,  with  the  complete  model  only  capable   
of  modelling  a  single  generation,  in-silico  cells  that  would  not  produce  a  dividing   
second  generation  in-silico  cell  (or  a  functioning  in-vivo  cell)  can  divide  successfully  and   
appear  functional.      
  
Modelling  multiple  generations  is  required  to  allow  the  production  of  in-silico  genome   
designs  that  could  reliably  predict  in-vivo  genome  function.  In  theory,  if  the  final   
conditions  of  a  simulation  (post  division)  were  extractable  and  the  initial  conditions   
could  be  set  for  simulations,  the  final  conditions  of  the  previous  simulation  could  be   
used  as  the  initial  conditions  of  the  next.  By  keeping  the  genetic  edits  constant,   
M.genitalium  whole-cell  model  simulations  could  be  chained  together  in  an   
approximation  of  multiple  generations.  The  E.coli  whole-cell  model  152   (code  available,   
currently  in  review )  models  multiple  generations,  as  should  all  future  whole-cell  models.      
  
4.4.9 Comparison  of  Shared  Deletions  to  JCVI-Syn3.0   
I  attempted  to  gain  further  insight  by  using  BLAST  to  compare  the  shared  deletions  to   
JCVI-Syn3.0  (Table  20)  (tblastn,  query:  JCVI-Syn3.0  amino  acid  sequence,  database:   
nucleotide  collection  (nr/nt),  organism:  Mycoplasma  genitalium  G37  (taxid:243273)).  I   
matched  56%  of  JCVI-Syn3.0  genes  to  the  M.genitalium  whole-cell  modelled  genes,   
finding  that  73  of  the  141  shared  deletions  had  no  BLAST  match  with  JCVI-Syn3.0 .   
There  were  15  deletions  in  common  and  53  deletions  not  removed  in  JCVI-Syn3.0 .  Any   
conclusions  drawn  from  this  explicit  comparison  would  be  weak,  as  even  the  56%   
matched  JCVI-Syn3.0  genes  varied  in  the  BLAST  confidence.  This  is  mainly  due  to   
differences  between  species,  JCVI-Syn3.0  is  a  reduction  of  JCVI-Syn1.0  which  is   





Deleted  in-silico  and  in  
JCVISyn3.0   
Deleted  in-silico ,  not   
deleted  in  JCVISyn3.0   
No  tblastn  match  for   
gene  deletion   
15  genes    53  genes    73  genes   
MG_009    MG_030    MG_012   
MG_062    MG_046    MG_014   
MG_063    MG_048    MG_015   
MG_097    MG_050    MG_020   
MG_183    MG_055    MG_027   
MG_293    MG_059    MG_029   
MG_339    MG_061    MG_040   
MG_346    MG_072    MG_052   
MG_352    MG_073    MG_064   
MG_359    MG_083    MG_065   
MG_391    MG_085    MG_075   
MG_399    MG_109    MG_086   
MG_401    MG_110    MG_101   
MG_447    MG_119    MG_105   
MG_498    MG_121    MG_120   
   MG_122    MG_123   
   MG_132    MG_127   
   MG_139    MG_130   
   MG_170    MG_143   
   MG_172    MG_149   
   MG_205    MG_184   
   MG_206    MG_186   
   MG_208    MG_187   
   MG_209    MG_188   
   MG_214    MG_189   
   MG_235    MG_190   
   MG_239    MG_191   
   MG_240    MG_192   
   MG_244    MG_200   
   MG_252    MG_210   
   MG_262    MG_213   
   MG_265    MG_217   
   MG_297    MG_218   
   MG_298    MG_225   
   MG_324    MG_226   
   MG_329    MG_227   
   MG_333    MG_236   
   MG_335    MG_259   
   MG_336    MG_264   
   MG_369    MG_277   
   MG_370    MG_288   
   MG_380    MG_309   
   MG_400    MG_310   
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   Deleted  in-silico ,  not   
deleted  in  JCVISyn3.0   
No  tblastn  match  for   
gene  deletion   
   MG_402    MG_312   
   MG_404    MG_316   
   MG_405    MG_317   
   MG_409    MG_318   
   MG_421    MG_327   
   MG_442    MG_344   
   MG_457    MG_349   
   MG_460    MG_353   
   MG_463    MG_355   
   MG_464    MG_356   
      MG_358   
      MG_376   
      MG_385   
      MG_386   
      MG_390   
      MG_392   
      MG_393   
      MG_398   
      MG_403   
      MG_408   
      MG_425   
      MG_428   
      MG_438   
      MG_448   
      MG_454   
      MG_467   
      MG_468   
      MG_476   
      MG_482   
      MG_526   
Table  20.  Comparing  shared  gene  deletions  to  JCVI-Syn3.0  using  tblastn.  A  published   
version  of  the  table  is  available  56   .   
  
4.5 Discussion   
The  group  created  two  genome  design  algorithms  (Minesweeper  and  GAMA)  that  used   
computational  design-simulate-test  cycles  to  produce  in-silico  M.genitalium  minimal   
genomes  (Minesweeper_256  and  GAMA_237,  36%  and  41%  in-silico  reductions   
respectively),  producing  evidence  for  multiple  minima  for  M.genitalium  in-silico .  If   
biologically  correct,  the  subsequent  in-vivo  minimal  genome  predictions  are  smaller   
than  JCVI-syn3.0  (currently  the  smallest  genome  that  can  be  grown  in  pure  culture  at   
473  genes  12 )   and  smaller  than  the  most  recent  predictions  for  a  reduced  Mycoplasma   
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genome  (413  genes)  13 .  However,  these  predicted  genomes  have  not  been  tested  for   
successful  growth  and  division  over  multiple  generations.  In  addition  to  predicting  these   
greatly  reduced  predicted  genomes,  I  identified  10  low  essential  genes  10   (Table  18).   
  
Specific  issues  have  been  highlighted,  including  the  modelling  of  DisA ,  and  the   
biologically-infeasible  removal  of  the  high  essential  genes  in-silico  (an  outcome  of  the   
model’s  single  generation  lifespan).  I  do  not  have  confidence  in  the  in-silico  high   
essential  or  DisA  gene  deletions.     
  
There  are  limitations  to  the  approach  presented  here.  Models  are  not  perfect   
representations  of  reality.  Through  necessity,  the  M.genitalium  whole-cell  model  bases   
some  of  its  parameters  on  data  from  other  bacteria  6 .  Additionally,  complete   
multi-generation  simulations  are  not  possible  with  the  M.genitalium  whole-cell  model   
(the  only  whole-cell  model  available  at  the  time),  and  M.genitalium  has  genes  of   
unknown  function  that  the  model  cannot  account  for.  The  success  of  our  in-silico   
genomes  in-vivo  will  be  dependent  on  the  accuracy  of  the  model,  which  is  untested  at   
this  large-scale  number  of  genetic  modifications.     
  
However,  the  gene  deletions  shared  by  GAMA_237  and  Minesweeper_256  (141  gene   
deletions,  Table  15)  and  the  deletions  responsible  for  each  of  the  phosphate  “pivot   
points”  are  worthy  of  in-vivo  testing.  It  remains  possible  that  these  could  predict  a   
viable  M.genitalium  minimal  cell.  Given  that  the  impact  of  the  unmodelled  genes  is   
unknown  (e.g.  if  they  perform  a  unique  essential  function  with  a  gene  /  gene  product   
that  has  already  been  removed,  then  the  in-vivo  cell  will  not  survive)  until  these   
predictions  are  tested  experimentally  we  cannot  firmly  state  how  long  the  predicted   
reduced  in-vivo  cells  would  survive  and  replicate,  and  whether  they  represent  a  truly   






Chapter  5  -  Testing  Theoretical  Minimal  Genomes  in-silico   
5.1 Statement  of  Collaboration   
Sections  of  this  chapter  have  previously  been  published  with  the  author  of  this  thesis  as   
the  lead  author.  The  sections  reproduced  here  are  solely  this  author's  work,  with   
guidance  from  the  supervisors.     
● Rees-Garbutt,  J.,  Grierson,  C.  &  Marucci,  L.  Testing  theoretical  minimal   
genomes  using  whole-cell  models.  bioRxiv.  doi:10.1101/2020.03.26.010363   
(2020).   
○ Lead  author     
  
5.2 Aims     
Numerous  authors  have  pondered  what  the  minimal  gene  set  for  life  might  be  (Section   
1.3.2.c)  and  many  hypothetical  minimal  gene  sets  have  been  proposed,  including  at   
least  10  for  M.genitalium  6,55,57,59–61,74–77 .  None  of  these  have  been  reported  to  be  tested   
in-vivo  or  in-silico .  In-vivo  testing  would  be  extremely  difficult  as  M.genitalium  is  very   
difficult  to  grow  in  the  laboratory  and  laborious  to  engineer  11,12 .  However,  having  the  
M.genitalium  model  running  provided  an  excellent  opportunity  to  test  them  in-silico .  I   
edited  and  ran  versions  of  the  M.genitalium  whole-cell  model  equivalent  to  the  eight   
smallest  hypothetical  minimal  gene  sets  from  the  literature.  None  of  these  initially   
produced  in-silico  cells  that  could  grow  and  divide.  Taking  into  account  knowledge  that   
I  had  accumulated  about  the  M.genitalium  whole-cell  model  genome  and  the  functions   
of  its  genes,  I  was  able  to  repair  these  sets  by  reintroducing  selected  genes,  so  that   
they  produced  dividing  in-silico  cells.  
  
5.3 Results   
5.3.1 Adapting  the  Minimal  Gene  Sets  to  the  M.genitalium  whole-cell  Model  
Ten  minimal  gene  sets  were  found  in  the  literature  that  were  designed  with  M.genitalium   
genes  6,55,57,59–61,74–77 ,  however  two  sets  57,77   were  excluded  as  they  were  considered   
derivative  of  the  Gil  2014  set  55   being  identical  apart  from  four  genes  in  the  Shuler  et  al.   
set  (MG_056,  MG_146,  MG_388,  MG_391)  and  four  genes  not  in  the  Gil  et  al.  2004  set   




Minimal  Gene  Set    Code  Name    Design  Methodology   
  Mushegian  and  Koonin  1996  59    Bethesda    Comparative  Genomics   
Hutchison  et  al.  1999  60    Rockville    Single  Gene  Deletions   
Tomita  et  al.  1999  74    Fujisawa    Protocell  
Glass  et  al.  2006  61    Rockville  2    Single  Gene  Deletions   
Forster  and  Church  2006  75    Nashville    Protocell  
Karr  et  al.  2012  6    Stanford    Single  Gene  Deletions   
Huang  et  al.  2013  76    Guelph    Comparative  Genomics   
Gil  2014  55   Valencia    Comparative  Genomics   
Table  21.  Code  names  for  the  minimal  gene  sets  from  the  literature.   
  
To  prevent  confusion,  I  named  the  sets  after  the  main  location  where  the  set  was   
constructed  (Table  21).  The  Bethesda  set  is  a  comparison  of  M.genitalium  protein   
sequences  to  Haemophilus  influenzae  (representatives  of  gram-positive  and   
gram-negative  bacteria  respectively)  59 .  The  Rockville  set  is  the  result  of  applying  global   
transposon  mutagenesis  to  M.genitalium  in-vivo  to  identify  non-essential  genes  60 .  The   
Fujisawa  set  is  an  in-silico  model  of  a  hypothetical  cell  constructed  from  127   
M.genitalium  genes  using  the  E-Cell  software  74 .  The  Rockville  2  set  is  an  expansion  of   
the  original  global  transposon  mutagenesis  research  on  M.genitalium ,  with  properly   
conducted  isolation  and  characterisation  of  pure  clonal  populations  61 .  The  Nashville  set   
is  a  list  of  151  E.coli  genes  (compared  to  M.genitalium  genes  within  the  paper)  to   
produce  a  chemical  system  capable  of  replication  and  evolution  75  .  The  Stanford  set  is   
the  result  of  in-silico  single  gene  knockouts  conducted  using  the  M.genitalium   
whole-cell  model  6 .  The  Guelph  set  is  the  result  of  a  comparative  genomics  analysis  of   
186  bacterial  genomes  76 .  The  Valencia  set  compared  the  genome  of  M.genitalium  with   
genetic  data  of  five  insect  endosymbionts  55  .   
  
To  begin  testing  the  eight  minimal  gene  sets  to  see  if  they  produced  in-silico  dividing   
cells,  I  had  first  to  adapt  each  set  for  use  in  simulations,  removing  any  genes   
unmodelled  in  the  M.genitalium  whole-cell  model.  The  sets  Nashville,  Fujisawa  and   
Stanford  are  as  they  appear  in  the  literature,  the  others  needed  adapting  by  removing   
genes  as  follows  (Table  22).  Guelph  had  seven  genes  removed:  six  because  they  are   
not  in  the  whole-cell  model  and  one  copy  of  MG_231  was  removed  as  it  was  originally   
listed  twice.  Valencia  had  eight  genes  removed:  seven  that  are  not  present  in  the   
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M.genitalium  whole-cell  model  and  one  copy  of  MG_231  was  removed  as  it  was   
originally  listed  twice.  Bethesda  had  15  genes  removed:  13  as  they  are  not  in  the   
whole-cell  model  and  MG_297  and  MG_336  were  reduced  to  a  single  copy  each  as   
they  were  both  originally  listed  twice.  Rockville  had  41  genes  removed  as  they  are  not   
in  the  whole-cell  model.  Rockville  2  had  44  genes  removed  as  they  were  not  in  the   
whole-cell  model.   
  
As  expected,  the  minimal  gene  sets  designed  as  protocells  (Nashville,  Fujisawa)  have   
the  smallest  predicted  in-silico  genome  size.  Of  the  comparative  genomics  minimal   
gene  sets,  Guelph  is  substantially  smaller  than  Valencia  and  Bethesda  due  to   
comparing  186  bacterial  species  for  common  genes  76 ,  with  Valencia  only  six  species   
55 ,  and  Bethesda  directly  comparing  two  species  59 .  The  single  gene  deletion  minimal   
gene  sets  (Stanford,  Rockville,  Rockville  2)  have  similar  numbers  of  in-vivo  deletions,   
but  Rockville  and  Rockville  2  have  the  highest  numbers  of  genes  that  are  missing  from   
the  M.genitalium  whole-cell  model.  This  is  due  to  the  nature  of  exploratory  genetic   
work,  genes  can  be  disrupted  in-vivo  whether  or  not  the  gene  function  is  known.  To  be   
implemented  in-silico ,  however,  the  function  of  the  genes  also  must  be  known.  All  the   
genes  in  Stanford  are  contained  in  the  whole-cell  model,  as  the  single  gene  deletions   
were  conducted  in-silico  using  the  model  and  so  did  not  target  unmodelled  genes.  The   
gene  content  of  the  minimal  gene  sets  (Table  23)  and  the  required  gene  deletions  to   










g enome   
design  size*  
Unmodelled   
genes^  in   
genome  design   
Single  in-vivo   
gene  deletions*  
Unmodelled   
genes^  in  single   
gene  deletions   
Predicted   
in-silico   
genome  size*  
Predicted   
gene  deletions  
in-silico *   
Nashville    Protocell   89    0    -    -    89    270   
Fujisawa    Protocell   98    0    -    -    98    261   
Guelph   
Comparative   
Genomics   123    5    -    -    118    241   
Valencia   
Comparative   
Genomics   180    6    -    -    174    185   
Bethesda   
Comparative   
Genomics   253    12    -    -    241    118   
Stanford   
Single  Gene   
Deletions    -    -    117    0    242    117   
Rockville  2   
Single  Gene   
Deletions    -    -    101    44    302    57   
Rockville   
Single  Gene   
Deletions    -    -    94    41    306    53   
M.genitalium   
whole-cell  Model*    -    -    124    -    -    359    -   
M.genitalium  in-vivo  *   -    483       -    -    -    -   
Table  22.  Minimal  gene  sets  from  the  literature,  compared  with  M.genitalium  in-vivo   
and  the  whole-cell  model.  M.genitalium  has  42  RNA-coding  genes  that  are  not   






   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_001   I    I       I       I    I    I    I   
MG_002                  I            
MG_003   I    I       I       I    I    I    I   
MG_004   I    I       I       I    I    I    I   
MG_005   I    I    I    I    I    I    I    I    I   
MG_006   I    I       I       I       I      
MG_007      I       I       I       I      
MG_008   I    I       I       I    I    I    I   
MG_009   I                           
MG_010                  I            
MG_011                  I            
MG_012   I    I             I            
MG_013   I    I       I       I            
MG_014            I                  
MG_015   I    I       I                  
MG_018                  I            
MG_019   I    I       I       I    I    I    I   
MG_020      I       I       I            
MG_021   I    I    I    I    I    I    I    I    I   
MG_022      I       I       I            
MG_023   I    I    I    I       I       I      
MG_024   I    I             I    I    I      
MG_025            I       I            
MG_026   I    I       I    I    I       I      
MG_027      I       I                  
MG_028      I       I       I            
MG_029            I                  
MG_030   I    I       I             I      
MG_031      I       I       I       I      
MG_032                  I            
MG_033   I       I                     
MG_034      I       I       I            
MG_035   I    I    I    I    I    I    I    I    I   
MG_036   I    I    I    I    I    I    I    I    I   
MG_037      I       I       I            
MG_038   I    I    I    I       I            
MG_039      I                        
MG_040      I                        
MG_041      I    I    I       I       I      
MG_042   I    I       I       I            
MG_043   I    I       I       I            
MG_044   I    I       I       I            
MG_045   I    I       I       I            
MG_046      I       I       I    I    I      
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_047   I    I       I       I    I    I    I   
MG_048   I    I       I       I    I    I    I   
MG_049   I          I       I            
MG_050   I    I       I                  
MG_051                  I            
MG_052   I          I                  
MG_053   I    I       I       I            
MG_054   I    I       I       I    I    I    I   
MG_055      I       I             I      
MG_473      I       I       I            
MG_474      I       I       I            
MG_056   I    I             I    I    I      
MG_057      I       I       I            
MG_058   I    I       I       I    I    I    I   
MG_059   I    I       I          I    I      
MG_060   I    I       I       I            
MG_061      I                        
MG_062                             
MG_063   I    I                        
MG_064      I       I                  
MG_065   I    I       I                  
MG_066   I    I             I    I    I      
MG_067                  I            
MG_068      I       I       I            
MG_069      I    I    I       I       I      
MG_070   I    I    I    I    I    I    I    I    I   
MG_071   I    I       I       I            
MG_072   I    I       I       I    I    I    I   
MG_073   I    I       I                  
MG_074      I       I       I            
MG_075      I       I                  
MG_076      I       I       I            
MG_077   I    I       I       I            
MG_078   I    I       I       I            
MG_079   I    I       I       I            
MG_080   I    I       I       I            
MG_081   I    I    I    I    I    I    I    I    I   
MG_082   I    I    I    I    I    I    I    I    I   
MG_083   I    I       I          I    I      
MG_084      I       I       I    I    I      
MG_085            I                  
MG_086   I    I       I                  
MG_087   I    I    I    I    I    I    I    I    I   
MG_088   I    I    I    I    I    I    I    I    I   
MG_089   I    I    I    I    I    I    I    I    I   
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_090   I    I    I    I    I    I       I      
MG_091   I    I       I       I            
MG_092   I    I    I    I    I    I    I    I    I   
MG_093   I    I    I    I    I    I       I      
MG_094   I    I       I       I    I    I    I   
MG_095      I       I       I            
MG_096                  I            
MG_097   I    I       I             I      
MG_098      I       I       I            
MG_099      I       I    I    I            
MG_100      I       I    I    I            
MG_101      I       I                  
MG_102   I    I       I       I    I    I    I   
MG_103                  I            
MG_476      I       I       I            
MG_104   I    I       I       I            
MG_105      I       I                  
MG_106   I    I       I       I            
MG_107   I    I       I       I    I    I    I   
MG_108      I       I       I            
MG_109      I       I       I            
MG_110                  I            
MG_111   I    I    I    I       I    I    I    I   
MG_112   I    I             I    I    I      
MG_113   I    I    I    I    I    I    I    I    I   
MG_114   I    I    I          I            
MG_115      I             I            
MG_116      I             I            
MG_117      I       I       I            
MG_118   I    I       I       I            
MG_119   I    I       I                  
MG_120   I    I       I                  
MG_121      I                        
MG_122   I    I       I       I            
MG_123      I       I                  
MG_124   I    I       I       I    I    I    I   
MG_125   I    I       I       I            
MG_126   I    I    I    I    I    I    I    I    I   
MG_127   I    I       I                  
MG_128      I       I       I            
MG_129      I       I       I            
MG_130            I                  
MG_131                  I            
MG_132            I                  
MG_133      I       I       I            
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_134      I             I            
MG_135      I       I       I            
MG_136   I    I    I    I    I    I    I    I    I   
MG_137      I       I       I            
MG_138   I    I             I    I    I      
MG_139      I       I       I            
MG_140                  I            
MG_141   I    I       I       I    I    I    I   
MG_477            I       I            
MG_142   I    I    I    I    I    I    I    I    I   
MG_143   I    I       I       I       I      
MG_144      I       I       I            
MG_145   I    I       I       I    I    I    I   
MG_146      I       I       I            
MG_147      I       I       I            
MG_148      I       I       I            
MG_149                             
MG_478      I             I            
MG_150   I    I    I    I    I    I    I    I    I   
MG_151   I    I    I    I    I    I    I    I    I   
MG_152   I    I    I    I    I    I    I    I    I   
MG_153   I    I    I    I    I    I       I      
MG_154   I    I    I    I    I    I    I    I    I   
MG_155   I    I    I    I    I    I    I    I    I   
MG_156   I    I    I    I    I    I    I    I    I   
MG_157   I    I    I    I    I    I    I    I    I   
MG_158   I    I    I    I    I    I    I    I    I   
MG_159   I    I    I    I    I    I       I      
MG_160   I    I    I    I    I    I    I    I    I   
MG_161   I    I    I    I    I    I    I    I    I   
MG_162   I    I    I    I    I    I    I    I    I   
MG_163   I    I    I    I    I    I    I    I    I   
MG_164   I    I    I    I    I    I       I      
MG_165   I    I    I    I    I    I    I    I    I   
MG_166   I    I    I    I    I    I    I    I    I   
MG_167   I    I    I    I    I    I    I    I    I   
MG_168   I    I    I    I    I    I    I    I    I   
MG_169   I    I       I    I    I       I      
MG_170   I    I       I       I    I    I    I   
MG_171   I    I       I    I    I    I    I    I   
MG_172   I    I       I       I    I    I    I   
MG_173   I    I    I    I    I    I    I    I    I   
MG_174   I    I    I    I    I    I       I      
MG_175   I    I    I    I    I    I    I    I    I   
MG_176   I    I    I    I    I    I    I    I    I   
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MG_177   I    I    I    I       I    I    I    I   
MG_178   I    I    I    I    I    I    I    I    I   
MG_179      I       I       I            
MG_180   I    I       I       I            
MG_181      I       I       I            
MG_182   I          I       I            
MG_183                  I            
MG_184      I       I       I            
MG_185                  I            
MG_186            I                  
MG_187   I    I       I                  
MG_188      I       I                  
MG_189      I       I                  
MG_190      I       I                  
MG_191            I       I            
MG_192            I       I            
MG_194   I    I    I    I    I    I    I    I    I   
MG_195   I    I       I    I    I    I    I    I   
MG_196   I    I    I    I    I    I    I    I    I   
MG_197   I    I    I    I    I    I       I      
MG_198   I    I    I    I    I    I    I    I    I   
MG_199      I       I       I            
MG_200      I       I                  
MG_201   I    I       I       I       I      
MG_202            I       I            
MG_203   I    I       I                  
MG_204   I    I       I       I            
MG_205      I       I                  
MG_206   I    I       I                  
MG_207                  I            
MG_208      I       I       I            
MG_209   I          I                  
MG_210   I    I             I            
MG_480      I       I       I            
MG_481      I       I       I            
MG_211      I       I       I            
MG_482      I       I                  
MG_212   I    I       I       I       I      
MG_213                             
MG_214      I                        
MG_215   I    I    I    I       I       I      
MG_216   I    I    I    I       I       I      
MG_217      I       I       I            
MG_218      I       I       I            
MG_491      I       I       I            
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MG_219      I       I       I            
MG_220      I             I            
MG_221   I    I       I       I            
MG_222   I    I       I       I    I    I      
MG_223      I       I       I            
MG_224   I    I       I       I    I    I      
MG_225      I       I                  
MG_226                             
MG_227   I    I                   I      
MG_228   I    I       I       I       I      
MG_229   I    I       I       I       I      
MG_230      I       I       I            
MG_231   I    I       I       I    I    I    I   
MG_232   I    I    I    I    I    I       I      
MG_233      I       I       I            
MG_234   I    I    I    I    I    I    I    I    I   
MG_235      I       I             I      
MG_236      I       I                  
MG_237                  I            
MG_238   I    I             I            
MG_239   I    I       I       I            
MG_240      I       I                  
MG_241      I       I       I            
MG_242      I       I       I            
MG_243      I       I       I            
MG_244   I    I                        
MG_245   I    I       I       I            
MG_246      I       I       I            
MG_247   I    I       I       I            
MG_248      I             I            
MG_249   I    I    I    I       I    I    I    I   
MG_250   I    I       I          I    I      
MG_251   I    I    I    I    I    I       I      
MG_252   I    I                        
MG_253   I    I    I    I    I    I    I    I    I   
MG_254   I    I       I       I    I    I    I   
MG_255                  I            
MG_494                  I            
MG_256                  I            
MG_257   I    I    I    I    I    I    I    I    I   
MG_258   I    I       I    I    I    I    I    I   
MG_259   I    I       I    I          I      
MG_260      I             I            
MG_261   I    I       I       I    I    I    I   
MG_262   I    I       I          I    I      
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MG_498   I    I                        
MG_263      I       I       I            
MG_264                        I      
MG_265   I    I       I                  
MG_266   I    I    I    I    I    I    I    I    I   
MG_267      I       I       I            
MG_268   I                I            
MG_269                  I            
MG_270   I    I       I       I            
MG_271   I    I             I            
MG_272   I    I       I       I            
MG_273   I    I       I       I            
MG_274   I    I       I       I            
MG_275   I    I       I       I            
MG_276   I    I       I       I            
MG_277      I       I       I            
MG_278   I    I       I       I            
MG_279                  I            
MG_280                  I            
MG_281                  I            
MG_282   I    I       I       I    I    I    I   
MG_283   I    I    I    I    I    I       I      
MG_284      I             I            
MG_285                  I            
MG_286                  I            
MG_287   I    I       I       I            
MG_288                             
MG_289      I                        
MG_290      I                        
MG_291                             
MG_505      I       I       I            
MG_292   I    I    I    I    I    I    I    I    I   
MG_293   I                           
MG_294                  I            
MG_295   I          I       I    I    I      
MG_296            I       I            
MG_297   I    I       I       I    I    I    I   
MG_298      I                        
MG_299   I    I       I       I            
MG_300   I    I    I    I       I    I    I    I   
MG_301   I    I    I    I       I    I    I    I   
MG_302      I       I       I            
MG_303      I       I       I            
MG_304      I       I       I            
MG_305   I    I       I       I    I    I    I   
154   
  
   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_306      I       I       I            
MG_307      I       I       I            
MG_308            I       I            
MG_309      I       I                  
MG_310            I                  
MG_311      I    I    I    I    I    I    I      
MG_312      I       I       I            
MG_313      I       I       I            
MG_314      I       I       I            
MG_315      I             I       I      
MG_316                             
MG_317            I       I            
MG_318      I       I       I            
MG_319      I       I       I            
MG_320      I       I       I            
MG_321      I       I       I            
MG_322   I    I       I       I            
MG_323      I       I       I            
MG_515            I       I            
MG_324      I       I                  
MG_325   I    I    I    I    I    I       I      
MG_326      I       I       I            
MG_327            I                  
MG_328                  I            
MG_329      I       I       I    I    I      
MG_330   I    I       I       I            
MG_331      I       I       I            
MG_332   I    I       I       I            
MG_333   I    I       I                  
MG_334   I    I    I    I    I    I    I    I    I   
MG_335   I          I       I            
MG_516      I       I       I            
MG_517      I       I       I            
MG_336   I    I       I             I      
MG_337      I       I       I            
MG_338            I       I            
MG_339   I                           
MG_340   I    I    I    I       I    I    I    I   
MG_341   I    I    I    I       I    I    I    I   
MG_342      I       I       I            
MG_343                  I            
MG_344      I    I    I                  
MG_345   I       I    I    I    I    I    I      
MG_346   I                      I      
MG_347   I    I       I       I            
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MG_348      I       I       I            
MG_349      I       I                  
MG_350      I       I       I            
MG_521      I       I       I            
MG_351   I    I    I    I    I    I       I      
MG_352                             
MG_353   I    I       I             I      
MG_354      I       I       I            
MG_355   I    I                        
MG_356      I       I                  
MG_357   I    I       I       I            
MG_358   I    I                        
MG_359   I    I                        
MG_360      I             I            
MG_361   I    I    I    I    I    I    I    I    I   
MG_362   I    I    I    I    I    I    I    I    I   
MG_363   I    I    I    I    I    I       I      
MG_522   I    I    I    I    I    I       I      
MG_364      I       I       I            
MG_365   I    I    I    I    I    I            
MG_366            I       I            
MG_367   I    I             I    I    I      
MG_368      I       I       I            
MG_369      I       I                  
MG_370                             
MG_371      I       I       I            
MG_372            I       I            
MG_373      I       I       I            
MG_374      I       I       I            
MG_375   I    I    I    I    I    I       I      
MG_376      I       I                  
MG_377      I       I       I            
MG_378   I    I    I    I    I    I    I    I    I   
MG_379   I    I       I       I       I      
MG_380   I                           
MG_381      I       I       I            
MG_382   I    I       I       I            
MG_383   I    I       I       I            
MG_384   I    I       I       I    I    I    I   
MG_524      I       I       I            
MG_385                             
MG_386      I       I       I            
MG_387   I    I       I       I       I      
MG_388      I       I       I       I      
MG_389      I       I       I            
156   
  
   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford   Guelph    Valencia    Common   
MG_390                             
MG_391   I    I       I       I       I      
MG_392   I    I       I    I    I    I    I    I   
MG_393   I    I       I    I    I       I      
MG_394   I          I       I    I    I      
MG_395            I       I            
MG_396      I       I       I       I      
MG_397      I             I            
MG_398   I    I                   I      
MG_399   I    I       I          I    I      
MG_400   I    I       I          I    I      
MG_401   I    I       I          I    I      
MG_402   I    I       I             I      
MG_403   I    I       I             I      
MG_404   I    I       I             I      
MG_405   I    I       I             I      
MG_406   I    I       I       I            
MG_407   I    I    I    I       I    I    I    I   
MG_408   I                           
MG_409      I       I                  
MG_410   I                           
MG_411   I                           
MG_412                             
MG_414                  I            
MG_525                  I            
MG_417   I    I    I    I    I    I    I    I    I   
MG_418   I    I    I    I    I    I    I    I    I   
MG_419      I       I       I            
MG_421   I          I                  
MG_422      I       I       I            
MG_423            I       I            
MG_424   I    I    I    I    I    I    I    I    I   
MG_425   I    I       I       I    I    I    I   
MG_426   I       I    I    I    I       I      
MG_427      I       I                  
MG_428                             
MG_429      I    I    I       I    I    I      
MG_430   I    I    I    I       I       I      
MG_431   I    I    I    I       I    I    I    I   
MG_432      I       I       I            
MG_433   I    I    I    I    I    I    I    I    I   
MG_434   I    I       I       I            
MG_435   I    I       I    I    I    I    I    I   
MG_437   I    I    I          I       I      
MG_438                             
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MG_439      I       I       I            
MG_440            I       I            
MG_441      I       I       I            
MG_442            I       I            
MG_443      I       I       I            
MG_444   I    I    I    I    I    I    I    I    I   
MG_445   I    I       I    I    I    I         
MG_446   I    I    I    I    I    I    I    I    I   
MG_447      I       I                  
MG_448   I    I       I                  
MG_449   I                I            
MG_450      I       I       I            
MG_451   I    I    I    I    I    I    I    I    I   
MG_452                  I            
MG_453   I    I       I       I            
MG_454      I       I                  
MG_455   I    I    I    I    I    I    I    I    I   
MG_456      I             I            
MG_457   I    I       I          I    I      
MG_458   I    I       I       I       I      
MG_459      I       I       I            
MG_460      I    I    I                  
MG_461      I       I       I            
MG_462   I    I    I    I    I    I    I    I    I   
MG_463   I    I       I          I    I      
MG_464      I       I       I       I      
MG_465   I    I       I    I    I       I      
MG_466   I    I    I    I    I    I       I      
MG_467            I                  
MG_468            I                  
MG_526      I       I                  
MG_469   I    I       I       I    I         
MG_470            I                  
Table  23.  Comparing  the  gene  content  of  the  minimal  gene  sets.  Light  grey  genes  are   
unmodelled  in  the  M.genitalium  whole-cell  model.  Dark  grey  genes  cause  the   
simulation  to  crash  when  deleted  on  our  implementation  (using  Matlab  R2013B  on   
University  of  Bristol  BlueGem’s  supercomputer  (Section  3.4)).  I  =  gene  included  in  the   
minimal  gene  set.  Common  =  genes  that  the  minimal  gene  sets  agree  upon,  but   





   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford    Guelph    Valencia    Agreed   
MG_001         x       x               
MG_002      x       x                  
MG_003         x       x               
MG_004         x       x               
MG_005                             
MG_006         x       x       x         
MG_007   x       x       x       x         
MG_008         x       x               
MG_009      x    x    x    x    x    x    x      
MG_010      x       x                  
MG_011      x       x                  
MG_012         x    x    x       x    x      
MG_013         x       x       x    x      
MG_014   x    x    x       x    x    x    x      
MG_015         x       x    x    x    x      
MG_018      x       x                  
MG_019         x       x               
MG_020   x       x       x       x    x      
MG_021                             
MG_022   x       x       x       x    x      
MG_023               x       x         
MG_024            x                  
MG_025      x                        
MG_026         x             x         
MG_027   x       x       x    x    x    x      
MG_028                             
MG_029   x    x    x       x    x    x    x      
MG_030         x       x    x    x         
MG_031   x       x       x       x         
MG_032      x       x                  
MG_033      x       x    x    x    x    x      
MG_034   x       x       x       x    x      
MG_035                             
MG_036                             
MG_037   x       x       x       x    x      
MG_038               x       x    x      
MG_039   x       x    x    x    x    x    x      
MG_040   x       x    x    x    x    x    x      
MG_041   x             x       x         
MG_042         x       x       x    x      
MG_043         x       x       x    x      
MG_044         x       x       x    x      
MG_045         x       x       x    x      
MG_046   x       x       x               
MG_047         x       x               
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MG_048         x       x               
MG_049      x    x       x       x    x      
MG_050         x       x    x    x    x      
MG_051   x    x    x    x    x       x    x      
MG_052      x    x       x    x    x    x      
MG_053         x       x       x    x      
MG_054                             
MG_055   x       x       x    x    x         
MG_473   x       x       x       x    x      
MG_474                             
MG_056            x                  
MG_057                             
MG_058         x       x               
MG_059         x       x    x            
MG_060                             
MG_061   x       x    x    x    x    x    x      
MG_062   x    x    x    x    x    x    x    x    x   
MG_063         x    x    x    x    x    x      
MG_064   x       x       x    x    x    x      
MG_065         x       x    x    x    x      
MG_066         x    x    x               
MG_067      x       x                  
MG_068                             
MG_069   x             x       x         
MG_070                             
MG_071         x       x       x    x      
MG_072         x       x               
MG_073         x       x    x    x    x      
MG_074                             
MG_075   x       x       x    x    x    x      
MG_076                             
MG_077         x       x       x    x      
MG_078         x       x       x    x      
MG_079         x       x       x    x      
MG_080         x       x       x    x      
MG_081                             
MG_082                             
MG_083         x       x    x            
MG_084   x       x       x               
MG_085   x    x    x       x    x    x    x      
MG_086         x       x    x    x    x      
MG_087                             
MG_088                             
MG_089                             
MG_090                     x         
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MG_091         x       x       x    x      
MG_092                             
MG_093                     x         
MG_094         x       x               
MG_095                             
MG_096      x       x                  
MG_097         x       x    x    x         
MG_098   x       x       x       x    x      
MG_099   x       x             x    x      
MG_100   x       x             x    x      
MG_101   x       x       x    x    x    x      
MG_102         x       x               
MG_103      x       x                  
MG_476   x       x       x       x    x      
MG_104         x       x       x    x      
MG_105   x       x       x    x    x    x      
MG_106         x       x       x    x      
MG_107         x       x               
MG_108                             
MG_109   x       x       x       x    x      
MG_110   x    x    x    x    x       x    x      
MG_111               x               
MG_112         x    x    x               
MG_113                             
MG_114            x    x       x    x      
MG_115            x                  
MG_116            x                  
MG_117                             
MG_118         x       x       x    x      
MG_119         x       x    x    x    x      
MG_120         x       x    x    x    x      
MG_121   x       x    x    x    x    x    x      
MG_122         x       x       x    x      
MG_123   x       x       x    x    x    x      
MG_124         x       x               
MG_125                             
MG_126                             
MG_127         x       x    x    x    x      
MG_128   x       x       x       x    x      
MG_129                             
MG_130   x    x    x       x    x    x    x      
MG_131      x       x                  
MG_132   x    x    x       x    x    x    x      
MG_133                             
MG_134            x                  
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MG_135                             
MG_136                             
MG_137   x       x       x       x    x      
MG_138            x                  
MG_139   x       x       x       x    x      
MG_140      x       x                  
MG_141         x       x               
MG_477      x                        
MG_142                             
MG_143         x       x       x         
MG_144                             
MG_145         x       x               
MG_146                             
MG_147                             
MG_148                             
MG_149   x    x    x    x    x    x    x    x    x   
MG_478            x                  
MG_150                             
MG_151                             
MG_152                             
MG_153                     x         
MG_154                             
MG_155                             
MG_156                             
MG_157                             
MG_158                             
MG_159                     x         
MG_160                             
MG_161                             
MG_162                             
MG_163                             
MG_164                     x         
MG_165                             
MG_166                             
MG_167                             
MG_168                             
MG_169         x             x         
MG_170         x       x               
MG_171         x                     
MG_172         x       x               
MG_173                             
MG_174                     x         
MG_175                             
MG_176                             
MG_177               x               
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MG_178                             
MG_179   x       x       x       x    x      
MG_180         x       x       x    x      
MG_181   x       x       x       x    x      
MG_182      x    x       x       x    x      
MG_183   x    x    x    x    x       x    x      
MG_184   x       x       x       x    x      
MG_185      x       x                  
MG_186   x    x    x       x    x    x    x      
MG_187         x       x    x    x    x      
MG_188   x       x       x    x    x    x      
MG_189   x       x       x    x    x    x      
MG_190   x       x       x    x    x    x      
MG_191   x    x    x       x       x    x      
MG_192   x    x    x       x       x    x      
MG_194                             
MG_195         x                     
MG_196                             
MG_197                     x         
MG_198                             
MG_199                             
MG_200   x       x       x    x    x    x      
MG_201         x       x       x         
MG_202      x                        
MG_203         x       x    x    x    x      
MG_204         x       x       x    x      
MG_205   x       x       x    x    x    x      
MG_206         x       x    x    x    x      
MG_207      x       x                  
MG_208   x       x       x       x    x      
MG_209      x    x       x    x    x    x      
MG_210         x    x    x       x    x      
MG_480                             
MG_481   x       x       x       x    x      
MG_211                             
MG_482   x       x       x    x    x    x      
MG_212         x       x       x         
MG_213   x    x    x    x    x    x    x    x    x   
MG_214   x       x    x    x    x    x    x      
MG_215               x       x         
MG_216               x       x         
MG_217   x       x       x       x    x      
MG_218   x       x       x       x    x      
MG_491                             
MG_219                             
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MG_220            x                  
MG_221         x       x       x    x      
MG_222                             
MG_223                             
MG_224         x       x               
MG_225   x       x       x    x    x    x      
MG_226   x    x    x    x    x    x    x    x    x   
MG_227         x    x    x    x    x         
MG_228         x       x       x         
MG_229         x       x       x         
MG_230   x       x       x       x    x      
MG_231         x       x               
MG_232                     x         
MG_233                             
MG_234                             
MG_235   x       x       x    x    x         
MG_236   x       x       x    x    x    x      
MG_237      x       x                  
MG_238         x    x    x       x    x      
MG_239         x       x       x    x      
MG_240   x       x       x    x    x    x      
MG_241                             
MG_242                             
MG_243                             
MG_244         x    x    x    x    x    x      
MG_245         x       x       x    x      
MG_246                             
MG_247                             
MG_248            x                  
MG_249               x               
MG_250         x       x    x            
MG_251                     x         
MG_252         x    x    x    x    x    x      
MG_253                             
MG_254         x       x               
MG_255      x       x                  
MG_494      x       x                  
MG_256      x       x                  
MG_257                             
MG_258         x                     
MG_259         x          x    x         
MG_260            x                  
MG_261         x       x               
MG_262         x       x    x            
MG_498         x    x    x    x    x    x      
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MG_263                             
MG_264   x    x    x    x    x    x    x         
MG_265         x       x    x    x    x      
MG_266                             
MG_267                             
MG_268      x       x                  
MG_269      x       x                  
MG_270         x       x       x    x      
MG_271         x    x    x       x    x      
MG_272         x       x       x    x      
MG_273         x       x       x    x      
MG_274         x       x       x    x      
MG_275         x       x       x    x      
MG_276         x       x       x    x      
MG_277   x       x       x       x    x      
MG_278         x       x       x    x      
MG_279      x       x                  
MG_280      x       x                  
MG_281      x       x                  
MG_282         x       x               
MG_283                     x         
MG_284            x                  
MG_285      x       x                  
MG_286      x       x                  
MG_287         x       x       x    x      
MG_288   x    x    x    x    x    x    x    x    x   
MG_289   x       x    x    x    x    x    x      
MG_290   x       x    x    x    x    x    x      
MG_291   x    x    x    x    x    x    x    x    x   
MG_505                             
MG_292                             
MG_293      x    x    x    x    x    x    x      
MG_294      x       x                  
MG_295      x    x       x               
MG_296      x                        
MG_297         x       x               
MG_298   x       x    x    x    x    x    x      
MG_299         x       x       x    x      
MG_300               x               
MG_301               x               
MG_302   x       x       x       x    x      
MG_303   x       x       x       x    x      
MG_304   x       x       x       x    x      
MG_305         x       x               
MG_306                             
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MG_307                             
MG_308      x                        
MG_309   x       x       x    x    x    x      
MG_310   x    x    x       x    x    x    x      
MG_311   x                           
MG_312   x       x       x       x    x      
MG_313                             
MG_314                             
MG_315   x       x    x    x       x         
MG_316   x    x    x    x    x    x    x    x    x   
MG_317   x    x    x       x       x    x      
MG_318   x       x       x       x    x      
MG_319                             
MG_320                             
MG_321   x       x       x       x    x      
MG_322         x       x       x    x      
MG_323   x       x       x       x    x      
MG_515      x                        
MG_324   x       x       x    x    x    x      
MG_325                     x         
MG_326                             
MG_327   x    x    x       x    x    x    x      
MG_328      x       x                  
MG_329   x       x       x               
MG_330         x       x       x    x      
MG_331                             
MG_332                             
MG_333         x       x    x    x    x      
MG_334                             
MG_335      x    x       x       x    x      
MG_516                             
MG_517   x       x       x       x    x      
MG_336         x       x    x    x         
MG_337                             
MG_338      x                        
MG_339      x    x    x    x    x    x    x      
MG_340               x               
MG_341               x               
MG_342   x       x       x       x    x      
MG_343      x       x                  
MG_344   x             x    x    x    x      
MG_345      x                        
MG_346      x    x    x    x    x    x         
MG_347         x       x       x    x      
MG_348                             
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford    Guelph    Valencia    Agreed   
MG_349   x       x       x    x    x    x      
MG_350                             
MG_521                             
MG_351                     x         
MG_352   x    x    x    x    x    x    x    x    x   
MG_353         x       x    x    x         
MG_354                             
MG_355         x    x    x    x    x    x      
MG_356   x       x       x    x    x    x      
MG_357         x       x       x    x      
MG_358         x    x    x    x    x    x      
MG_359         x    x    x    x    x    x      
MG_360            x                  
MG_361                             
MG_362                             
MG_363                     x         
MG_522                     x         
MG_364                             
MG_365                     x    x      
MG_366      x                        
MG_367         x    x    x               
MG_368   x       x       x       x    x      
MG_369   x       x       x    x    x    x      
MG_370   x    x    x    x    x    x    x    x    x   
MG_371                             
MG_372   x    x    x       x       x    x      
MG_373                             
MG_374                             
MG_375                     x         
MG_376   x       x       x    x    x    x      
MG_377                             
MG_378                             
MG_379         x       x       x         
MG_380      x    x    x    x    x    x    x      
MG_381                             
MG_382         x       x       x    x      
MG_383         x       x       x    x      
MG_384         x       x               
MG_524                             
MG_385   x    x    x    x    x    x    x    x    x   
MG_386   x       x       x       x    x      
MG_387         x       x       x         
MG_388                             
MG_389                             
MG_390   x    x    x    x    x    x    x    x    x   
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford    Guelph    Valencia    Agreed   
MG_391         x       x       x         
MG_392         x                     
MG_393         x             x         
MG_394      x    x       x               
MG_395      x                        
MG_396   x       x       x       x         
MG_397            x                  
MG_398         x    x    x    x    x         
MG_399         x       x    x            
MG_400         x       x    x            
MG_401         x       x    x            
MG_402         x       x    x    x         
MG_403         x       x    x    x         
MG_404         x       x    x    x         
MG_405         x       x    x    x         
MG_406                             
MG_407               x               
MG_408      x    x    x    x    x    x    x      
MG_409   x       x       x    x    x    x      
MG_410      x    x    x    x    x    x    x      
MG_411      x    x    x    x    x    x    x      
MG_412   x    x    x    x    x    x    x    x    x   
MG_414      x       x                  
MG_525      x       x                  
MG_417                             
MG_418                             
MG_419   x       x       x       x    x      
MG_421      x    x       x    x    x    x      
MG_422                             
MG_423      x                        
MG_424                             
MG_425         x       x               
MG_426      x                x         
MG_427   x       x       x    x    x    x      
MG_428   x    x    x    x    x    x    x    x    x   
MG_429   x             x               
MG_430               x       x         
MG_431               x               
MG_432                             
MG_433                             
MG_434         x       x       x    x      
MG_435         x                     
MG_437            x    x       x         
MG_438   x    x    x    x    x    x    x    x    x   
MG_439                             
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   Bethesda   Rockville    Fujisawa    Rockville  2    Nashville    Stanford    Guelph    Valencia    Agreed   
MG_440      x                        
MG_441                             
MG_442   x    x    x       x       x    x      
MG_443                             
MG_444                             
MG_445         x                x      
MG_446                             
MG_447   x       x       x    x    x    x      
MG_448         x       x    x    x    x      
MG_449      x       x                  
MG_450                             
MG_451                             
MG_452      x       x                  
MG_453         x       x       x    x      
MG_454   x       x    x    x    x    x    x      
MG_455                             
MG_456            x                  
MG_457         x       x    x            
MG_458         x       x       x         
MG_459                             
MG_460   x          x    x    x    x    x      
MG_461                             
MG_462                             
MG_463         x    x    x    x            
MG_464   x       x       x       x         
MG_465         x             x         
MG_466                     x         
MG_467   x    x    x       x    x    x    x      
MG_468   x    x    x       x    x    x    x      
MG_526   x       x       x    x    x    x      
MG_469         x       x          x      
MG_470   x    x    x       x    x    x    x      
Table  24.  Comparing  the  gene  deletions  of  the  minimal  gene  sets.  Light  grey  genes  are   
unmodelled  in  the  M.genitalium  whole-cell  model.  Dark  grey  genes  cause  the   
simulation  to  crash  when  deleted  on  our  implementation  (using  Matlab  R2013B  on   
University  of  Bristol  BlueGem’s  supercomputer  (Section  3.4)).  x  =  a  gene  deletion   




5.3.2 Analysing  the  Minimal  Gene  Sets   
A  comparison  of  six  of  the  minimal  gene  sets  (the  protocell  minimal  gene  sets   
(Nashville,  Fujisawa)  were  excluded  due  to  their  much  more  reduced  size)  showed  that   
they  had  96  genes  in  common  (Table  23,  Common  Column).  Of  these  96  genes,  87   
were  classified  as  essential  by  single  gene  deletion,  eight  were  non-essential,  and  one   
gene  was  unmodelled  (Table  6).  The  87  essential  genes  identify  the  cellular  functional   
groups  that  the  six  minimal  gene  sets  agree  are  essential:  DNA  (repair,  supercoiling,   
chromosome  replication,  synthesis  and  modification  of  nucleotides,  sigma  factors,   
ligation,  transcription  termination,  and  DNA  polymerase);  RNA  (ribosome  proteins,   
initiation  factors  for  translation,  tRNA  modification,  ribonucleases,  and  RNA   
polymerase);  and  cellular  processes  (protein  folding  and  modification,  shuttling  of   
proteins,  protein  membrane  transport,  production  and  recycling  of  metabolic  substrates   
and  intermediates,  redox  signalling,  oxidation  stress  response,  and  the  pyruvate   
dehydrogenase  complex).  Of  the  eight  non-essential  genes,  four  (MG_048,  MG_072,   
MG_170,  MG_297)  are  associated  with  the  SecYEG  complex  171   (which  moves  protein   
across  or  inserts  them  into  the  cell  membrane),  while  MG_172  removes  the  start  codon   
that  initiates  protein  synthesis  from  synthesised  nascent  proteins,  MG_305  and   
MG_392  assist  in  late  protein  folding,  and  MG_425  processes  ribosomal  RNA   
precursors.  Although  these  eight  genes  are  classified  as  singly  non-essential,  by  single   
gene  deletion  in-silico  6   and  in-vivo  61 ,  they  all  play  a  part  in  essential  functions  within   
the  cell,  hence  their  inclusion  in  published  minimal  gene  sets.   
  
A  comparison  of  the  genes  deleted  from  the  M.genitalium  genome  by  all  the  eight   
minimal  gene  sets  showed  that  they  shared  14  gene  deletions  in  common  (Table  24,   
Agreed  Column).  The  function  of  these  genes  includes:  fructose  import,  activation  of   
host  immune  response,  chromosomal  partition,  amino  acid  transport,  antibody  binding,   
phosphonate  transport,  external  DNA  uptake,  DNA  repair,  rRNA  modification,   
membrane  breakdown,  toxin  transport,  quorum  sensing,  and  a  restriction  enzyme.   
These  have  all  been  previously  classified  as  non-essential  for  cell  survival  by  single  gene   
deletion  in-silico  6   and  in-vivo  61 ,  hence  their  exclusion  from  the  minimal  gene  sets.  I   
deleted  these  14  common  genes  to  produce  an  ‘Agreed  set’  which  was  simulated  in   
addition  to  the  minimal  gene  sets  from  the  literature.      
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5.3.3 Testing  the  Minimal  Gene  Sets   
I  simulated  each  minimal  gene  set  in  the  M.genitalium  whole-cell  model  and  found  that   
every  set,  including  the  Agreed  set,  produced  a  non-dividing  in-silico  cell.  Each  minimal   
gene  set  was  simulated  ten  times  per  experiment,  and  each  experiment  was  repeated   
three  times  (Table  25).  These  cells  showed  faults  in  metabolism,  resulting  in  no  DNA   
replication,  RNA  production,  protein  production,  growth,  or  successful  cell  division.     
  
An  initial  analysis  found  that  every  one  of  the  sets  from  the  literature  deleted  essential   
genes  (as  previously  defined  in  Section  1.3.2.a).  The  number  of  essential  genes  deleted   
varied  depending  on  the  set:  Nashville  deleted  121,  Fujisawa  deleted  112,  Guelph   
deleted  107,  Valencia  deleted  69,  Bethesda  deleted  34,  Rockville  and  Rockville  2  both   
deleted  9,  and  Stanford  deleted  3.  This  follows  a  similar  pattern  to  in-silico  genome  size   
(Section  5.3.1),  protocell  minimal  gene  sets  removed  the  largest  number  of  essential   
genes  and  comparative  genomics  removed  greater  numbers  of  essential  genes  the   
higher  the  number  of  genomes  compared.  However,  single  gene  deletion  minimal  gene   
sets  also  removed  essential  genes.  This  is  likely  due  to  transposon  mutagenesis  issues   
at  the  time  of  the  minimal  gene  set  design.  Rockville  labelled  six  genes  as  non-essential   
and  so  were  excluded  from  the  minimal  gene  set  in  1999,  but  were  later  found  to  be   
essential  by  Rockville  2  in  2006.  Even  as  recently  as  2016,  Hutchison  et  al.  12   had  to   
make  major  improvements  to  their  transposon  mutagenesis  protocol  while  producing   
JCVI-Syn3.0 ,  due  to  incorrect  identification  of  essentiality.  Stanford  removed  MG_203,   
MG_250,  and  MG_470,  likely  due  to  averaging  multiple  simulation’s  data  together   
before  computationally  assessing  (Section  4.4.1).  These  are  three  genes  that  my   




Repetitions    1    2    3   
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Bethesda    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    -    No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    -    No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Rockville    No  Division   No  Division   No  Division  
Fujisawa    -    No  Division   -   
Fujisawa    -    -    -   
Fujisawa    -    -    No  Division  
Fujisawa    No  Division   -    -   
Fujisawa    -    -    -   
Fujisawa    No  Division   No  Division   -   
Fujisawa    No  Division   -    -   
Fujisawa    -    -    -   
Fujisawa    -    No  Division   -   
Fujisawa    -    -    -   
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Rockville  2    No  Division   No  Division   No  Division  
Nashville    -    No  Division   -   
Nashville    -    No  Division   -   
Nashville    -    -    No  Division  
Nashville    -    -    -   
Nashville    -    No  Division   -   
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Repetitions    1    2    3   
Nashville    -    -    -   
Nashville    -    -    -   
Nashville    -    -    -   
Nashville    No  Division   No  Division   -   
Nashville    -    -    -   
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Stanford    No  Division   No  Division   No  Division  
Guelph    -    No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Guelph    No  Division   No  Division   No  Division  
Valencia    No  Division   No  Division   No  Division  
Valencia    -    No  Division   No  Division  
Valencia    -    -    -   
Valencia    -    -    No  Division  
Valencia    -    -    No  Division  
Valencia    -    -    -   
Valencia    No  Division   -    -   
Valencia    -    No  Division   -   
Valencia    -    -    -   
Valencia    -    -    -   
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
Agreed    No  Division   No  Division   No  Division  
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Table  25.  Simulating  the  minimal  gene  sets  as  represented  in  the  literature  in  the   
M.genitalium  whole-cell  model.   -  =  a  failed  simulation  due  to  supercomputer  error.   
  
5.3.4 Repairing  the  Minimal  Gene  Sets     
I  reintroduced  the  essential  genes  to  the  minimal  gene  sets,  in  an  attempt  to  restore   
in-silico  division.  Based  on  previous  research  (Section  4.4.7),  I  also  reintroduced  low   
essential  genes  (e.g.  if  the  gene  is  dispensable  in  some  contexts,  i.e.  redundant   
essential  genes  and  gene  complexes  10 ),  knowing  that  they  would  impact  the  in-silico  
cell’s  ability  to  divide.  Each  “repaired”  minimal  gene  set  was  simulated  ten  times  per   
experiment,  and  each  experiment  was  repeated  three  times  (Table  26).  By  reintroducing   
these  genes,  specific  to  each  set  (Table  27),  each  set  produced  a  dividing  cell  in-silico   





Repetitions    1    2    3   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Bethesda    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Rockville    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    No  Division   Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Fujisawa    Dividing    No  Division   Dividing   
Fujisawa    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Rockville  2    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
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Repetitions    1    2    3   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    Dividing    No  Division   Dividing   
Nashville    Dividing    Dividing    Dividing   
Nashville    No  Division   Dividing    No  Division  
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    No  Division   Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Stanford    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    No  Division  
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    No  Division  
Guelph    Dividing    Dividing    Dividing   
Guelph    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    No  Division   Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Valencia    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
Agreed    Dividing    Dividing    Dividing   
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Table  26.  Simulating  the  minimal  gene  sets  with  genes  reintroduced  to  “repair”  them  in   
the  M.genitalium  whole-cell  model.  The  reintroduced  genes  are  listed  in  Table  27.   
  
  
   Protocells    Comparative  Genomics    Single  Gene  Knockouts   
   Nashville    Fujisawa    Guelph    Bethesda   Valencia    Stanford    Rockville  2    Rockville   
MG_001    r    r                     
MG_003    r    r                     
MG_004    r    r                     
MG_006    r    r    r                  
MG_007    r    r    r    r               
MG_008    r    r                     
MG_013    r    r    r       r            
MG_019    r    r                     
MG_022    r    r    r    r    r            
MG_023    r       r                  
MG_026       r    r                  
MG_031    r    r    r    r               
MG_034    r    r    r    r    r            
MG_037    r    r    r    r    r            
MG_038    r       r       r            
MG_039    r    r    r    r    r    r    r    r   
MG_041    r       r    r               
MG_042    r    r    r       r            
MG_043    r    r    r       r            
MG_044    r    r    r       r            
MG_045    r    r    r       r            
MG_047    r    r                     
MG_049    r    r    r       r          r   
MG_051    r    r    r    r    r       r    r   
MG_053    r    r    r       r            
MG_058    r    r                     
MG_066    r    r                r      
MG_069    r       r    r               
MG_071    r    r    r       r            
MG_077    r    r    r       r            
MG_078    r    r    r       r            
MG_079    r    r    r       r            
MG_080    r    r    r       r            
MG_084    r    r       r               
MG_090          r                  
MG_091    r    r    r       r            
MG_093          r                  
MG_094    r    r                     
MG_098    r    r    r    r    r            
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   Nashville    Fujisawa    Guelph    Bethesda   Valencia    Stanford    Rockville  2    Rockville   
MG_099       r    r    r    r            
MG_100       r    r    r    r            
MG_102    r    r                     
MG_104    r    r    r       r            
MG_106    r    r    r       r            
MG_107    r    r                     
MG_111    r                        
MG_112    r    r                r      
MG_114    r       r       r       r      
MG_118    r    r    r       r            
MG_124    r    r                     
MG_128    r    r    r    r    r            
MG_137    r    r    r    r    r            
MG_141    r    r                     
MG_145    r    r                     
MG_153          r                  
MG_159          r                  
MG_164          r                  
MG_169       r    r                  
MG_171       r                     
MG_174          r                  
MG_177    r                        
MG_179    r    r    r    r    r            
MG_180    r    r    r       r            
MG_181    r    r    r    r    r            
MG_182    r    r    r       r          r   
MG_195       r    r                  
MG_201    r    r    r                  
MG_203    r    r    r       r    r         
MG_204    r    r    r       r            
MG_212    r    r    r                  
MG_215    r       r                  
MG_216    r       r                  
MG_221    r    r    r       r            
MG_224    r    r                     
MG_228    r    r    r                  
MG_229    r    r    r                  
MG_230    r    r    r    r               
MG_231    r    r                     
MG_232          r                  
MG_238    r    r    r       r       r      
MG_245    r    r    r       r            
MG_249    r                        
MG_250    r    r             r         
MG_251          r                  
178   
  
   Nashville    Fujisawa    Guelph    Bethesda   Valencia    Stanford    Rockville  2    Rockville   
MG_254    r    r                     
MG_258       r                     
MG_261    r    r                     
MG_270    r    r    r       r            
MG_271    r    r    r       r       r      
MG_272    r    r    r       r            
MG_273    r    r    r       r            
MG_274    r    r    r       r            
MG_275    r    r    r       r            
MG_276    r    r    r       r            
MG_278    r    r    r       r            
MG_282    r    r                     
MG_283          r                  
MG_287    r    r    r       r            
MG_289    r    r    r       r    r    r      
MG_290    r    r    r       r    r    r      
MG_291    r    r    r       r    r    r    r   
MG_295    r    r                   r   
MG_299    r    r    r       r            
MG_300    r                        
MG_301    r                        
MG_302    r    r    r    r    r            
MG_303    r    r    r    r    r            
MG_304    r    r    r    r    r            
MG_305    r    r                     
MG_311             r               
MG_315    r    r    r    r       r    r      
MG_321    r    r    r    r    r            
MG_322    r    r    r       r            
MG_323    r    r    r    r    r            
MG_325          r                  
MG_330    r    r    r       r            
MG_340    r                        
MG_341    r                        
MG_342    r    r    r    r    r            
MG_345                         r   
MG_347    r    r    r       r            
MG_351          r                  
MG_357    r    r    r       r            
MG_363          r                  
MG_365          r       r            
MG_367    r    r                r      
MG_368    r    r    r    r    r            
MG_372    r    r    r    r    r          r   
MG_375          r                  
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   Nashville    Fujisawa    Guelph    Bethesda   Valencia    Stanford    Rockville  2    Rockville   
MG_379    r    r    r                  
MG_382    r    r    r       r            
MG_383    r    r    r       r            
MG_384    r    r                     
MG_387    r    r    r                  
MG_394    r    r                   r   
MG_396    r    r    r    r               
MG_407    r                        
MG_419    r    r    r    r    r            
MG_424    r                        
MG_426          r                r   
MG_427    r    r    r       r    r         
MG_429    r          r               
MG_430    r       r                  
MG_431    r                        
MG_434    r    r    r       r            
MG_435       r                     
MG_437    r       r             r      
MG_444                r            
MG_445       r                     
MG_453    r    r    r       r            
MG_458    r    r    r                  
MG_465       r    r                  
MG_466          r                  
MG_469    r    r          r            
MG_470    r    r    r    r    r    r       r   
MG_473    r    r    r    r    r            
MG_481    r    r    r    r    r            
MG_517    r    r    r    r    r            
MG_522          r                  
Table  27.  Comparing  the  gene  reintroductions  made  to  make  the  minimal  gene  sets   
produce  in-silico  dividing  cells.  Light  grey  genes  are  low  essential  genes  in  the   




   Design  approach    In-silico  gene  deletions  
(cell  did  not  divide)   
In-silico  gene  deletions  
(cell  divided)   
Genes  reintroduced   Size  of  in-silico   
genome   
Nashville    Protocell   270    142    128    217   
Fujisawa    Protocell   261    141    120    218   
Guelph    Comparative   
Genomics  
241    129    112    230   
Valencia    Comparative   
Genomics  
185    110    75    249   
Stanford    Single  Gene   
Deletions   
117    109    8    250   
Bethesda    Comparative   
Genomics  
118    82    36    277   
Rockville  2    Single  Gene   
Deletions   
57    45    12    314   
Rockville    Single  Gene   
Deletions   
53    43    10    316   
Agreed    -    14    13    1    346   
Table  28.  Minimal  gene  sets  that  produce  dividing  in-silico  cells.  After  the  reintroduction   
of  essential  and  low  essential  genes.   
  
To  repair  the  Agreed  set,  one  low  essential  gene  had  to  be  reintroduced  (MG_291),   
which  is  involved  in  phosphonate  transport  with  two  other  genes  (MG_289,  MG_290).   
The  Agreed  set  also  removed  MG_412,  a  gene  that  along  with  MG_410  and  MG_411,   
is  involved  with  phosphate  transport.  By  disrupting  both  these  processes,  the  Agreed   
set  produced  an  in-silico  cell  that  did  not  have  a  source  of  phosphate.  This  relationship   
has  been  established  previously  (Section  4.4.7,  Table  16).  MG_291  had  to  be   
reintroduced  in  every  minimal  gene  set  apart  from  Bethesda,  which  does  not  remove   
phosphate  transport  (MG_410,  MG_411,  MG_412).  MG_289  and  MG_290  also  had  to   
be  reintroduced  in  six  of  the  minimal  gene  sets.   
  
I  identified  31  genes  that  were  reintroduced  into  at  least  five  of  the  minimal  gene  sets   
(Table  29).  26  were  classified  as  essential  and  5  as  low  essential.  The  cellular  functional   
groups  that  the  minimal  gene  sets  needed  reintroducing  were:  DNA  (polymerase  delta  /   
gamma  /  tau  subunits,  introduction  of  thymidine  into  DNA,  rescue  of  pyrimidine  bases   
for  nucleotide  synthesis,  chromosome  segregation);  RNA  (polymerase  subunit  delta,   
tRNA  modification,  50S  and  30S  ribosomal  subunits);  transporters  (cobalt,   
phosphonate,  potassium);  production  (NAD,  flavin,  NADP,  fatty  acid/phospholipids);   






1    MG_022    11    MG_203    21    MG_321   
2    MG_034    12    MG_238    22    MG_323   
3    MG_037    13    MG_271    23    MG_342   
4    MG_039    14    MG_289    24    MG_368   
5    MG_051    15    MG_290    25    MG_372   
6    MG_098    16    MG_291    26    MG_419   
7    MG_128    17    MG_302    27    MG_427   
8    MG_137    18    MG_303    28    MG_470   
9    MG_179    19    MG_304    29    MG_473   
10   MG_181    20    MG_315    30    MG_481   
            31    MG_517   
Table  29.  31  genes  that  were  reintroduced  into  at  least  five  minimal  gene  sets.  They   
are  all  classified  as  essential  (previously  classified  by  single  gene  deletion  in-silico  8,31 ),   
apart  from  MG_039,  MG_289,  MG_290,  MG_291,  MG_427,  which  are  classified  as  low   
essential  (previously  classified  by  single  gene  deletion  in-silico  31 ).   
  
Of  the  26  essential  genes,  19  did  not  need  to  be  reintroduced  into  the  single  gene   
deletion  minimal  gene  sets  (Stanford,  Rockville,  Rockville  2)  as  they  had  not  been   
previously  deleted.  Two  of  these  19  genes,  MG_137  (involved  in  cell  wall  production  of   
mycobacteria)  and  MG_517  (produces  fundamental  components  for  plasma  membrane   
stability)  are  specifically  essential  for  Mycoplasma  species,  which  were  not  identified  as   
essential  by  the  other,  non  species-specific,  methodologies.  Additionally,  five  of  the  19   
genes  were  involved  in  cobalt  transport.  Cobalt  is  used  in  the  cell  to  produce  cobalamin   
(otherwise  known  as  vitamin  B12),  an  enzyme  cofactor  which  increases  the  reaction   
rates  of  DNA  synthesis,  fatty  acid  metabolism,  and  amino  acid  metabolism.  This  was   
also  not  identified  as  essential  by  the  other  design  methodologies.   
  
Interestingly,  of  the  five  low  essential  genes,  Rockville  and  Bethesda  did  not  delete  four   
out  of  the  five  genes  and  Rockville  2  did  not  delete  two  of  the  five  genes.  It  is  likely  that   
Bethesda  did  not  remove  the  low  essential  genes  due  to  the  direct  comparison  with  a   
closely  related  species,  the  genes  with  low  essentiality  being  conserved  to  a  greater   
degree  than  non-essential  genes.  I  would  speculate  that  Rockville  removed  less  low   
essential  genes  than  Rockville  2  due  to  Rockville  using  a  transposon  mutagenesis   
protocol  with  less  precise  results  (as  stated  by  Rockville  2  83 ),  cells  were  grown  in  mixed   
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pools  with  DNA  isolated  from  these  mixtures  rather  than  from  isolated  pure  colonies  of   
cells.  This  may  have  led  to  low  essential  genes  that  should  have  been  labelled  singly   
non-essential  genes  being  incorrectly  labelled  as  singly  essential  genes.   
  
I  investigated  further  the  gene  reintroductions  to  the  protocell  sets,  as  they  could  outline   
additional  cellular  requirements  for  the  successful  future  unification  of  independent   
protocell  systems.  The  genes  reintroduced  to  the  Nashville  set  repaired  functions  that   
had  been  reduced  (translation,  glycolytic  process,  protein  folding)  and  restored   
functions  that  had  been  removed  including:  cell  (division,  cycle,  transport,  redox   
homeostasis),  DNA  (topological  change,  transcription),  rRNA  processing  (including   
pseudouridine  synthesis),  protein  transport,  and  cellular  processes  (carbohydrate   
metabolic,  glycerol  metabolic,  fatty  acid  biosynthesis,  UMP  salvage)  (Supplementary   
Data  27).  The  glycolytic  process  had  the  most  change,  with  10  of  11  genes  being  
reintroduced,  and  DNA  repair  had  the  least,  with  only  one  gene  being  reintroduced   
(MG_254),  however,  this  did  reintroduce  single  strand  DNA  break  repair.  The  genes   
additionally  reintroduced  to  the  Fujisawa  set  included  tRNA  processing  and  protein   
folding  (Supplementary  Data  28),  with  8  out  of  10  DNA  replication  genes  reintroduced.   
  
The  protocell  minimal  gene  sets  (Nashville  and  Fujisawa)  produced  the  smallest   
genomes  in-silico  (Table  28,  Figure  16),  once  they  were  made  functional,  but  they   
required  the  most  number  of  genes  to  be  reintroduced.  The  comparative  genomics   
minimal  gene  sets  (Guelph,  Valencia,  Bethesda)  produce  larger  genomes  in-silico  but   
required  less  genes  to  be  reintroduced.  The  smaller  the  number  of  genomes  compared   
in  their  design,  the  less  genes  had  to  be  reintroduced  to  make  dividing  in-silico  cells.   
Interestingly,  Stanford  produced  a  smaller  in-silico  genome  than  Bethesda,  as  the   
Stanford  minimal  gene  set  did  not  target  unmodelled  gene  deletions  and  only  required   







Figure  16.  Repairing  minimal  gene  sets  from  the  literature  to  produce  dividing  in-silico   
cells.  Minimal  gene  sets  are  shown  from  a  range  of  design  methodologies,  produced   
across  the  past  twenty  years,  and  organised  by  the  size  of  genome  they  produce  in  the   
whole-cell  model.  None  of  the  original  genome  designs  (light  grey  bars)  produced  a   
dividing  in-silico  cell  in  the  M.genitalium  whole-cell  model.  By  reintroducing  essential   





5.4 Discussion   
I  tested  minimal  gene  sets  from  the  literature  6,55,59–61,74–76   for  the  first  time,  finding  that   
they  produced  in-silico  cells  that  did  not  divide,  but  by  reintroducing  specific  essential   
and  low  essential  genes  the  sets  could  produce  dividing  in-silico  cells.   
  
It  currently  appears  that  there  is  little  to  be  learned  for  minimal  genome  research  from   
modelling  protocell  minimal  gene  sets  in  the  M.genitalium  whole-cell  model,  given  the   
amount  of  genetic  modifications  required  to  produce  a  viable  in-silico  cell.  The   
comparative  genomics  minimal  gene  sets  are  closest  to  producing  dividing  cells   
in-silico  when  a  lower  number  of  genomes  are  compared.  The  single  gene  deletion   
minimal  gene  sets  required  the  least  genes  to  be  reintroduced,  so  could  be  considered   
closest  to  viable  in-silico  minimal  genomes  from  the  outset,  but  without  the  ability  to   
identify  low  essential  genes,  minimal  gene  sets  designed  with  this  methodology  will  still  
require  correcting.     
  
The  identification  of  genes  to  reintroduce  was  straightforward  given  the  previous   
labelling  of  M.genitalium  in-silico  essential  and  low  essential  genes,  which  would  have   
been  required  if  the  information  had  not  already  been  available.  The  results  from  this   
work  reinforce  a  broader  trend  of  moving  away  from  universal  minimal  genomes  81   to   
species-specific  minimal  gene  sets  and  minimal  genomes  (Sections  1.3.2.c,  1.3.5),  and   
the  need  to  specifically  identify  low  essential  genes  and  their  interactions.   
  
This  research  has  the  same  limitations  associated  with  the  use  of  the  M.genitalium   
whole-cell  model,  and  the  same  uncertainty  around  the  impact  of  the  unmodelled   
genes  on  in-vivo  experiments,  as  stated  previously  (Section  4.5).   
  
This  research  advances  minimal  genome  design.  The  computational  predictions  I  have   
produced  need  to  be  tested  in  living  cells,  but  with  the  advancement  of  gene  synthesis   
and  genome  transplantation  in  other  Mycoplasma  species  11,62,113,114,172,173   this  is   







Chapter  6  -  E.coli  Genome  Engineering:  in-silico  and  in-vivo     
6.1 Aims   
The  E.coli  whole-cell  model  being  developed  by  the  Covert  Lab  is  the  second   
whole-cell  model  152   and  presents  the  first  opportunity  to  test  whole-cell  model  results   
in-vivo ,  due  to  the  difficulty  of  using  M.genitalium  in-vivo  (Section  1.3.2.c).  I  installed  the   
E.coli  whole-cell  model  on  the  University  of  Bristol’s  BlueCrystal  supercomputer,  in  the   
first  steps  towards  combining  the  Minesweeper  algorithm  with  the  E.coli  whole-cell   
model.     
  
6.2 Implementing  and  Running  the  E.coli  whole-cell  Model   
6.2.1 Implementing  the  E.coli  whole-cell  Model   
The  E.coli  whole-cell  model  (Section  1.3.4.a)  is  currently  under  active  development  at   
the  Covert  Group,  Stanford.  They  have  made  a  release  snapshot  of  it  available  for   
researchers  outside  of  the  group  in  advance  of  its  publication.  The  M.genitalium   
whole-cell  model  was  difficult  to  use  even  in  its  published  state.  Although  the  E.coli   
whole-cell  model  shows  remarked  improvement  in  usability,  it  is  still  at  an  early  stage  of   
development  and  implementing  it  on  the  University’s  BlueCrystal  supercomputer  took   
several  months.     
    
6.2.2 Issues  with  Installing  the  E.coli  whole-cell  Model   
The  current  installation  instructions  (Oct  29 th   2019)   
( github.com/CovertLab/WholeCellEcoliRelease/blob/master/docs/create-pyenv.md )  for   
the  E.coli  whole-cell  model  have  improved  from  the  original  drafts  (June  12 th   2019),  but   
these  instructions  are  still  based  on  a  Slurm  rather  than  PBS  supercomputer  queueing   
system  and  assume  advanced  user  controls  which  are  not  available  to  users  of  the   
University  of  Bristol’s  BlueCrystal.     
  
The  E.coli  whole-cell  model  uses  FireWorks  (Section  6.2.3),  a  workflow  management   
tool,  to  organise  and  conduct  simulations.  This  requires  the  creation  of  an  online  
database  (specifically  a  MongoDB  database)  where  information  can  be  stored  and   
retrieved  by  different  computers  running  FireWorks.  The  provider  of  online  databases   
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(MLab)  used  by  the  Covert  Lab  has  been  acquired  since  they  started  development.  The   
implementation  of  the  newly  renamed  product  MongoDB  Atlas  is  substantially  different   
from  MLab’s  previous  offering  and  led  to  a  host  of  issues.  The  solution  I  found  was  to   
use  Heroku  (a  cloud  application  platform)  to  create  my  own  version  of  MLab’s  online   
database  ( elements.heroku.com/addons/mongolab )  and  then  proceed  with  the   
installation  as  described  by  the  Covert  Group.     
  
  
To  run  FireWorks,  you  need  to  create  .yaml  files  (detailed  in  Section  6.2.3)  that  define   
where  the  online  database  is  and  what  information  is  required  by  the  supercomputer  to   
run  simulations.  Compared  to  the  original  documentation,  I  had  to  create  a  PBS  queue   
version  of  the  my_qadapter.yaml  file.  In  addition,  I  had  to  add  additional  arguments  to  
scripts  that  start  the  FireWorks  process,  giving  the  location  of  the  .yaml  files:   
LAUNCHPAD_FILE='/newhome/jr0904/wholecell/WholeCellEcoliRelease/wholecell/fir 
eworks/my_launchpad.yaml'     
  
qlaunch  -r  -l  my_launchpad.yaml  -w  my_fworker.yaml  -q  my_qadapter.yaml  . .   
  
There  was  also  a  step  missing  from  the  documentation  due  to  structural  differences   
between  the  development  version  of  the  model  and  the  release  snapshot.  The  release   
snapshot  version  of  the  model  could  not  find  the  files  it  needed  to  run  simulations,  so  I   
had  to  tell  the  model  where  its  main  directories  were,  using  one  of  the  installed  python   
tools:   
pyenv  virtualenvwrapper   
add2virtualenv  .     
  
Likewise,  the  model  could  not  find  the  tools  it  needed  from  the  supercomputer  to  run   
simulations.  I  could  not  tell  the  model  where  to  find  the  files  directly,  as  that  would   
require  changing  a  number  of  different  parts  of  the  model  to  search  in  specific  
BlueCrystal  locations,  rather  than  conduct  a  general  search  around  the  supercomputer.   
Thanks  are  due  to  Dee  (Ms  Dianaimh  Greene)  of  the  Advanced  Computing  Research   
Centre,  Bristol,  who  confirmed  my  hypothesis  and  provided  the  syntax  for  solving  this   
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final  issue.  This  resulted  in  step  four  of  the  installation  process,  modifying  the  startup   
process  to  load  specific  tools  from  the  supercomputer.  As  these  tools  (git  and  gcc)  are   
pre-loaded,  the  model  is  capable  of  finding  them  through  general  searching:   
~/.bash_profile:   
module  add  tools/git-2.22.0   
module  add  languages/gcc-7.1.0   
  
6.2.3  Using  the  FireWorks  workflow  tool   
FireWorks  is  an  open-source  tool  for  defining,  managing,  and  executing  workflows,   
compatible  with  Python  and  supercomputer  queueing  systems  174,175 .  Workflows  are   
defined  as  a  number  of  tasks  (Firetasks)  within  a  hierarchy  of  jobs  (Fireworks).  These   
are  uploaded  to,  stored,  and  managed  on  an  online  database  (the  LaunchPad).   
Computers  or  supercomputers  (Fireworkers)  connect  to  the  online  database  (the   
Launchpad),  retrieve  jobs  (Fireworks),  execute  them  either  locally  or  on  the   
supercomputer  queuing  system,  and  record  the  results  on  the  online  database.  The   
Fireworkers  can  be  set  to  keep  fetching  and  launching  Fireworks  until  the  workflow  is   
complete.  This  allows  you  to  have  multiple  supercomputers  working  together  to   
complete  the  same  workflow,  running  Fireworks  in  parallel.  Workflows  can  also  be   
paused  and  restarted,  and  Fireworks  rerun,  without  causing  errors.     
To  run  FireWorks,  you  have  to  create  three  .yaml  files.  The  first,  my_fworker.yaml,   
names  and  allocates  the  current  computer  as  a  Fireworker:   
name:  default  fireworker   
category:  ''   
query:  '{}'   
The  second,  my_launchpad.yaml,  provides  the  directions  and  login  information  for  the   
online  database  (the  Launchpad):   
logdir:  /newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/logs/launchpad   
host:  ds345028.mlab.com   
name:  heroku_llcd42gj   
username:  squishybinary   
password:  *********   
port:  45028   
strm_lvl:  INFO   
user_indices:  []   
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wf_user_indices:  []   
The  third,  my_qadapter.yaml,  provides  information  about  what  queueing  system  the   
supercomputer  uses,  where  the  other  .yaml  files  are  located,  and  what  information  the   
supercomputer  requires  to  accept  a  job:      
logdir:  /newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/logs/qadapter   
_fw_name:  CommonAdapter   
_fw_q_type:  PBS   
rocket_launch:  rlaunch  -w   
/newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/my_fworker.yaml  -l   
/newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/my_launchpad.yaml   
singleshot   
nnodes:  1   
ppnode:  1   
walltime:  '10:00:00'   
queue:  'veryshort'   
account:  'jr0904'   
job_name:  'jr0904ecoli'   
email:  'joshua.rees@bristol.ac.uk'   
notification_options:  'bea'   
pre_rocket:  null   
post_rocket:  null   
  
The  online  database  (the  Launchpad)  records  the  status  of  Fireworks  and  workflows  as:   
fizzled  (the  Firework  has  failed,  it  was  executed  but  threw  an  error  during  the  process,  it   
can  be  rerun);  running  (the  Firework  is  currently  running);  and  completed  (the  Firework   
has  successfully  finished  running).  This  can  be  checked  at  any  time,  from  within  the   
fireworks  folder  in  the  E.coli  whole-cell  model:   
#  Get  a  Launchpad  report  as  a  text  file   
lpad  report  -c  fws  -i  months  -n  2  >  NAME_report_fws.txt   
lpad  report  -c  wflows  -i  months  -n  2  >  NAME_report_wflows.txt   
lpad  report  -c  launches  -i  months  -n  2  >  NAME_report_launches.txt   
  
#  Get  Launchpad  to  assess  errors  in  Fireworks  and  save  to  a  text  file   
lpad  introspect  >  NAME_introspection.txt   
  
#  Check  Fizzled  Fireworks  and  rerun   
lpad  get_fws  -s  FIZZLED  -d  all  >  NAME_fizzled.txt   
lpad  rerun_fws  -s  FIZZLED   
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6.2.4 Running  the  E.coli  whole-cell  model  using  FireWorks     
The  E.coli  whole-cell  model  contains  a  script  that  translates  designed  simulations  into   
workflows  of  Fireworks,  which  are  subsequently  uploaded  to  the  online  database,  and   
a  Fireworks  command  that  sets  the  supercomputer  to  fetching  and  launching   
Fireworks,  until  the  simulations  and  subsequent  analysis  are  complete.   
  
To  create  wild  type  E.coli  simulations,  a  description  of  the  simulation  has  to  be  provided   
to  the  fw_queue.py  script,  which  translates  it  into  a  workflow.  This  is  adapted  from  the   
Covert  Group’s  simulation  scripts   
github.com/CovertLab/WholeCellEcoliRelease/blob/master/runscripts/paper/paper_run 
s.sh .  For  example,  to  create  four  wild  type  simulations  running  for  a  single  generation:   
DESC= "WildType_Test_1gen4seed"  \   
VARIANT= "wild  type"  FIRST_VARIANT_INDEX= 0  LAST_VARIANT_INDEX= 0  \   
SINGLE_DAUGHTERS= 1  N_GENS= 1  N_INIT_SIMS= 4  \   
MASS_DISTRIBUTION= 1  GROWTH_RATE_NOISE= 1  D_PERIOD_DIVISION= 1  \   
LAUNCHPAD_FILE= '/newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/my_la 
unchpad.yaml'  \   
python  /newhome/jr0904/wholecell2/wcEcoli/runscripts/fw_queue.py   
  
To  create  E.coli  gene  knockout  simulations,  a  different  simulation  description  is   
provided  to  the  fw_queue.py  script,  which  translates  it  into  a  workflow.  For  example,  to   
create  one  simulation,  knocking  out  gene  metB  (EG10582)  for  two  generations:   
DESC= "KO  Name  EG10582  KO  Index  592"  \   
VARIANT= "geneKnockout"  FIRST_VARIANT_INDEX= 592   
LAST_VARIANT_INDEX= 592  \   
SINGLE_DAUGHTERS= 1  N_GENS= 2  N_INIT_SIMS= 1  \   
MASS_DISTRIBUTION= 1  GROWTH_RATE_NOISE= 1  D_PERIOD_DIVISION= 1  \   
LAUNCHPAD_FILE= '/newhome/jr0904/wholecell2/wcEcoli/wholecell/fireworks/my_la 
unchpad.yaml'  \   





The  Fireworks  command  that  sets  the  supercomputer  (Fireworker)  to  fetching  and   
launching  Fireworks,  is  called  queue  launcher.     
qlaunch  -r  -l  my_launchpad.yaml  -w  my_fworker.yaml  -q  my_qadapter.yaml  rapidfire   
--nlaunches  infinite  --sleep  30  --maxjobs_queue  100     
These  settings  allow  it  to  keep  a  maximum  of  100  Fireworks  in  the  supercomputer   
queue  at  any  one  time,  to  pause  for  thirty  seconds  between  each  Firework  submission   
to  the  queue  (allowing  the  supercomputer  to  keep  up),  and  to  launch  an  infinite  number   
of  Fireworks  collected  from  the  Launchpad  (i.e.  until  the  simulations  and  subsequent   
analysis  are  complete).   
  
The  simulation  description  and  fireworks  command  are  run  on  the  supercomputer  by  
writing  them  into  a  bash  script,  which  I  call  FireWorksBoxes   
( github.com/squishybinary/Ecoli_whole-cell_model_FireWorksBoxes ).  This  script  is   
uploaded  to  the  supercomputer  and  left  running  until  all  the  simulations  are  complete.     
  
6.3 In-silico  Results   
Following  the  successful  setup  of  the  E.coli  whole-cell  model  and  FireWorks  on   
BlueCrystal,  I  successfully  conducted  wild  type  simulations  and  single  gene  knockout   
simulations  of  all  1214  implemented  genes.  The  wildtype  simulations  were  conducted   
for  five  generations  (the  minimum  number  of  generations  that  the  Covert  Group  has   
been  conducting  is  four  generations),  whereas  the  single  gene  knockout  simulations   
were  conducted  for  two  generations  as  a  trade-off  between  computational  space   
restrictions  and  the  need  for  multiple  generations  to  interpret  gene  essentiality  (Section   
4.4.8).     
  
Figure  17  shows  all  28  wild  type  E.coli  in-silico  cells  simulated  to  date.  All  these   
simulations  were  continued  for  five  generations,  successfully  producing  dividing  cells  at   





Figure  17.  Overlay  of  28  E.coli  whole-cell  model  simulations.  These  are  wild  type   
simulations  running  for  five  generations.  Changes  in  the  mass  of  the  cell,  protein,  rRNA,   
mRNA,  and  DNA  are  plotted.   
  
Of  the  1214  modelled  genes  that  were  knocked  out  in  individual  in-silico  cells  for  two   
generations,  688  modelled  genomes  successfully  produced  output  i.e.  simulation  data   
and  automated  graphs  (Figure  18).  These  knockouts  are  non-essential  genes,  which  do   
not  prevent  the  cells  from  dividing  regardless  of  the  initial  conditions  of  the  cell.   
However,  this  indicates  that  the  current  release  of  the  E.coli  whole-cell  model  does  not   
have  a  designated  output  for  cells  that  fail  to  divide.  Those  that  do  not  divide,  do  not   
produce  a  subsequent  generation  and  so  do  not  produce  any  automated  graphs  
(which  occurs  after  all  generations  are  complete).  Each  of  these  526  genes  will  have  to   
be  assessed  individually  to  see  whether  the  first  or  second  generation  failed  to  divide,   
and  if  a  cause  can  be  determined.  Currently,  I  can  infer  that  the  genes  are  either  high  or   
complete  essential  genes  that  prevent  division  of  the  cell,  prior  or  after  a  single   




Figure  18.  Comparing  the  plots  of  three  single  gene  knockouts  in  the  E.coli  whole-cell   
model.  These  simulations  ran  for  two  generations  and  plotted  changes  in  the  mass  of   




Further  simulations  can  be  run  in  the  future,  to  check  how  the  single  gene  knockouts   
perform  for  one  generation  and  five  generations,  to  gain  more  understanding  about   
each  gene’s  essentiality.  Currently  this  work  has  to  wait,  as  I  have  encountered  the   
more  mundane  issue  of  exceeding  my  supercomputer  storage  capacity.   
  
For  the  526  genes  that  did  not  produce  any  automated  graphs  one  of  four  errors  was   
recorded  in  the  online  database  (the  Launchpad):   
● assert(np.all(moleculeCounts  +  np.dot(self.stoichMatrix,  rxnFluxes)  >=  0   
(AssertionError)   
● GLP_EFAIL:  Solver  failure   
● Negative  value(s):  WATER  in  RnaDegradation,  WATER  in  ProteinDegradation"   
● UniqueObjectsContainerException:  Object  set  is  empty   
These  are  all  computational  errors,  rather  than  biological  errors,  which  are  difficult  to   
interpret  without  the  model  creators'  help.  As  previously  mentioned,  gene  knockout  has   
been  implemented  but  not  tested  (Section  1.3.4.a).  Following  correspondence  with  the   
model  creators,  these  sorts  of  computational  bugs  in  knockout  simulations  are   
expected  as  they  have  not  explored  how  the  model  behaves  in  this  condition  ( personal   
communication ).   
  
6.3.1 In-silico  Issues   
Both  Figure  17  and  18  show  inconsistent  axis  plotting.  Different  labels  are  applied  to   
the  X  axis  (every  hour,  every  half  hour,  or  every  three  quarter  hours)  in  different   
simulations.  The  Y  axis  labels  only  record  the  highest  and  lowest  mass  value  across  the   
five  generations,  the  range  of  these  Y  axis  labels  is  recorded  in  Table  30.  This  means   
the  consistency  seen  in  Figure  17  is  not  representative,  as  the  plots  are  centred  in  a   
relative  position  to  the  highest  and  lowest  mass  values.  This  makes  manual,  visual   
interpretation  difficult  and  automated  comparison  difficult  to  implement.  These  figures   
are  produced  automatically  by  the  E.coli  whole-cell  model.  Modifying  this  graphing  will   






















Lowest    241  -  360    98  -  158    25  -  39    1.4  -  2.4    4.2  -  6.2   
Highest    755  -  922    315  -  378    81  -  100    4.8  -  7.7    13.2  -  16.4   
Table  30.  Range  of  Y  axis  values  across  28  E.coli  whole-cell  model  simulations.  These   
are  wild  type  simulations,  running  for  five  generations   
  
For  the  three  gene  knockouts  in  Figure  18  (EG1007  (A),  EG10183  (B),  EG10207  (C)),   
rRNA  mass  is  shown  to  increase  in  each  generation  of  each  knockout,  but  the  time   
scales  do  not  match,  making  actual  interpretation  difficult.  Additionally,  the  B  and  C   
gene  knockouts  show  similar  protein  mass  behaviour  in  the  second  generation,  but   
they  actually  have  substantially  different  protein  mass  (109.7fg  and  81.23fg),  which  is   
not  easily  observable  from  the  plots.  These  two  examples  demonstrate  that  effective   
intercomparison  of  these  single  gene  knockouts,  as  well  as  comparison  to  wild  type   
cells'  normal  range  of  cellular  performance,  is  not  trivial  using  these  automated  graphs.   
  
6.4 Future  changes  for  using  the  E.coli  whole-cell  Model   
The  first  change  I  would  need  to  make  is  implementing  graphing  with  absolute  axis   
values.  This  requires  identifying  and  extracting  the  simulation  data  that  is  currently  used   
to  generate  the  automated  graphs.  The  absolute  values  for  the  axis  can  be  initially   
decided  by  assessing  the  maximum  values  of  several  hundred  wild  type  simulations   
(which  can  be  adjusted  as  more  simulations  are  conducted),  and  setting  the  minimum   
values  at  zero.     
  
Secondly,  I  would  need  to  modify  the  E.coli  whole-cell  model  to  allow  non  continuous   
multi-gene  editing.  Currently  the  model  allows  the  deletion  of  single  genes,  and  multiple   
genes  within  a  range  (i.e  you  can  delete:  gene  1,  genes  2  -  5,  genes  7-10;  but  you   
cannot  delete  genes  2,  4,  and  5  or  genes  7,  8,  and  10).  To  do  this,  I  need  to  create  a   
version  of  geneknockout.py  that  allows  the  deletion  of  multiple  genes  that  are  not   
ordered  with  a  range.  This  requires  hijacking  the  FIRST_VARIANT_INDEX=N   
LAST_VARIANT_INDEX=N  line  passed  to  fwqueue.py,  instead,  using  it  to  pass  a  row   
number.  This  subsequently  requires  writing  a  parsing  function  in  geneknockout.py  that   
intercepts  the  FIRST_VARIANT_INDEX=N  LAST_VARIANT_INDEX=N  row  number,  and   
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uses  that  to  extract  a  gene  deletion  string  from  a  gene  deletions  text  file  placed  in  a   
specific  location,  which  is  then  passed  to  existing  functions  in  geneknockout.py  to   
process  the  gene  deletions  as  normal.  Alternatively,  I  could  modify  fwqueue.py  to  take   
lists  instead  of  integers  for  the  FIRST_VARIANT_INDEX=N  LAST_VARIANT_INDEX=N ,   
but  this  will  likely  have  knock  on  effects  elsewhere  in  the  model  as  some  functions  rely   
on  these  values  to  be  integers.     
  
Thirdly,  I  would  need  to  automate  the  creation  of  my  version  of  the  graphs  and  the  
creation  of  a  summary  text  file.  This  summary  text  file  needs  to  contain  a  description  of   
the  simulation  (including  the  FireWorksBox  file  name),  the  genes  deleted  (and  the   
associated  row  number),  and  whether  the  cell  divided.  This  information  is  required  so   
that  Minesweeper  can  be  run  with  the  E.coli  whole-cell  model,  and  can  assess  the   
success  of  executed  simulations  and  design  the  next  cycle  of  simulations.     
  
Finally,  I  would  need  to  modify  Minesweeper  so  that  it  can  interpret  this  new  format  of   
summary  text  file,  output  FireWorksBox  bash  scripts  (with  the  correct  row  and   
description)  and  the  associated  gene  deletions  text  file,  and  be  able  to  track  the  new   
results  format  in  the  log.  These  changes  would  allow  me  to  run  the  Minesweeper   
minimal  genome  design  algorithm  with  the  E.coli  whole-cell  model.   
  
6.5 Experimental  Design  for  testing  E.coli  whole-cell  model  results  in-vivo   
6.5.1 Statement  of  Collaboration   
I  supervised  two  undergraduate  students  (Julia  Needham  and  Cameron  Matthews)  for  a   
summer  studentship  and  am  currently  supervising  a  Masters  by  Research  student   
(Jake  Rightmyer).  I  wrote  the  in-vivo  experimental  design,  shortlisted  and  selected  the   
plasmid-based  techniques,  and  trained  and  supervised  the  students.  The  students   
conducted  all  the  laboratory  work  themselves.  An  overview  of  their  work  is  included  in   





6.5.2 Laboratory  Work   
One  of  the  motivations  for  choosing  E.coli  as  the  next  whole-cell  model  was  the  ability   
to  test  its  in-silico  predictions  easily  in-vivo .  The  difficulty  of  using  M.genitalium  in  the  lab   
11,12   is  one  of  the  main  issues  with  using  the  M.genitalium  whole-cell  model.  I  began   
making  preparations  in  advance  of  receiving  access  to  the  E.coli  whole-cell  model,  so   
that  myself  or  other  members  of  the  group  would  be  able  to  test  the  model’s  output  in   
the  lab.  As  the  focus  is  currently  on  minimal  genomes  as  a  proof-of-concept,  this  would   
require  conducting  large-scale  reductions  of  the  E.coli  genome.  As  highlighted   
previously  (Section  1.3.2.d.1.a),  there  are  a  number  of  CRISPR-cas9  homologous   
recombination  plasmid  based  techniques  that  show  promise  for  doing  this  (Table  31),   
all  of  which  benefit  from  reusable  plasmids,  elimination  of  selection  steps,  and  absence   
of  genomic  scar  sites  compared  to  older  techniques.  CRISPR  non  homologous  end   
joining  techniques  would  save  124bp  112   per  deletion,  halving  the  cost  of  DNA  per   
deletion,  but  they  require  an  additional  plasmid  containing  non  homologous  end  joining   
Mycoplasma  genes.   
  
Authors    Jiang  108    Li  107    Pyne  105    Reisch  106    Zhao  109    Zerbini  9   
Availability    AddGene    AddGene    AddGene    AddGene    Contact  Lab    Contact  Lab   
BPs  (>50%  succ)    -    1000  -  12,000    8  -  818    500  -  3000    513  -  1400    30  -  2325   
BPs  (<1%  succ)    -    -    19378    45000    -    -   
Multiplexing    3  (47%)    2  (83%)  3  (23%)   -    3    -    2   
Plasmids    2    2    3    2    1    2   
Retargeting   
Inverse  PCR  /   
BioBrick   
Self  Ligation   
GGA   
pCRISPR   
Ligation  /  BsaI   
CPEC  /  DpnI   
Golden  Gate   
Assembly   
pCRISPR  Ligation  /  
BsaI   
Plasmid  Curing    37°C  /  pMB1    pGRB-p15  /  Bla   37°C  /  None   
37°C  /   
pKDsgRNA-p15  
37°C   
-Cam  /   
SacB(sucrose)   
E.coli  Strain    MG1655    EcPHE    DH5a    MG1655    MG1655  /  DH5a    BL21(DE3)-ompA  
Days     
(n  per  deletion)   














Retargeting  and  




proteins  required  
No  curing?   
5  days  to  start,  
3  days  each  for  n  
deletion   
Shorter  homology   
arms,   
lower  success  rate  
(16%  vs  100%)   
Non-standard  time  
calculation  for   
methodology   
Table  31.  Comparison  of  CRISPR-cas9  homologous  recombination  techniques.   
  
During  my  PhD,  I  supervised  two  undergraduate  students  who  completed  summer   
projects  as  part  of  the  group.  They  attempted  to  test  the  protocol  and  results  of  Zhao  et   
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al.  109 ,  a  CRISPR-cas9  -  lambda  protein  single  plasmid  system  combining  
CRISPR-cas9,  lambda-red  proteins,  guideDNA  and  donorDNA.  This  edits  bacterial   
genomes  by  using  CRISPR-cas9  to  make  a  double  stranded  break  at  a  targeted   
location  via  the  guideDNA  (i.e.  in  this  case  the  poxB  gene),  which  is  then  repaired  by   
homologous  recombination  using  the  donorDNA,  promoted  by  lambda-red  proteins.   
Successful  gene  deletions  are  then  confirmed  by  colony  PCR.  Testing  the  protocol  and   
replicating  the  results  required  growing  up  bacterial  cultures,  constructing  the  plasmid   
from  four  component  parts  (using  Golden  Gate  Assembly  in  E.coli  DH5a),  and  inserting   
the  plasmid  into  E.coli  MG1655  and  triggering  its  activity.     
  
A  new  Masters  by  Research  student  has  recently  joined  the  group.  He  is  continuing  to   
work  on  producing  gene  deletions  in  the  E.coli  genome,  this  time  using  the  no-scar   
method  106   which  is  a  two  plasmid  CRISPR-cas9  homologous  recombination   
technique.  One  plasmid  contains  the  CRISPR-cas9  and  lambda-red  proteins,  which  is   
inserted  into  the  E.coli  cell  for  the  duration  of  the  experimental  series,  and  only   
denatured  when  all  deletions  have  been  completed.  A  second  plasmid  contains  the   
guideDNA.  A  new  version  of  this  plasmid  is  constructed  for  each  deletion  and  is   
inserted  along  with  free  floating  donorDNA.  This  is  expressed  and  then  denatured.  This   
technique  was  chosen  over  the  previous  system  due  to  simpler  plasmid  construction,   
using  a  single  antibiotic,  and  has  plasmid  curing  steps  for  all  plasmids  involved  (Table   
31).  This  work  is  currently  progressing  and,  global  pandemic  allowing,  there  is  the   
potential  for  the  Masters  student  to  test  in-silico  predictions  for  multi-gene  deletions   
in-vivo  before  the  end  of  their  project.     
  
6.6 Discussion   
Planned  research  that  could  be  completed  in  the  future  includes:  modifications  to  the   
E.coli  whole-cell  model  (Section  6.4)  to  make  it  amenable  to  the  Minesweeper   
algorithm;  developing  and  standardising  an  analysis  process  for  E. coli  whole-cell  model   
data;  the  production  of  multi-generational  single  gene  knockouts  for  the  E.coli   
whole-cell  model  using  the  analysis  process;  the  application  of  the  Minesweeper   
minimal  genome  design  algorithm  to  the  E.coli  whole-cell  model;  and  the  testing  of   






Chapter  7  -  General  Discussion   
7.1 Summary   
Prior  to  the  start  of  this  PhD,  the  development  of  whole-cell  mathematical  models  6   and   
CRISPR-cas9  gene  editing  techniques  7–9 ,  had  produced  the  possibility  of  in-silico   
design  and  in-vivo  editing  for  entire  genome  engineering.  However,  algorithms  for   
genome  design  had  not  been  developed.   
  
During  this  PhD,  I:  created  an  analysis  process  for  the  M.genitalium  whole-cell  model;   
created  Minesweeper,  a  minimal  genome  design  algorithm;  produced   
Minesweeper_256,  an  in-silico  M.genitalium  minimal  genome;  tested  and  reintroduced   
genes  to  eight  minimal  gene  sets  from  the  literature  to  produce  dividing  in-silico   
M.genitalium  cells;  and  tested  1418  single  gene  knockouts,  for  two  generations  of  cells,   
in  the  E.coli  whole-cell  model.   
  
I  made  less  progress  towards  a  computational  minimal  genome  for  E.coli  than  I  hoped.   
We  received  access  to  the  whole-cell  model  in  March  2019  but  I  could  not  start   
working  with  it  until  July  due  to  being  in  the  process  of  completing  and  submitting  a   
paper.  The  implementation  on  the  University’s  supercomputer  proved  difficult,  even  with   
the  invaluable  help  of  the  Advanced  Computing  Research  Centre  at  Bristol,  simulations   
were  not  successfully  running  until  mid-December.  It  is  currently  still  not  at  the  stage   
where  Minesweeper  can  be  applied  (Section  6.4).     
  
More  time  is  required  to  produce  the  computational  predictions  from  which  large-scale   
reductions  of  an  E.coli  genome  could  be  generated.  I  identified  the  best  available  in-vivo   
techniques  to  use.  One  of  these  was  tested  by  undergraduate  students,  and  another  is   
in  the  process  of  being  implemented  by  a  Masters  by  Research  student.  Confidence  in   
these  techniques  being  fit  for  purpose  was  increased  by  the  production  of  E.coli  Syn61   





7.2 Future  Work   
Minesweeper  is  adaptable  to  future  whole-cell  models,  as  the  algorithm  interacts  with   
the  models  only  via  the  input  of  gene  deletion  lists  and  analysing  the  output.  With   
future,  multi-generational,  whole-cell  models  I  will  have  greater  confidence  that  the   
algorithm  has  produced  in-silico  genome  designs  that  will  be  viable  in-vivo .  This   
includes  the  E.coli  whole-cell  model  at  the  Covert  Lab,  Stanford  152   and  the   
Mycoplasma  pneumoniae  whole-cell  model  at  the  Karr  Lab,  Mount  Sinai,  New  York  156 .     
  
It  is  difficult  to  see  beyond  the  near-future  of  the  genome  design  field.  Gene  synthesis   
will  continue  to  fall  in  price  as  the  technology  improves  1  and  projects  like  GP  Write   
progress.  But  unless  it  does  so  drastically,  the  costs  for  genome-scale  synthesis  will   
likely  still  be  outside  the  capabilities  of  any  but  the  most  well  funded  institutes  (JCVI,   
Autodesk,  Microsoft,  BBN  technologies)  and  large,  international  collaborations   
(Synthetic  Yeast  2.0).  This  means  optimal  chassis  development  and  novel  microbial   
constructs  will  remain  theoretical  for  the  foreseeable  future,  at  least  for  the  majority  of   
researchers  (Section  1.3.2.d.1).     
  
In  regards  to  gene  editing,  CRISPR-cas9’s  capabilities  currently  exceed  requirements.   
More  still  needs  to  be  known  about  the  potential  off-target  edits  in  prokaryotes  and  the   
success  rates  for  conducting  larger  (tens  of  thousands  of  base  pair)  deletions,  but  it  is   
otherwise  fit  for  entire  genome  engineering  72,93 .  Both  the  Church  Lab  and  the  Chin  Lab   
are  capable  of  genome  recoding  entire  genomes  with  the  tools  available.     
  
Finally,  gene  sequencing,  through  MiniION  sequencing  (although  more  error  prone  than   
Illumina  sequencing),  can  be  conducted  at  a  low  enough  cost  that  any  genome  you   
want  to  sequence  you  feasibly  can.     
  
More  granularly,  the  current  available  whole-cell  models  are  likely  to  be  the  only  ones   
available  for  the  next  five  years  due  to  their  rate  of  development  150 .  The  Karr  Lab  is   
currently  developing  data  aggregation  tools  and  a  whole-cell  modelling  programming   
language  151 ,  necessary  steps  to  democratise  and  speed  up  the  production  of   
whole-cell  models  but  until  these  tools  are  functional  and  available,  new  models  are   
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unlikely  to  appear.  The  work  of  the  Covert  Lab  in  creating  the  second  whole-cell  model   
152   in  much  the  same  way  they  did  the  first  is  therefore  necessary  to  keep  the  whole-cell   
model  research  community  alive,  sustainable,  and  publishing.  Without  new  models  of   
one  or  more  cells  that  can  be  easily  manipulated  in  the  laboratory,  continued  interest  in   
the  field,  and  the  ability  for  the  field  to  compete  for  funding,  will  wither.  Concerted  effort   
needs  to  be  made  to  expand  the  whole-cell  modelling  community  to  include  new   
research  teams  who  use  rather  than  develop  the  models,  particularly  geneticists  and   
synthetic  biologists.     
  
Even  so,  there  is  a  chance  the  field  may  stagnate  after  any  immediate  research  gains   
from  the  E.coli  whole-cell  model.  Researchers  may  be  in  a  holding  pattern  outside  of  a   
few  established  groups  (JCVI  progressing  the  understanding  of  minimal  genomes,  the   
Church  Lab  and  the  Chin  Lab  progressing  the  development  of  genome  recoded   
strains,  whole-cell  model  development  continuing  at  the  Covert  Lab  and  Karr  Lab)  with   
the  need  for  greater  funding  to  edit  genomes  in-vivo ,  the  requirement  of  greater   
knowledge  to  aid  genome  design  in-silico ,  and  the  lack  of  new  tools  being  developed  in   
the  short-term.     
  
To  avoid  this,  a  new  branch  of  research  needs  to  be  found  for  whole-cell  models.  This   
could  be  something  as  simple  as  a  new  genome  design  problem.  There  is  plenty  of   
research  interest  in  designing  optimal  processes  for  a  cell,  especially  in  E.coli ,  which  is   
feasible  in  whole-cell  models.  However,  any  optimality  predictions  produced  will  be  tied   
to  an  even  greater  degree  to  the  accuracy  of  the  model  in-vivo ,  which  is  yet  to  be  
tested  (Section  4.5).   
  
Alternatively,  this  could  be  the  application  of  whole-cell  models  to  the  unification  of   
protocells  (Section  5.3.4).  Analysis  in  Chapter  5  underlined  the  cellular  components  that   
protocell  minimal  gene  sets  had  omitted,  which  were  required  to  produce  a  dividing   
in-silico  cell.  In  the  future,  when  individual  protocell  systems  are  being  introduced  
together  in  a  cell-like  environment,  these  omitted  functions  should  be  considered  for   
introduction  to  produce  desired,  integrated  behaviour.  An  in-development  whole-cell   
model  for  an  “archetypal  bacterium”  151 ,  that  can  represent  a  user-specified  number  of   
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genes,  has  the  potential  to  be  repurposed  by  the  protocell  community  for  modelling   
protocell  systems;  allowing  for  the  continued  search  for  omitted  functions  that  can  help   
glue  individual  systems  together.   
  
This  new  application  for  whole-cell  models  could  also  be  found  by  using  computational   
analysis  to  interrogate  existing  whole-cell  model  data  (Section  4.4.2),  finding  new   
minima  or  key  features  that  can  advance  genome  design.  New  applications  could  also   
be  found  by  developing  and  applying  new  algorithms  to  whole-cell  models,  including   
more  advanced  machine  learning  approaches.  However,  these  algorithms  will  have  to   
be  developed  by  interdisciplinary  teams,  to  be  able  to  both  understand  how  the   
algorithm  works  and  how  to  interpret  the  data  it  produces.  This  is  especially  true  if   
black  box  algorithms  are  used,  as  the  output  still  needs  to  be  connected  to  the  input  in   
an  understandable,  biological  narrative  to  give  confidence  in  the  results.  I  would  advise   
the  preservation  of  real-world  biological  units  (singular  genes  or  entire  genomes)  to   
make  this  easier.  Even  basic  tools,  like  principal  component  analysis*  (PCA),  that  violate   
this  rule  make  biological  interpretation  very  difficult.     
  
*  PCA  is  a  dimensionality  reduction  technique  that  attempts  to  represent  features  and   
patterns  of  large  data  sets  in  a  new  smaller  package,  creating  new  variables  by   
combining  and  reducing  the  original  data.  It  can  be  useful  for  finding  patterns,  but   
muddies  interpretation  to  the  point  of  making  inference  ill-advised  to  impossible  (new   
data  one  is  part  gene  x,  part  gene  y,  part  relationship  between  genes  a  and  c),  and   
always  requires  secondary  analysis.  I  dislike  PCA.  I  have  seen  it  used  regularly,  and   
incorrectly,  for  inference,  when  researchers  should  instead  spend  their  time  becoming   
intimately  familiar  with  their  datasets;  gaining  familiarity  narrows  the  jump  from  pattern   
recognition  to  new  understanding,  and  helps  catch  flaws  and  irregularities  in  datasets.      
  
Successfully  constructing  a  (likely  minimal)  genome  in-vivo ,  from  an  in-silico  design   
would  change  the  methodology  for  future  large-scale  cellular  research.  It  would  move   
the  field  onto  new  genome  design  goals,  increase  momentum  for  using  and  improving   
the  whole-cell  model  ecosystem,  and  could  integrate  with  laboratory  automation.   
Coupling  established  CRISPR-cas9  gene  editing  with  biological  programming   
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languages  (such  as  Antha)  and  laboratory  automation  tools,  directed  by  in-silico   
predictions,  could  revolutionise  design-build-test  cycles.   
  
7.3 Conclusions   
Whole-cell  modelling  had  a  vast  amount  of  research  potential  but  is  not  fully  ready  for   
use  by  the  broader  synthetic  biology  research  community.  The  continued  use  of  the   
M.genitalium  whole-cell  model  is  difficult  to  recommend,  due  to:  it  producing  only  single   
generations  of  cells,  it  not  being  solely  based  on  M.genitalium  data,  and  it  being   
incredibly  difficult  to  test  genome  engineering  scale  in-silico  predictions  in  the   
laboratory.  The  E.coli  whole-cell  model  should  be  adopted  for  research  purposes  but:  is   
currently  not  published,  only  contains  1214  genes  of  ~4000,  and  is  missing  a  number   
of  sub-models.  Additionally,  analysis  of  the  data  produced  by  both  models  is  difficult.   
This  is  due  to  the  need  to  apply  machine  learning  approaches  to  extract  key  information   
from  the  quantity  of  data  produced,  but  machine  learning  approaches  can  be   
confounded  by  the  complex  nature  of  the  data.   
  
Single  gene  knockout  studies  will  continue  to  incorrectly  estimate  minimal  genome  size,   
as  low  essential  genes  will  be  scored  as  non-essential  12,13,52   and  if  high  essential  genes   
are  present  they  will  be  scored  as  essential.  The  presence  of  low  essential  genes  in   
even  the  M.genitalium  in-silico  genome  (Section  4.4.7,  Table  18)  provides  further   
evidence  that  single  gene  knockout  classifications  are  unreliable  for  genome  
minimisation,  as  they  fail  to  take  into  account  genomic  context.  It  is  likely  low  essential   
genes  will  be  identified  in  the  E.coli  in-silico  genome.  These  results  reinforce  a  broader   
trend  of  moving  away  from  universal  minimal  genomes  81   to  species-specific  research   
(Sections  1.3.2.c,  1.3.5),  and  the  need  to  specifically  identify,  and  avoid  deleting,  low   
essential  genes  and  their  interactions.  Currently,  our  understanding  of  cellular  life  is  not     
adequate  to  design  novel  or  reduced  minimal  cells  without  further  information.   
  
Genome  engineering  using  in-silico  design  closely  combined  with  in-vivo  editing  would   
produce  quicker,  cheaper  and  more  predictable  laboratory  results  than  currently   
possible,  opening  up  genome  design  research  to  broader  and  more  interdisciplinary   
research  communities.  However,  the  cost  of  each  deletion  is  still  high  enough  to  make   
205   
  
the  production  of  minimal  genomes  out  of  the  scope  for  many  individual  PhD  students   
and  postdoctoral  researchers.     
  
As  stated  at  the  beginning  of  this  thesis,  tailoring  entire  genomes  to  produce   
custom-made  cells  is  now  on  the  horizon.  If  this  is  the  case,  E.coli  is  probably  the   
bacterial  species  it  will  happen  in  first.  Minesweeper  in  combination  with  the  E.coli   
whole-cell  model,  with  its  testing  over  multiple  generations  and  basis  in  species-specific   
data,  should  be  able  to  produce  in-silico  minimal  genomes  that  are  viable  in-vivo .  The   
creation  of  E.coli  Syn61  72   has  increased  the  research  community's  confidence  in   
successfully  conducting  large-scale  genetic  edits  using  CRISPR-cas9  based  methods.   
The  process  of  in-silico  design  and  in-vivo  editing  from  metabolic  engineering,  given   
some  more  development  time,  will  be  available  for  genome  engineering  in  E.coli .  This   
would  be  in-silico  design  and  in-vivo  editing  at  a  greater  scale  and  depth  (number  and   
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9.1 Formalising  Minesweeper  by  Analogy     
In  an  attempt  to  explain  the  stages  of  the  algorithm,  I  likened  it  to  the  game  of   
Minesweeper  176 ,  envisioning  removing  genes  from  the  in-silico  cell  to  see  if  it  causes   
cell  death  as  equivalent  to  pressing  tiles  to  potentially  reveal  a  mine.     
In  this  analogy,  the  first  stage  is  easy.  We  press  each  tile  one  by  one  (one  tile  equals  a   
single  gene).  If  a  tile  is  hiding  a  mine  (i.e.  gene  removal  kills  the  cell),  we  lock  that  tile   
and  prevent  it  from  being  pressed  again  (the  gene  is  no  longer  considered  for  deletion).     
  
The  second  stage  is  trickier  because  we  have  found  all  the  obvious  mines.  Some  tile   
presses  (gene  deletions)  only  trigger  mines  in  combination  with  another,  or  can  be   
primed  or  deactivated  by  another  tile  being  pressed  first  (an  associated  gene  being   
deleted  previously).  To  find  these  conditional  mines,  we  have  to  press  as  many  tiles  as   
we  can  without  setting  them  off,  and  note  when  we  do.  In  the  second  step,  we  press   
the  remaining  unlocked  tiles  (singly  non-essential  genes)  in  big  groups,  the  largest  being   
100%  of  the  unlocked  tiles,  the  smallest  being  12.5%.     
  
The  third  stage  takes  all  the  groups  of  tiles  that  did  not  contain  a  mine  (prevent  the   
in-silico  cell  from  dividing)  from  the  second  stage,  combines  them  in  all  possible   
non-overlapping  combinations,  and  tests  them  all.   
  
The  fourth  stage  takes  the  biggest  combination  of  tiles  that  did  not  set  off  a  conditional   
mine  (the  largest  group  of  gene  deletions),  and  locks  them  in.  The  remaining  unlocked   
tiles  (singly  non-essential  genes  that  are  yet  to  be  deleted)  are  divided  into  eight  groups.   
The  eight  groups  are  tested  individually  and  in  combination,  from  two  to  seven  of  the   
eight  groups,  in  addition  to  the  locked  tiles  (while  also  deleting  the  largest  group  of   
gene  deletions),  to  find  the  groups  that  do  contain  conditional  mines.  This  step  is   
repeated  as  we  find  lock  in  more  tiles  and  isolate  the  location  of  conditional  mines,  until   
we  cannot  press  any  more  tiles  without  setting  off  a  mine  (prevent  the  in-silico  cell  from   
dividing).   
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